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GENERAL INTRODUCTION 
Ever since the means to manipulate DNA was discovered 
approximately 15 years ago, it has been clear that the 
invention and application of recombinant DNA (rDNA) technology 
would have a wide variety of impacts on society. Indeed, over 
the last ten years, an entire biotechnology industry has 
arisen to explore the full economic potential that this 
relatively recent technological innovation may offer. 
With specific regard to the potential agricultural 
applications of rDNA biotechnology, many preliminary research 
efforts appear to hold considerable promise for the future 
(growth hormones, herbicide resistance, plant and animal 
disease resistance, reproduction enhancement, and many 
others). As a result, federal and state governments, in 
addition to a wide variety of private sector interests, have 
begun to invest heavily in research focussing upon genetic 
engineering and agricultural biotechnology. 
In 1988 for example, the federal government was spending 
approximately $2.7 billion annually for basic research in 
biotechnology (Lacy et al., 1988). While only $150 million of 
that money was earmarked specifically for the development of 
agricultural biotechnology, the National Research Council's 
Board on Agriculture recommended in 1988 that this level of 
funding be dramatically increased over a very short period of 
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time, to approximately $500 million annually by 1990 (Moses et 
al., 1988). 
State governments have also increased their funding of 
biotechnology research programs dramatically, and were 
spending a combined total of approximately $150 million 
annually on such projects by 1987 (U.S. Congress, 1986). And, 
in comparison to the funding expenditures of the federal 
government, state governments are spending a considerably 
greater portion of these funds on the development of 
agricultural biotechnologies. Primary examples of projects 
established with the assistance of these funds are New York 
State's Center for Biotechnology in Agriculture at Cornell 
University and Iowa's Biotechnology Council at Iowa State 
University (Lacy et al., 1988). The hoped-for result of such 
expenditures is most often the establishment of research and 
development centers linking industry to universities, with the 
anticipated result of such linkages being the enhancement of 
economic development in these areas. 
In addition to these research expenditures by federal and 
state governments, biotechnology industries have also invested 
heavily in university research. In 1984 for example, 
biotechnology companies awarded about $120 million in 
contracts and grants to universities (Lacy et al., 1988) As 
a result of these private investments, a variety of 
contractual linkages have also developed between these 
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companies and individual faculty, departments, and institutes. 
The transfer of biotechnological innovation from the 
laboratory to the marketplace has thus followed a clear and 
logical progression: technological breakthroughs have occurred 
as a result of basic research in universities; these 
technological innovations and breakthroughs spark business 
interest and investment; applied research and development 
occurs in order to create an investment payoff; products are 
created, marketed, and put to use. 
The players in this process are also clear: government 
and business, seeking economic development and private profit, 
respectively; the universities, which serve as tools to assist 
in the economic development process; and consumers (i.e., 
farmers), to whom the products are marketed. While the 
impacts/benefits of economic development for governments, and 
profits for businesses, are fairly evident, the impact of this 
overall process is less clear· in terms of the outcomes that 
may result for the universities involved in this research, and 
the farmers who will likely put these biotechnological 
products to use. 
It is therefore my intent to more closely examine the 
relationship of these two entities--universities and 
agricultural producers--with the ever-expanding program of 
agri-biotechnological research and development. 
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Review of Literature 
The University 
Over the last several decades, much attention has been 
focussed upon the changing nature of the modern university, 
particularly in terms of its purpose, role, and 
responsibilities in today's research-hungry, business-oriented 
social world. Some have argued for a 'pristine' model of 
university operation, wherein the creation of knowledge is a 
process which remains unpolluted by the influences of the 
external world. Proponents of such a model argue that these 
external influences may serve to alter the nature or character 
of new knowledge, and aiso impinge upon academic freedom. 
Others, however, view the university in a more utilitarian 
light, stressing that the knowledge created by universities 
must not only build in some way upon past knowledge or 
achievements to create a general advancement in the cumulative 
body of knowledge in a given field, but also ·be of 
substantial, practical use in ,the 'real world.' 
Another debate regarding the operation of the nation's 
universities regards their financial ability to maintain 
adequate efforts at the creation (through research) and 
impartation (through instruction) of knowledge. With federal 
funding of many academic institutions severely restricted in 
the budget-tightenings of the 1980s and early 1990s, the 
procurement of research funding has become paramount to many 
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universities around the nation. As a result, with revenues 
declining and operating costs increasing, many universities 
have been forced to 'hire-out' their research abilities to 
private industries or governmental agencies in order to 
maintain operation at levels comparable to those achieved when 
federal funds were in ample supply. 
Growing numbers of analysts are therefore coming to 
recognize some of the more negative aspects that may accompany 
the increasing influence of private funding for public 
universities. Leslie Roberts (1983) states; 
In the face of declining federal support, universities 
need money for research and instruments. For industry, 
such agreements mean access to the scientific expertise 
that is still centered in the universities and rights to 
any patentable discoveries. And both sides espouse the 
societal good arising from rapid technology transfer. 
There is less agreement, however, on how serious a threat 
corporate funds pose to the integrity of the university, 
(p. 159). 
Charles Caldart (1983) stresses four fundamental 
implications that the trend towards industry investment in 
university research may have: 1) such investments may have a 
negative impact on institutional autonomy, due to an over-
reliance on private funds for institutional survival; 2) 
problems may arise in that the nature and direction of 
research may come to be based more upon corporate need than 
academic merit; 3) access to the results of university 
research may become restricted, due to competitive needs of 
private sector investors; and, 4) long-term university 
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policies may become altered in the effort to accommodate 
corporate or other economic interests, and thus 
institutionalize a heightening acquiescence to the needs of 
private investors. 
Lacy et al. (1988) also express concerns regarding the 
impacts that may result from the heightened drive towards 
private research investments for universities, but addresses 
these concerns with a specific eye towards the impact of 
biotechnology investments. Several impacts are discussed: 
1) industrial interests and research administrators may 
increase pressure for public sector scientists to abandon 
varietal breeding and applied research for molecular biology 
and biotechnology research; 
2) in addition to traditional animal and plant breeding, other 
important disciplinary and methodological perspectives may be 
neglected due to an over-concentration on biotechnology and 
molecular biology; 
3) due to the highly specialized nature of biotechnology 
research, research funds and scientific talent may become 
over-concentrated at the small number of colleges and 
universities capable of carrying out such research; 
4) long-term research projects may be greatly reduced due to 
the short-term, profit-oriented emphasis of private investors; 
5) communications may be restricted regarding research 
findings; 
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6) releases of technology may become much more exclusive, via 
patent rights or restricted licensing procedures; 
7) the likelihood of conflicts of interest or scientific 
misconduct will increase, due to the growing clash between 
public and private occupational demands; 
8) changes may arise in the general orientation of, and 
clientele benefitted by, public research (away from farmers 
and farm cooperatives to larger pharmaceutical, agrichemical, 
and food processing corporations), and; 
9) the benefits of biotechnology may become increasingly 
concentrated in the agribusiness sector, resulting in a 
continuation of the 'industrialization' of agriculture (p. 
10) . 
Another factor of specific relevance to the increase in 
biotechnology research is that this new industry is in a very 
tenuous state. Over three-quarters of biotechnology firms 
continue to lose money, and, in 1988, at least 24 
biotechnology companies filed for bankruptcy- and five of 
these were publicly supported (Lacy et al., 1988). Reflecting 
this uncertainty was a 1989 poll (Kumar, 1989) showing that a 
majority of executives in biotechnology companies believe that 
within ten years, roughly half of the nearly 500 biotechnology 
companies in the United States will fail, merge, or form 
cost-sharing alliances. Over-reliance upon the funds of 
individual corporations may thus present serious financial 
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dangers to those departments reliant upon them. 
It is also worth noting that the impacts of this 
increased level of research and investment in biotechnology 
have not been restricted to the research laboratories of the 
beneficiary universities. Curriculum offerings are being 
altered, both to accommodate the needs of the burgeoning 
biotechnology industries (by providing them with trained 
personnel), as well as to serve as a vent through which the 
expertise of the growing number of university biotechnologists 
may find curricular release. Each year, growing numbers of 
universities, colleges, and institutes have incorporated 
courses in biotechnology into their curricular offerings, and 
have established undergraduate majors in biotechnological 
fields (Amatniek, 1983). 
In essence then, factors such as these have served to 
alter the makeup of the modern university by placing a heavier 
emphasis upon research-oriented activities than may have been 
present in the past. A fundamental question thus becomes, 
'will this alteration in operational emphasis in turn alter 
the ability of the university to perform the functions it was 
originally intended to perform?' In order to answer this 
question, it is useful to examine a specific case in which 
such a research-oriented shift has taken place. 
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Biotechnology at Iowa State University 
As has been previously discussed, universities around the 
nation have become increasingly involved in research efforts 
geared towards the development of biotechnological innovations 
and applications. As has also been discussed, the university 
system in the State of Iowa is no exception to this trend, and 
substantial amounts of money have been invested towards 
utilizing rDNA biotechnology to assist in the development and 
well-being of that state's agriculturally-oriented econorry. 
This course of action began in 1985, when the Iowa 
Development Commission, at the behest of the Seventy-first 
Iowa General Assembly, allocated the sum of $10 million to the 
State's Board of Regents, public universities, and/or 
independent colleges (Laws of the Seventy-first General 
Assembly, 1986 session: 295-296). This money was to be used 
in an effort to explore the potential for biotechnological 
industries, and their products, to assist in the recovery of 
Iowa's ailing rural economy. After initial investments began 
to show promise, additional biotech monies were appropriated 
to the State's universities to further develop their growing 
proficiency in the field. As a result, biotechnology has now 
become an area of research expertise in many academic 
departments at the State's universities. 
A primary participant in this effort has been Iowa State 
University, a land-grant institution with an enrollment of 
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approximately 25,000 students. In fiscal year 1985, the Iowa 
General Assembly allocated $500,000 to Iowa State University 
for the purpose of agricultural biotechnology research. 
Additional appropriations were to follow, with the allocation 
of $3.75 million in 1986, and $4.25 million each for fiscal 
years 1987, 1988, and 1989 (Laws of the Seventy-first General 
Assembly, 1986 session). Projects resulting from these 
appropriations have included the development of new 
biodegradable plastics, technologies for using cholesterol 
reductase to produce animal products with lower cholesterol 
content, and molecular and genetic techniques for the 
isolation of maize genes to control crop yields (Worthy, 
1989). 
As has been previously stated, the fundamental goal of 
many biotechnology research efforts-rand many private and 
public research efforts in general--is economic development. 
Iowa State's program is no exception to this trend, with the 
explicitly-stated purpose of the General Assembly's allocation 
being the enhancement of economic development and research and 
development. This goal has remained intact throughout the 
implementation of the program, as evidenced by the remarks of 
the chairman of the oversight committee of the Iowa State 
Biotechnology Council, Walter Fehr: 
With regard to the vision for biotechnology at Iowa State 
University, our ultimate goal is to use the new 
techniques of molecular biology to enhance the economic 
welfare of the state. We believe that this will occur 
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through research in three primary areas: (1) the 
development of new products from our traditional 
commodities through bioprocessing; (2) improving the 
efficiency and profitability of crop and livestock 
production; and (3) development of new products and 
processes through the genetic modification of plants, 
animals, and microorganisms. The vision of Iowa State 
University's biotechnology program is strongly influenced 
by the desire to fully utilize the agricultural resources 
of the state for the welfare of its constituents. (Fehr, 
1987). 
In order to bolster the effectiveness of this 
research-centric approach to economic development, technology 
transfer networks have been put in place at I.S.U., in order 
to enhance the speed and accessibility with which innovations 
may be transferred from university laboratories to local 
industries desirous of the new biotechnological advancements 
(e.g., the Eastman Kodak fermentation plant in Cedar Rapids, 
the Cargill biotechnology facility in Eddyville, and the 
Ajinomoto Heartland Lysine feed-additive plant, also located 
in Eddyville--Worthy, 1989). 
State policy makers appear content with the results-to-
date of this biotechnology-grounded economic development plan 
(and Iowa State University's role in it). Iowa's General 
Assembly has extended appropriations for the operation of the 
Biotechnology Council, and for the entire program of 
biotechnology research, beyond the initial three-year 
implementation period (FY 1986/87-88/89). And, in assessing 
the general effectiveness of the project, Iowa's governor, 
Terry E. Branstad, states: 
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Iowa is turning biotech breakthroughs into business 
success stories. Partnerships between private industry 
and Iowa's two world-class research universities are 
resulting in innovative products and economic progress. 
(Worthy, 1989) . 
The university system in Iowa thus appears to have been 
an effective tool for economic development in that state, and 
shall likely continue this function for the foreseeable 
future. Iowa's effort to stimulate economic development 
through the funding of university-based research thereby 
serves as a model by which other states may attempt to 
undertake their own research-oriented programs of economic 
development (biotech or otherwise) in the future. And, within 
this model, the utilization of Iowa State University serves as 
a case-study by which to examine the impact of such a program 
upon a participant university, or other institution, involved 
in the research and development process. 
Farmers and the Rural Concern 
Another set of questions arises regarding the impact 
biotechnology research will have on those for whom its 
products are targeted--farmers and others involved in the 
agricultural production industry. Concerns regarding the 
impact of rDNA technology on agricultural producers focus on 
several key issues. 
One major concern involves the general potential of 
biotechnology to heighten the productivity and efficiency of 
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plant and animal production and utilization. Several 
varieties of production enhancement are possible through the 
application of rDNA technology; 
1) the heightening of plants' and animals' capacity to create 
useable goods (e.g., the enhancement of milk production 
through Bovine Somatotropin, or bST--Hansel, 1986; OTA, 1986); 
2) the heightening of producers' ability to produce more 
product per plant or animal (e.g., the enhancement of growth 
rates and capacities through the use of porcine Somatotropin, 
or pST--Kliebenstein, 1989); 
3) the improvement of plant and animal health using rDNA-
inspired advances in disease control and disease resistance 
(biotechnological techniques have produced promising vaccines 
related to the control of pseudorabies, hoof and mouth 
disease. Rift Valley fever, trichinosis, mastitis, and a 
variety of other viruses and disease-producing organisms--
CAST, 1986); 
4) the alteration of agricultural products themselves (e.g., 
decreased fat or cholesterol content, taste enhancement or 
alteration, etc.--Kuchler, et.al., 1989); 
5) the alteration of the reproductive capacities of 
plants/animals (Seidel, 1989), and; 
6) the potential to decrease the cost of plant and animal 
production by obtaining higher rates of product output for 
lower levels of input (e.g., nitrogen fixing, improved feed 
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conversion efficiency, etc.--Kliebenstein, 1989; CAST, 1986; 
Riepe, 1989). 
The most problematic of the impacts identified with these 
likely applications of agricultural biotechnology is the 
potential for overproduction. Alper (1987) states; 
Bovine growth hormone, which is slated to come on the 
market in 1988, should increase milk production by about 
30%. Yet dairy farmers are already plagued with surplus 
milk. So most farmers see little need for a product that 
will result in further surpluses, (p. 60) . 
Thus, to economic sectors in which supply is short and 
demand is strong, such production-enhancing technologies would 
be highly welcome and beneficial to producers as well as 
consumers. However, when supply is strong and demand is 
static, the productive enhancement may indeed be of a 
detrimental nature. The dangers of overproduction are also 
raised by Pimentel, 1989; Kvistgaard, 1986; Mix, 1987; Kalter, 
1985; Kliebenstein, 1989; Hayenga, 1988; and CAST, 1986, among 
others. 
More specific concerns have been raised with regard to 
the effect of biotechnological production practices on small 
farms and the rural way of life. Patrick Madden and Paul 
Thompson illustrate the manner by which farmers may be acting 
to their own economic detriment through the widespread 
adoption of biotechnological means of production enhancement; 
...dislocation associated with new technology may be 
associated not with the scale or type of technology, but 
with the rapidity with which a farmer is able to adopt 
it. Early adopters reap profits, but as many adopt and 
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prices go down, adoption becomes a necessity in order to 
remain competitive, and many who cannot afford to adopt 
the technology are forced out of farming... If this 
picture is correct, farmers themselves may be the agents 
with greatest causal responsibility for changing farm 
structure, (p. 103-104). 
DuPuis and Geisler (1988) further summarize that, as a 
result of such technologies, 
...large farms would adopt the technique first, reaping 
innovators' benefits. And smaller farms would be left to 
make ends meet in an environment of lower milk prices and 
more expensive dairy technologies. Some of the small 
farms would be expected to go out of business, (p. 408). 
Kalter (1985), similarly observes the potential for an 
eventual elimination of low-yield dairy farms from the 
productive environment, and discusses, "...the necessity to 
design policy to encourage the orderly exodus of resources, 
including farmers, from dairying." 
Gary Comstock (1988) therefore concludes that. 
To the extent that potentially displaced dairy farmers 
have done nothing for which they ought to be punished; to 
the extent that the research establishment has clearly 
favored large producers in its development of techniques 
and technologies; to the extent that fiscal, monetary and 
economic policies have disadvantaged small dairy 
producers; and to the extent that bGH will only 
exacerbate the unjust consequences of the past; to that 
extent we ought to oppose this particular biotechnology, 
(p. 49). 
Considerable attention has also been devoted to this 
issue by Alper (1987); Pimentel et al. (1989); Fox (undated); 
Buttel (1988); and many others. 
Kliebenstein (1989) also tends to examine the issue of 
affected subgroup populations in terms of the differential 
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impacts that biotechnology utilization may have on the various 
segments of the agricultural industry. For example, it is 
stressed that, through a combination of price reduction from 
increased production, and product improvement through the 
lowering of fat and cholesterol content, pork producers may 
come to recapture the health-conscious and price-wary 
consumers that currently purchase poultry or fish products 
(with the result being a negative impact on the poultry and 
fish producers). It is also pointed out that biotechnological 
products may result in uneven impacts upon feed producers, for 
example,'through heightening the demand for high-protein feeds 
such as soybeans, and decreasing the demand for traditional 
feeds such as corn. 
Alper (1987) therefore summarizes that: 
Although pig farmers will benefit, grain farmers will be 
hurt, as PGH-treated pigs will consume less grain. And 
if consumers eat more pork, they will buy less beef, 
chicken and other meats, thereby hurting producers of 
these commodities, (p. 60). 
Another subgroup of concern is nonfarm rural populations. 
Frederick Buttel (1988) devotes considerable attention to this 
issue, and states that: 
A final neglected issue related to biotechnology and 
rural people concerns the virtual lack of attention to 
how biotechnologies will affect nonfarm rural people and 
rural regions... There seems... to be little likelihood 
that rural America will benefit directly from industrial 
bioprocessing in this 'hand-me-down' fashion, (p. 4). 
Another area of concern is the impact that genetically 
altered products may have upon consumer health, and of 
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potential consumer reactions to products created through the 
utilization of recombinant DNA technologies. Buttel (1988) 
states, 
...the matter of 'public reactions to biotechnology' 
particularly concerning whether 'the public,' or the more 
articulate and influential segments thereof, will become 
mobilized to create a 'climate' unconducive to testing 
and commercializing new agricultural biotechnology 
products--has recently become a major preoccupation, (p. 
4) . 
Halbrendt et al. (undated) examined consumer attitudes 
towards pork produced with pST, and found that, although there 
is a high degree of concern regarding the use of genetically 
engineered products, pST use is acceptable under certain 
conditions (such as reducing production costs, producing 
leaner or higher quality meat products, etc.). Approximately 
half of the respondents in his study indicated they would not 
change their consumption of pork due to the use of pST. 
Others project that consumers might even come to prefer 
products made with the assistance of biotechnology. Alper 
(1987) states; 
Growth hormones like PGH also provide an attractive 
replacement for the steroid hormones and subtherapeutic 
doses of antibiotics now used in animal feed. Those 
growth promoters are less effective and more costly than 
growth hormone, and they have generated consumer concern 
about trace amounts of the promoters in meat. (p. 60). 
Another concern related to agricultural biotechnology is 
the potential for environmental or ecological harm that may 
result from the introduction of biologically altered organisms 
into the environment. For example, Fox (undated) states: 
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Farmers have been using dangerous pesticides for decades, 
many of which are so harmful that they have been banned 
for use in the countries of origin. Soon they will be 
using patented, genetically engineered bacteria, the so-
called 'new generation of bacterial pesticides.' 
Agribusiness has been reticent to acknowledge that 
pesticides are a health hazard, devastate wildlife 
populations and threaten all terrestrial and aquatic 
ecosystems worldwide. We now have pesticide-laden rain 
and fog, drinking water, and mother's milk. The entire 
food-chain of life has been contaminated. There could be 
equivalent profound environmental consequences following 
the release of genetically-altered microorganisms. (Fox, 
undated, p. 4). 
Buttel (1988) also raises the possibility of secondary or 
tertiary negative environmental impacts that may result from 
the application of biotechnology: 
A case could be made... that the chief impacts of 
biotechnology on the agricultural environment may have 
little to do with the genetic engineering and ultimate 
'release' of agriculturally-related organisms. Instead, 
the greatest environmental implications of biotechnology 
will likely relate to the potential of a massive shift 
from fossil hydrocarbons and oxychemicals to plant-
derived feedstocks in the production of chemicals and 
other substances two to three decades from now... • 
biotechnology production could place profound demands on 
rural ecosystems by dictating increased intensification 
of primary production and causing more marginal lands to 
be brought under cultivation to provide the necessary 
feedstocks, (p. 4). 
Kvistgaard (1986) , Hayenga (1989) , Comstock (1988), and 
many others devote considerable attention to the environmental 
risks posed by the utilization of biotechnological methods of 
production enhancement and alteration. 
Thus, it is clear that farmers, as well as participating 
research universities, face a myriad of questions as a result 
of the growing ag biotech industry. It is therefore my intent 
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to examine the impact of the growing biotechnology research 
enterprise both upon the universities involved in this 
research, as well as the farmers toward whom its products are 
targeted. I propose to undertake this examination in the 
manner described below. 
An Explanation of the Dissertation Organization 
In light of the diverse nature of the concerns provoked 
by the growing biotechnology research effort, this 
dissertation is organized into four separate analyses. The 
first paper, "Economic Development Funding and the Public 
University; The Changing Nature of University Personnel and 
Their Research," has both a quantitative and qualitative 
component. In quantitative terms, the impacts of the push 
towards biotechnology research are evidenced by the shifts 
that have occurred in 'full time equivalency' (PTE) job 
categorizations within the individual departments of the 
university. Comprehensive listings of these PTE 
categorizations were obtained for the period from fiscal year 
1983/1984 to 1990/1991, and were obtained with the cooperation 
of Iowa State University's Office of Institutional Research, 
Affirmative Action Office, and Provost's Office. 
The qualitative component of the paper consists of input 
received from Departmental Executive Officers (DEOs), as well 
as from interviews with the biotechnology faculty hired at 
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Iowa State University since 1986/87. These interviews took 
place between March and May of 1991, and questions covered a 
wide range of topics (the nature of their research, how 
biotechnology research has altered their departments, the 
effectiveness of the biotech program at I.S.U., possible 
environmental impacts of the products that result from their 
research, farm production, animal welfare, and the status of 
biotechnology in general). The quantitative shifts revealed 
by the statistical analyses are thus translated into 
qualitative terms, through the input of DEOs and the 
researchers themselves. 
The second paper, "Economic Development Funding and the 
Public University: The Changing Fiscal Structure of Academia," 
deals with another important aspect of the biotechnology 
research program--the question of what differential impact- if 
any- the large infusions of biotechnology research monies have 
had upon the departments of the university. Data for this 
determination consists of comprehensive records of all 
research expenditures (grouped according to monies 
appropriated from General University Research, the 
Agricultural Experiment Station, and Contracts and Grants) for 
the period beginning fiscal year 1983/1984, and ending fiscal 
year 1989/1990. Thus, for purposes of comparison, the first 
two years (1983/1984-1984/1985) of this period reflect a time 
in which no biotechnology funding was received by the 
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university, and the last five (1985/1986-1989/1990) reflect a 
period of heavy biotechnology funding, as the research effort 
began its implementation. This information was gathered with 
the cooperation with Iowa State's Office of the Associate 
Provost for Research. 
As was also the case with the first paper, some 
information from the interviews with DEOs and the biotech 
researchers is utilized to describe the qualitative impacts of 
the budget changes that have accompanied the implementation of 
the biotech program at I.S.U. 
The third paper in the dissertation, "Economic 
Development Funding and the Public University: The Case of 
Biotechnology at Iowa State University," constitutes a summary 
review of both the budgetary and personnel data described 
above, and contains an overall assessment of the structural 
impact of the I.S.U. biotechnology research and development 
project. Methods, analyses, etc. are the same as those 
described in the first and second papers, but simply put into 
a combined format to examine the comprehensive impact of the 
biotech program. 
While it is clear that the first through third papers 
examine the direct structural impacts of the biotechnology 
research program on Iowa State University, the fourth paper 
serves to expand upon this analysis, by examining the broader 
social environment in which these developments have occurred. 
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This paper, "Economic Development and the Farm Economy : The 
Impact of Biotechnology," therefore focuses not upon the point 
of origin for biotechnology research (Iowa State University), 
but rather upon the market towards which the products of this 
research shall eventually be targeted- farmers. 
As was previously stated, the advent of recombinant DNA 
in the mid 1970s led to considerable optimism regarding the 
potential application of this new technology to agricultural 
production. This strong desire for positive outcomes from 
biotechnology research was well reflected in the 1987 Iowa 
Farm Poll, which showed farmers expressing high hopes 
regarding the potentials of agricultural biotechnology on a 
wide range of subjects. 
However, as farmers have continued to gain knowledge of, 
and experience with, both the pace of research and the 
applications that have occurred to date, questions have arisen 
as to whether the hopes expressed five years ago have been 
fulfilled by the biotechnology development project. In order 
to answer these questions, many of the same questions 
regarding farmers' opinions of biotechnology that were asked 
in the 1987 survey were repeated on the 1991 Iowa Farm Poll. 
An assessment of how well biotechnology has met the 
expectations of the Iowa farmers it was intended to help thus 
becomes possible. 
The dissertation concludes with an overall assessment of 
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the biotechnology research project at Iowa State University, 
by drawing upon conclusions and findings from all four of the 
papers just discussed. References and literature cited in the 
introduction, literature review, and overall assessment shall 
follow this general summary. 
In essence, then, this study seeks to examine the impacts 
of technological research from its beginning to ending points. 
At the beginning point, it is evident that universities will 
be increasingly forced to determine which factor will hold the 
most sway in determining university policies--academic 
freedom, or private control of the nature and usage of 
research and its results. And, if a primary purpose of the 
university is to impart the knowledge it creates, at what 
point does the emphasis upon research impinge upon the ability 
to convey that knowledge, both in terms of numbers of 
personnel allocated to perform that function (as manifested by 
shifts in the occupational make-ups of departments), as well 
as in terms of the qualifications or abilities displayed by 
such personnel to carry out this function effectively (as 
gauged by the degree to which faculty expertise is specialized 
in one narrow field)? 
At the end point of the research process, many cursory 
investigations into the potential impacts of agricultural 
biotechnology on the farming sector have taken place, and 
touched on a wide variety of economic, social, environmental. 
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and ethical concerns. However, the results of these various 
analyses remain somewhat unclear: some purport that 
biotechnological advances in plant and animal production will 
result in a nearly universal benefit to farm producers, while 
others see a tremendous potential for harm in the utilization 
of such technologies. In light of such confusing and 
conflicting claims, it would seem that those who stand to 
benefit or lose the most--the farmers themselves--should be 
the ones who could most accurately assess these impacts to 
date,and project about likely outcomes in the future. 
It is thus the intent in this dissertation to achieve a 
more comprehensive view of the structural and social impacts 
of the State of Iowa's program of biotechnology research and 
development. We have, for the most part, already received the 
assessments of governments and businesses regarding the 
economic implications of the program. However, as has been 
stated, the implications for others involved in the 
development process have not yet been fully explored. By 
examining the impacts both on those doing the research, and 
those consuming the products of the research, a more accurate 
assessment of the true and complete social impacts of 
agricultural biotechnology will hopefully be achieved. 
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PAPER 1. ECONOMIC DEVELOPMENT FUNDING AND THE PUBLIC 
UNIVERSITY; THE CHANGING NATURE OF UNIVERSITY PERSONNEL AND 
THEIR RESEARCH 
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Economic Development Funding and the Public University: 
The Changing Nature of University Personnel and Their Research 
by 
William J. Kinney 
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INTRODUCTION 
Academic institutions have traditionally been charged 
with two basic instructional functions in our society; the 
provision of quality education, and the provision of adequate 
access to quality education. However, recent restrictions on 
both federal and state funding for universities may severely 
hamper their ability to continue adequately performing these 
functions. A recent issue of the Chronicle of Higher 
Education states; 
Many academic leaders perceive that, even after the 
economy improves, their institutions will confront a 
major challenge involving tradeoffs between student 
access and academic quality. At least one of those 
traditional goals is likely to suffer, officials say, 
because neither state appropriations nor tuition rates 
will grow enough to finance them both as substantially as 
in the past. (Jacobson, 1991, p. 1). 
It is proposed that these problematic 'tradeoffs' may 
take a wide variety of forms, including enrollment caps, cuts 
in faculty, larger class sizes, fewer course offerings, 
tuition increases, cuts in student services, and others 
(Jacobson, 1991). In essence, due to the current fiscal 
situation around the country, colleges and universities must 
be prepared to either limit their current accessibility to 
students, or risk decreasing the quality of instruction that 
is offered to them. 
Apart from instruction, another important function of our 
institutions of higher education is the creation of knowledge 
through research. Research activities benefit academia in a 
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variety of ways. One fundamental benefit is that faculty 
involved in research supposedly enhance instructional quality 
by being 'current in their fields,' and in touch with the more 
practical applications of a given discipline. However, there 
is concern that research productivity may occur at the expense 
of instructional quality, in that time spent on research or 
publication efforts must necessarily detract from 
instructional activities such as course preparation. 
Research is also becoming an increasingly important 
determinant of professional advancement for university 
faculty. Shao (1991) states; 
In recent years, hiring and tenure decisions have come to 
be based largely on a professor's ability to generate 
world-class research. The most important criteria in. 
tenure decisions remain a professor's publications record 
and reference letters, mostly from other researchers... 
If you're a mediocre researcher but an excellent teacher, 
you're unlikely to get tenure, (p. 126) . 
Faculty thus receive a clear professional--and fiscal--
benefit through the pursuit of an active research agenda. 
Another important aspect of research activity is that it 
often provides departments with demand-driven funding sources. 
In many ways, the research capacity of an academic institution 
is a valuable asset, in that it offers a specialized ability 
to government or industry that may be too expensive or 
difficult to develop independently. A research contract thus 
represents an investment by governments or industries in a 
university, since they are paying for a service, and expect an 
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eventual profit or benefit in return for that payment. 
So, while instruction and research are both important 
functions of the university, it appears that instructional 
activities are in many ways bearing the brunt of the current 
financial difficulties facing so many universities. With 
opposition to tax and tuition increases at a peak and the 
economy in a state of uncertainty, the long-term benefits of 
instructional spending simply appear to have been placed at a 
low level of priority. Consequently, university 
administrators are anxious to increase the intake of 'self-
financing' research dollars to assist in the maintenance of 
existing operational levels. And, with teaching being a far 
less important determinant of professional success than 
research, many faculty appear compliant in the face of this 
trend. 
Rule (1988) underscores the benefit that the growing 
trend towards self-financing may hold for academia; 
Since the 1970s, American higher education as a whole has 
been experiencing a recession, if not a depression. The 
often indiscriminate expansion of the 1960s quickly gave 
way to a period where student populations were falling 
and where government support for research was cut, but 
where operating expenses rose sharply. Under these 
circumstances, the idea of making university functions 
self-financing has taken on a special appeal, (p. 433). 
As a result, Shulman (1987) concludes that, "...leading 
universities are turning more and more to corporate support as 
federal funding decreases." (p. 11). 
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However, not all forms of 'self-financed' research come 
from private corporations. While general research and 
development funds from the federal government have been cut 
substantially, 'earmarked' funds continue to flow. Earmarked 
research awards are made without a competitive review of the 
merit's of a specific research program or project. Earmarked 
research appropriations to colleges and universities have 
increased dramatically over the last four years, from only 
$225 million in FY 1988 to more than $684 million in FY 1992 
(Cordes et al., 1992). 
Critics accuse earmarking of being 'pork barrel science,' 
and claim that its dramatic increase over the last four years 
is linked to both budgetary problems on campus, and a 
desperate attempt to spur economic recovery: 
...the scope of the practice (earmarking)--and the link 
between many of the projects and economic development--
reflects a severe financial squeeze on higher education 
and Congressional concerns about the faltering economy. 
(Cordes et al., 1992, p. 1). 
Earmarking may thus represent a congressional attempt to 
'kill two birds with one stone,' by awarding non-competitive 
research monies to financially-strapped universities, while 
channeling research awards into economic development projects. 
State governments have also turned towards investing in 
university research--particularly technological research--to 
inspire economic development. Blumenstyk (1992) states that. 
By the end of the decade (the 1980s), nearly every state 
had created at least one program that provided grants to 
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universities for research with commercial potential... 
In the 1980's, states sort of discovered technology... 
(p. 1). 
So, while federal and state appropriations for 
instructional uses remain largely restricted due to concern 
over tax and tuition rates, the hope of quick economic payoffs 
has kept public funds for research (especially technological 
research) in ample supply. With revenues declining and 
operating costs increasing, many universities have therefore 
been forced to 'hire-out' their research abilities to private 
industries or governmental agencies in order to maintain 
present levels of operation. However, while such arrangements 
may be effective at maintaining a given level of operation for 
financially-strapped universities and departments, uncertainty 
exists as to what impact they will have on the style of 
operation for these entities. It is the intent of this paper 
to examine this issue. 
Biotechnology: A Growing Research Emphasis 
A prime example of the manner in which the trend towards 
research enhancement may impact upon the structure and 
operation of universities is evident in the effort to develop 
practical applications for agricultural biotechnology. Due to 
the promising nature of many preliminary efforts utilizing 
recombinant DNA technologies (growth hormones, herbicide 
resistance, disease resistance, reproduction enhancement, and 
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many others), federal and state governments, as well as a 
variety of private sector interests, have begun to invest 
heavily in research focussing upon genetic engineering and 
agricultural biotechnology. In 1988, for example, the federal 
government was spending approximately $2.7 billion dollars 
annually for basic research in biotechnology (Lacy et al., 
1988). While only $150 million of that money was earmarked 
specifically for the development of agricultural 
biotechnology, the National Research Council's Board on 
Agriculture recommended in 1988 that this level of funding be 
dramatically increased over a very short period of time, to 
approximately $500 million annually by 1990 (Moses et al., 
1988) . 
State governments have also increased their funding of 
biotechnology research programs dramatically, and were 
spending a combined total of approximately $150 million 
annually on such projects by 1987 (OTA, 1986). And, in 
comparison to the funding expenditures of the federal 
government, state governments are spending a considerably 
greater portion of these funds on the development of 
agricultural biotechnologies. Prime examples of projects 
established with these funds are New York State's Center for 
Biotechnology in Agriculture at Cornell University and Iowa's 
Biotechnology Council at Iowa State University (Lacy et al., 
1988). The hoped-for result of such expenditures is most 
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often the establishment of research and development centers 
linking industry to universities. The anticipated result of 
such linkages is the enhancement of economic development. 
In addition to research expenditures by federal and state 
governments, biotechnology industries have also invested 
heavily in university research. In 1984 for example, 
biotechnology companies awarded about $120 million in 
contracts and grants to universities (Lacy et al., 1988). As 
a result of these private investments, a variety of 
contractual linkages have also developed between these 
companies and individual faculty, departments, and institutes. 
The Biotechnology Research Effort at Iowa State University 
The state-supported push for biotechnology research in 
Iowa's university system was begun in 1985, when the Iowa 
Development Commission, at the behest of the Seventy-first 
Iowa General Assembly, allocated the sum of $10 million to the 
state's public Board of Regents, public universities, and/or 
independent colleges. These funds were supplied by revenues 
drawn from the State's lottery program. In fiscal year 1985, 
the Iowa General Assembly allocated $500,000 to Iowa State 
University for the purpose of agricultural biotechnology 
research. Additional appropriations were to follow, with the 
allocation of $3.75 million in 1986, and $4.25 million each 
for fiscal years 1987, 1988, and 1989 (for a total of $17 
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million in the first three years of the program- Shelley et 
al., 1990). 
Research projects and products resulting from these 
appropriations have included the development of new 
biodegradable plastics, technologies for using cholesterol 
reductase to produce animal products with lower cholesterol 
content, and molecular and genetic techniques for the 
isolation of maize genes to control crop yields (among many 
others- Worthy, 1989). 
As has been previously stated, the fundamental goal of 
many biotechnology research efforts--and many private and 
public research efforts in general--is economic development. 
Iowa State's program is no exception to this trend, with the 
explicitly-stated purpose of the General Assembly's allocation 
being the enhancement of economic development. That goal has 
remained intact throughout the implementation of the program, 
as evidenced by the remarks of Walter Fehr, Chairman of the 
Oversight Committee of the Iowa State Biotechnology Council: 
With regard to the vision for biotechnology at Iowa State 
University, our ultimate goal is to use the new 
techniques of molecular biology to enhance the economic 
welfare of the state. We believe that this will occur 
through research in three primary areas; (1) the 
development of new products from our traditional 
commodities through bioprocessing; (2) improving the 
efficiency and profitability of crop and livestock 
production; and (3) development of new products and 
processes through the genetic modification of plants, 
animals, and microorganisms. The vision of Iowa State 
University's biotechnology program is strongly influenced 
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by the desire to fully utilize the agricultural resources 
of the state for the welfare of its. constituents. (Fehr, 
1987). 
In order to bolster the effectiveness of this 
research-centric approach to economic development, technology 
transfer networks have also been put in place at I.S.U. These 
networks are designed to enhance the speed and accessibility 
with which innovations may be transferred from the lab to 
local industries desirous of the new biotechnological 
advancements (e.g., the Eastman Kodak fermentation plant in 
Cedar Rapids, the Cargill biotechnology facility in Eddyville, 
and the Ajinomoto Heartland Lysine feed-additive plant, also 
located in Eddyville--Worthy, 1989). 
To date, state policy makers appear content with the 
results of the biotechnology-grounded economic development 
plan. Iowa's General Assembly has extended appropriations for 
the operation of the Biotechnology Council, and for the entire 
program of biotechnology research, beyond the initial 
three-year implementation period. While, in assessing the 
general effectiveness of the project, the state's governor, 
Terry E. Branstad, states, 
Iowa is turning biotech breakthroughs into business 
success stories. Partnerships between private industry 
and Iowa's two world-class research universities are 
resulting in innovative products and economic progress. 
(Worthy, 1989). 
Governor Branstad has even proposed budget increases for 
economic development projects based on university research 
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like that taking place at Iowa State (Blumenstyk, 1992). 
The effort to stimulate economic development through the 
creation of the biotechnology program at I.S.U. therefore 
appears to have met with a substantial degree of success. The 
university system in Iowa has been effectively used as a tool 
to promote this stimulation, and appears likely to continue 
the performance of this function for the foreseeable future. 
In essence then, the state of Iowa's effort to stimulate 
economic development through funding university research in 
the ever-growing field of biotechnology serves as a model by 
which other states have, and may, attempt to undertake their 
own research-oriented programs of economic development in the 
future. As has been previously stated, by the end of the 
1980's, nearly every state had at least one program that 
provided research grants to universities in the hope of 
spurring this kind of economic development. However, while 
state economies may receive a variety of benefits from this 
utilization of the university system, concerns have been 
raised regarding the effect that this growing tendency may 
have upon the universities themselves. Shulman (1987) states; 
According to Tufts University science historian Sheldon 
Krimsky and others, corporate interests threaten to skew 
research priorities. Krimsky...believes that 'when a 
university has its own for-profit sector, it means that 
the institution has to manage according to very different 
rules.' (p. 11). 
Rule (1988) also expresses concern about the trend, and 
states; 
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... what will exploitation of such profitable 
technologies do for--and to--the universities? Even if 
the more extravagant projections for biotechnology prove 
overblown, genetic engineering is bound to be among the 
biggest money-making activities associated with American 
universities in the 1990s. How will pursuit of such 
profits shape institutions supposedly predicated on 
values quite different from profitability? 
.•.when universities accommodate themselves too 
thoroughly to the agenda of non-university institutions, 
they begin to lose the qualities that make universities 
worth having in the first place, (p. 432, 434) . 
Growing numbers of analysts are therefore coming to 
recognize some of the more negative aspects that may accompany 
the increasing influence of economic development and private 
funding for research in universities. Leslie Roberts (1983) 
states ; 
In the face of declining federal support, universities 
need money for research and instruments. For industry, 
such agreements mean access to the scientific expertise 
that is still centered in the universities and rights to 
any patentable discoveries. And both sides espouse the 
societal good arising from rapid technology transfer. 
There is less agreement, however, on how serious a threat 
corporate funds pose to the integrity of the university, 
(page 159). 
A primary concern about this possible 'threat' is that 
the increased trend towards university reliance on external 
research funds will redirect research efforts towards economic 
or corporate need, rather than academic merit (Caldart, 1983). 
More specifically, Caldart proposes that the biotech research 
push would result in increased pressure from industry and 
research administrators on public sector scientists to abandon 
varietal breeding and more applied forms of research. Another 
concern was that this trend would result in the reduction of 
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long-term research efforts, due to the short-term, 
profit-oriented emphasis of private sector investors or 
economic development programs. 
A second major issue raised by Lacy et al. (1988) 
concerns the possibility that the expansion in biotechnology 
research may result in the neglect of research into other 
important disciplinary and methodological perspectives. For 
example, scientists may become so focussed on molecular 
methods of reproduction enhancement that more traditional 
forms of plant or animal breeding (which may be more cost 
effective and efficient than biotechnological methods) become 
underutilized and increasingly unexplored. Thus, economic 
development or profit-oriented research may not only redirect 
existing research efforts (the first primary concern), but 
also re-direct them at the expense of other areas of necessary 
research (the second fundamental concern). 
A third set of concerns relates to the impact that the 
growing emphasis on research may have on the instructional 
abilities and capacities of academic institutions. Using 
Stanford University as an example, Maria Shao (1991) describes 
how research responsibilities tend to take precedence over 
instructional duties; 
Grants represent 28% of the school's research and 
instruction budget and make stars of the people who win 
them. Faculty can even 'buy out' of teaching by using 
grants to pay part of their salaries. Temporary teachers 
pick up the slack, (p. 126) . 
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Rule (1988) ' examines this issue not only with regard to 
the general priority research appears to take over teaching, 
but also with regard to the way in which shifting research 
emphases may eventually result in shifting teaching emphases; 
One form of responsibility incumbent on universities is 
to make available to students a wide array of 
intellectual possibilities. University collaboration 
with outside agencies may lead to distortion of such 
possibilities. There is the danger that curricula may be 
skewed toward the profitable, rather than the profound. 
Faculty absorbed in lucrative research ventures may be 
unwilling or unable to help students consider research 
problems whose merits are strictly intellectual. And all 
this may be true without conscious intent on the part of 
faculty, (p. 434). 
Lending possible credence to this concern is the fact 
that curriculum offerings are being altered around the 
country, both to accommodate the needs of the burgeoning 
biotechnology industries (in order to provide them with 
trained personnel), as well as to serve as a vent through 
which the expertise of the growing number of university 
biotechnologists may find curricular release. Each year, 
growing numbers of universities, colleges, and institutes have 
incorporated courses in biotechnology into their curricular 
offerings, and have established undergraduate majors in 
biotechnological fields (Amatniek, 1983) . 
The push towards research may therefore affect 
instructional activities in two basic ways; by diverting from 
the amount of time or effort faculty are able to put into 
them, and by altering the nature or body of information that 
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research specialists are willing or able to convey to their 
students. 
A final set of concerns relates to how the status of 
graduate students and faculty may be altered by their 
affiliation with profit-oriented research ventures. Rule 
(1988) states; 
How is the university to treat faculty and students 
associated with such 'profit centers'? As ordinary 
university citizens, subject to the same rules as others 
in terms of promotion, tenure, teaching and academic 
freedom (for faculty) and grading, distribution 
requirements, fellowships and progress toward degrees 
(for students)? Can the university act as investment 
manager toward an organization consisting of its own 
people, while still maintaining its role as a university? 
Unable to answer in the affirmative. President Bok of 
Harvard, at the urging of his faculty, declined in 1980 
to institute such a corporate experiment there, (p. 433). 
In essence, universities will increasingly be faced with 
the question of whether the more 'profitable' faculty and 
graduate students will be held to the same standards and 
rigors as those of a less business-oriented character. 
The overall trend towards 'self-financing' university 
operation through the attainment of private or public economic 
development research funds may therefore serve to alter the 
makeup of the modern university by placing a heavier emphasis 
on research-oriented activities than has been present in the 
past. Concern may also be warranted as to whether this more 
market-driven approach to university research may affect the 
social outcomes of research, and the future capacity for 
universities to adequately fulfill instructional 
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responsibilities, as well as undertake a broad base of 
independent, 'no strings attached' research activities. 
An understanding of how economic development projects 
impact upon participant universities is thus not only of 
benefit or relevance to the State of Iowa, but to all states 
engaged in such programs--and all universities participating 
in these programs. The overriding hypothesis that therefore 
guides this research is that this recent alteration in 
operational emphasis will in turn alter the ability of the 
university to perform the instructional and research functions 
it was originally intended to perform. 
By examining the situation at Iowa State University, it 
becomes possible to determine the likely impacts that 
biotechnology research in particular--and economic development 
research in general--will have upon participant universities. 
In essence, while biotechnology research represents but one 
means by which economic development may be attempted by state 
governments, the process by which such projects occur, and the 
outcomes that result from them, may be similar regardless of 
the specific means at hand (such as biotechnology). The 
utilization of Iowa State University therefore serves as a 
case-study by which the effects of such efforts may become 
more fully understood. 
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METHOD OF STUDY 
The first step necessary in assessing the impact of the 
biotechnology research effort on Iowa State University was to 
determine: 1) which departments should be considered the 
primary beneficiaries of the biotechnology funding; 2) which 
departments benefitted—but to a lesser degree, and; 3) which 
received no benefits at all. 
In order to achieve this determination, a technique known 
as 'snowball sampling,' or 'chain referral sampling,' was 
implemented among informed participants in the biotechnology 
research effort at Iowa State University. Under this method 
of examination, informed participants are questioned, not only 
with regard to their own knowledge of a given phenomenon, but 
also regarding their knowledge of other informed participants 
who may possess information relevant to the phenomenon. Thus, 
the sample begins with a small set of elements, and ends with 
a larger set of elements that are in some way connected to the 
initial set (Encyclopedia of Statistical Sciences, c.1982-
1988). 
In the Iowa State sample, the initial set of informed 
participants consisted of the Departmental Executive Officers 
(DEOs) of two departments acknowledged to be active in the 
biotechnology research effort (since interviewees were 
guaranteed confidentiality, names and departments of these 
interviewees shall not be listed). Interviews (conducted by 
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phone, or in person, if requested by the interviewee) focused 
primarily upon two basic questions: 1) 'Which departments 
would you describe as being central to the biotechnology 
research effort at Iowa State University (the 'Core'), and 
which are involved in the biotechnology research effort, but 
in a more supportive role (the 'Support' departments), and; 2) 
'Could you name three other persons familiar enough with the 
biotechnology research program to offer informed opinions on 
this question?' In addition, general comments regarding other 
aspects of the biotechnology research effort (e.g., 
effectiveness of its administration, success in the attainment 
of stated goals, etc.) were welcomed from all interviewees who 
offered them. 
Representatives (for the most part consisting of DEOs) 
were also contacted for all departments named as participants 
in either the Core or Supporting groups, but for whom a 
specific representative was not named in the course of the 
'snowballing' process. All participating Core and Support 
departments were thus represented by at least one spokesperson 
over the course of the interviews. Ultimately, 22 interviews 
were conducted with DEOs and other departmental 
representatives. 
As a result of these interviews, twelve departments were 
determined to operate within the Core of the biotechnology 
research effort: Biochemistry/Biophysics, Genetics, Zoology, 
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Horticulture, Agronomy, Chemical Engineering, Chemistry, Plant 
Pathology, Botany, Veterinary Microbiology and Preventive 
Medicine, Veterinary Pathology, and Veterinary Anatomy. Nine 
additional departments were determined to function within the 
Support group: Microbiology, Animal Science, Food Technology, 
Food and Nutrition, Forestry, Entomology, Veterinary 
Physiology and Pharmacology, Veterinary Clinical Sciences, and 
the Veterinary Diagnostic Laboratory (see Appendix I for 
departments, not included in either the Core or Support 
categories). Since the goal of this research is to examine 
the academic impacts of the biotechnology project, six non-
academic divisions of the University were not included in the 
analysis (Ames Laboratory, Statistics Laboratory, World Food 
Institute, Computation Center, Institute for Physical Research 





The impacts of the push towards biotechnology research 
are evidenced, first, by the quantitative shifts that have 
occurred in 'full time equivalency' (PTE) job categorizations 
within the individual departments of the university. 
Comprehensive listings of these FTE categorizations were 
collected for the eight-year period from fiscal years 
1983/1984 to 1990/1991, and were obtained with the cooperation 
of Iowa State University's Office of Institutional Research. 
Under this system of employment categorization, 
occupational positions are grouped into several broad funding 
categories. Four of these categories are relevant to this 
study; Instruction, Contracts and Grants (C&G), Research, and 
Agricultural Experiment Station (AES). Within these broad 
categorizations, positions are more specifically grouped in 
terms of employee type; Merit, Professional and Scientific 
(P&S), Graduate Student, Pre and Post-Doctoral, Hourly, and 
Faculty. 
In terms of these specific employee types, the raw 
numbers for the entire university reveal an overall decrease 
in the number of faculty over the eight year period under 
examination (Figure 1). Faculty FTEs were at a peak of 
1558.62 positions in fiscal year 1985/1986, but dropped to 
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Figure 1. FTE totals 
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positions). On the other hand, the combined number of 
Graduate Student and Pre/Post Doctoral PTEs rose from a low of 
689.62 in 1984/1985 to 864.22 by 1990/1991 (a net gain of just 
under 175 positions). P&S and Hourly PTEs also rose 
significantly, with P&S PTEs increasing by approximately 100 
positions, and Hourly PTEs increasing by just under 70 
positions. Raw numbers of Merit PTEs held relatively constant 
during the period (Table 1). 
Table 1. Raw numbers of university PTEs grouped by 
occupational category 
83/84 84/85 85/86 86/87 87/88 88/89 89/90 90/91 
Merit 477.5 455.8 476.7 490.0 482.8 443,3 467.8 474,8 
P&S 121.0 138.9 142,3 147,0 164.9 177.1 202.1 220.6 
Grad. 629.3 623.2 674.1 721.0 724.7 731.2 747,3 765.7 
P/Doc 67.2 66.4 65.7 77.3 89.5 96.4 117,0 98.6 
Hourly 148.0 165.0 166.3 182.0 191.2 224.5 222.6 216.2 
Fac. 1506.0 1529.0 1559,0 1546.0 1489.0 1464.9 1496,4 1478.1 
Total 2949.0 2979,0 3084.0 3163.0 3142,0 3137,3 3253.2 3253.9 
Grad & 
P/doc 696.5 689.6 739.9 798.0 814.2 827,6 864,3 864.2 
This raw data thus reveals that Paculty PTEs--as a 
percentage of total FTEs--have declined considerably during 
the eight year period under study (Pigure 2). Paculty 
positions constituted 51.34% of PTEs in PY 1984/1985, but 
steadily declined to represent only 45.42% of PTEs by FY 
1990/1991 (a drop of about 6 percentage points). Conversely, 
while Graduate Students and Pre/Post Doctoral employees 
constituted only 23.15% of total PTEs in 1984/1985, they rose 
83/84 84/85 85/86 86/87 87/88 88/89 89/90 90/91 
Year 
Merit -4- P&S Grads. & Pdocs 
-fc§- Hourly • X Faculty 
Figure 2. Percentage of PTE totals by occupational 
category 
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to represent 26.56% of overall PTEs by FY 1990/1991 (a gain of 
about 3.5 percentage points). Hourly and P&S employees also 
increased slightly in comparison to the other occupational 
categories (approximately 1.5 and 2.5 points, respectively), 
while Merit employees decreased slightly (approximately 1.5 
percentage points, Table 2). 
Table 2. Occupational categories as a percentage of total PTEs 
83/84 84/85 85/86 86/87 87/88 88/89 89/90 90/91 
Merit 16.19 • 15.3 15,46 15,5 15.36 14.13 14,38 14,59 
P&S 4.10 4.66 4.61 4,66 5.25 5.65 6,21 6.78 
Grad 21.34 20.92 21.86 22.8 23.06 23,31 22,97 23.53 
P/Doc 2.28 2.23 2.13 2.44 2.85 3,07 3,6 3.03 
Hourly 5.02 5.54 5.39 5.76 6.09 7,15 6,84 6,64 
Fac. 51.07 51.34 50,54 48.9 47.39 46,69 46, 45,43 
Total% 100.00 100.00 100,00 100.00 100.00 100,00 100,00 100,00 
Grad & 
Pdoc% 23.62 23,15 23,99 25.2 25.91 26,38 26,57 26,56 
While these findings indicate some alteration in the 
overall occupational structure of the University, an even more 
important set of findings occurs when these fluctuations are 
examined in the context of the aforementioned biotechnology 
departmental categorization. Within the Core (Pigure 3), 
Graduate Student and Pre/Post Doctoral PTEs increased by 
approximately five percent (in relation to total Core PTEs), 
from a low of 27.87% in fiscal year 1984/1985 (the year prior 
to the implementation of the biotechnology research effort) to 
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Figure 3. Core Fl'E breakdown 
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share of PTEs declined by 6.76%, from a high of 34.12% in 
1984/1985, to a low of 27.36% in 1989/1990. The P&S share of 
PTEs also rose by approximately three percent during this 
period, while the Merit share declined by approximately 3.5 % 
over the eight years under study. The Hourly share of Core 
PTEs increased slightly (Table 3). 
Table 3. Occupational categories as a percentage of total Core 
PTEs 
Core FTE Breakdown 
83/84 84/85 85/86 86/87 87/88 88/89 89/90 90/91 
Grad 24.7 22.97 25.27 26.77 27.15 26.04 25.45 25.81 
Pdoc 5.16 4.9 5.04 5.83 6.1 6.61 7.69 7.06 
P&S 6.85 8.0 8.14 8.14 9.11 10.61 11.32 11.14 
Merit 18.65 18.85 18.11 18.07 17.52 14.95 14.83 15.01 
Hourly 11.75 11.15 11.53 11.19 11.67 14.33 13.35 12.92 
Fac. 32.88 34.12 31.89 30.0 28.44 27 .46 27.36 28.05 
Total 99.99 99.99 99.98 100.00 99.99 100.00 100.00 99.99 
Grads & 
Pdocs 29.86 27 .87 30.31 32.6 33.25 32.65 33.14 32.87 
A similar trend is evident within the Support departments 
(Figure 4). Graduate Student and Pre/Post Doctoral PTEs rise 
steadily from a low of 16.62% in 1985/1986 (the first year of 
the biotechnology funding) to 22.51% in 1990/1991 (an overall 
increase of 5.89 percentage points). During this same period, 
Paculty PTEs steadily decreased from a high of 37.74% in 
1985/1986 to a low of 32.61% in 1990/1991 (a decline of about 
five percentage points). Other occupational categories remain 
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Figure 4. Support PTE breakdown 
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Table 4. Occupational categories as a percentage of total 
Support PTEs 
Support FTE Breakdown 
83/84 84/85 85/86 86/87 87/88 88/89 89/90 90/91 
Grad. 15.78 15.18 14.54 14.47 15.85 17.19 17.29 18.53 
Pdoc. 3.68 3.41 2.08 2.38 2.79 2.02 3.93 3.98 
P&S 7.68 7.18 7.86 7.85 7.7 7.99 7.93 9.02 
Merit 28.83 28.76 28.75 28.74 26.53 27.24 27.54 28.24 
Hourly 6.38 8.43 9.02 9.57 10.5 10.73 9.17 7.61 
Fac. 37.65 37.03 37.74 36.99 36.61 34.82 34.14 32.61 
Tot. 100.00 99.99 99.99 100.00 99.98 99.99 100.00 99.99 
Grads & 
Pdoc s 19.46 18.59 16.62 16.85 18.64 19.21 21.22 22.51 
. This same trend occurs in departments unrelated to the 
biotechnology research effort, though to a lesser degree 
(Figure 5). The comparative level of Graduate Student and 
Pre/Post Doctoral PTEs rise by a total of 2.89 percentage 
points during the eight-year period, Faculty PTEs fall by 5.54 
points, and other categories hold relatively constant (Table 
5) . 
. The significance of these changes may be tested by 
constructing a comparison of beginning and ending points for 
each of the six occupational groupings (Table 6). Such a 
comparison is useful in that the first year of data 
(1983/1984) represents a period which saw no biotechnology 
funding, while the last year of data (1990/1991) reflects a 
period in which the project was well underway. 
In Table 6, the mean value represents the Mean amount of 
change (+ or -) in the raw number of PTEs between FYs 
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Figure 5. Non-Biotech PTE breakdown 
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Table 5. Occupational categories as a percentage of total Non-
Biotech PTEs 
Non-biotech PTE Breakdown 
83/84 84/85 85/86 86/87 87/88 88/89 89/90 90/91 
Grad. 21.09 21.29 21.85 22.73 22.71 23.29 23.13 23.68 
Pdoc. 0.89 1.0 1.04 1.11 1.53 1.74 1.8 1.19 
P&S 2.34 2.92 2.65 2.7 3.21 3 .04 3 .68 4.53 
Merit 12.79 11.33 11.99 12.03 12.43 11.25 11.4 11.48 
Hourly 2.12 2.88 2.34 2.91 2.99 3.35 3.59 3.89 
Fac. 60.76 60.58 60.14 58.52 57.12 57 .32 56.4 55.22 
Totals 99.99 100.00 100.01 100.00 99.99 99.99 100.00 99.99 
Grad & 
Pdocs 21.98 22.29 22.89 23.84 24.24 25.03 24.93 24.87 
Table 6. A comparison of beginning and end-point mean 
differences between Core, Support, and Non-
Biotechnology occupational categories 
Mean Pr>F Scheffe 
Graduate Core 2.47 .47 C-S .99 
Support 1.48 C-N 1.4 
Non-Biotech 1.06 S-N .42 
Pre/Post Doc Core 1.95 .02* C-S 1.64 
Support .31 C-N 1.64* 
Non-Biotech .3 S-N .00 
Faculty Core -.62 .86 C-S -1.44 
Support .81 C-N -.46 
Non-Biotech -.16 S-N .97 
P&S Core 3.25 .0008* C-S 2 .71* 
Support .54 C-N 2 .78* 
Non-Biotech .47 S-N .07 
Merit Core -.77 .30 C-S -1.93 
Support 1.15 C-N -.59 
Non-Biotech -.18 S-N 1.34 
Hourly Core 1.93 .11 C-S .49 
Support 1.45 C-N 1.42 
Non-Biotech .51 S-N .93 
*p <. 05 
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For example, the mean value of 2.47 for Core Graduate Students 
represents an average increase of 2.47 PTEs per department 
within the Core over the eight years of available data. The 
Pr>F value represents the overall level of significance for 
these changes. A Scheffe' Multiple Comparison was then 
utilized in order to determine the significance of Mean 
differences for each of the possible pairings of departmental 
categories; Core-Support (C-S); Core-Non-Biotech (C-N), and; 
Support-Non-Biotech (S-N) (Agresti and Finlay, 1986). 
This general analysis yields statistically significant 
results for two of the occupational categories. Pre/Post 
Doctoral employees have increased substantially within the 
Core Departments (1.95 per department), and moderately within 
the Support and Non-Biotech departments (.31 and .3, 
respectively). Also, P&S employees have increased 
dramatically within the Core (3.25 FTEs per department, on 
average), and moderately within the Support and Non-Biotech 
groupings (.54 and .47, respectively). And, while the other 
analyses of occupational groupings were not found to be 
statistically significant (due to high variability) some of 
the findings do tend to lend credence to the trends described 
in Figures 3-5 (e.g., a substantial increase in Graduate 
Students per department, with the increase most pronounced 
among the Core, and least pronounced among the Non-
Biotechnology Departments). 
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Beyond this basic analysis of the five occupational 
groupings, it is important to remember that each of these 
groupings may be further analyzed in terms of the occupational 
activity (Instruction, C&G, Research, and AES) in which a 
given employee was engaged. For example, it is clear that the 
Graduate Student share of PTEs increased in all three of the 
departmental categorizations. However, it is still unclear 
whether these graduate students are engaged in instructional 
or research activities. The data on professional activity is 
therefore useful in answering this question, and reveals some 
interesting trends. 
As has been stated, within the Core categorization, the 
relative level of Graduate Student and Pre/Post Doctoral PTEs 
has increased by five percent, Faculty have decreased by 
nearly seven percent, and other occupational categories have 
held fairly constant. These trends appear even more dramatic 
in light of the occupational activity data. Among Core 
Graduate Students (Figure 6), there was a 20% drop in the 
proportional share of Graduate Students involved in 
Instructional activities between fiscal years 1984/1985 and 
1989/1990. This same period saw an increase of over 26 
percentage points in C&G related-activities for graduate 
students (a category reflective of the biotechnology funding). 
Research and Ag Experiment Station activities both declined 
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Figure 6, Graduate ETE categorization (Core) 
59 
Support departments (Figure 7), which reveal a 31 percentage 
point increase in C&G related activities, and a 19.5 point 
drop in Instructional activities. AES positions also declined 
by approximately 11.5 percentage points (there were no 
Graduate Student Research PTEs in the Support group--Table 8). 
A similar trend, though less pronounced, was found among the 
Non-Biotech departments. The Instructional share of PTEs for 
Graduate Students declined by approximately 16.7% in 
comparison to the other occupational categories, while the C&G 
portion of PTEs increased by approximately 17.7 percentage 
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Table 7. Funding category as a percentage of all Core 
occupational titles 
CORE CATEGORIZATIONS 
Merit Work Categorization 
83/84 84/85 85/86 86/87 87/88 88/89 89/90 90/91 
Instr. 37.11 40.12 36.6 35.05 37.02 38.68 40.6 42.35 
C&G 21.82 19.19 22.71 27.45 27.5 21.14 20.01 8.47 
Res. 17.13 16.94 16.17 15.56 15.0 16.02 15.06 14.8 
AES 23.93 23.75 24.52 21.94 20.48 24.16 24.33 24.38 
P&S Work Categorization • 
83/84 84/85 85/86 86/87 . 87/88 88/89 89/90 90/91 
Instr. 41.02 39.16 38.21 35.22 31.08 26.59 27.63 28.82 
C&G 25.26 24.82 27.82 32.11 34.55 46.1 45.19 41.01 
Res. 13.93 15.04 15.62 15.81 13.81 8.04 7.12 6.24 
AES 19.79 20.97 18.35 16.86 20.56 19.26 20.06 23.93 
Graduate Student Work Categorization 
83/84 84/85 85/86 86/87 87/88 88/89 89/90 90/91 
Instr. 52.82 55.28 44.22 41.06 41.1 37.2 34.98 36.97 
C&G 28.35 26.05 40.23 45.5 47.19 49.82 52.36 49.18 
Res. 3.46 4.82 3.74 4.41 3.59 3.86 2.65 2.11 
AES 15.36 13.85 11.8 9.03 8.12 9.12 10.00 11.74 
Pre and Post Doctoral Work Categorization 
83/84 84/85 85/86 86/87 87/88 88/89 89/90 90/91 
Instr. 0.91 0 5,28 4.32 2.03 3.62 1.54 1.83 
C&G 78.11 86.31 69.66 75.13 88.71 93.67 94.59 92.93 
Res. 7.65 1.44 5.94 9.19 3.55 1.36 1.16 1.32 
AES 13.33 12.25 19.13 11.35 5.71 1.36 2.7 3.92 
Hourly Work Categorization 
83/84 84/85 85/86 86/87 87/88 88/89 89/90 90/91 
Instr. 5.73 7.16 6.89 5.26 4.36 2.22 5.18 5.01 
C&G 76.21 71.65 77.98 78.94 89.8 94.96 83.49 87 .22 
Res. 3.91 2.1 2.71 2.95 0 0 1.98 1.92 
AES 14.15 19.09 12.42 12.84 5.84 2.82 9.35 5.85 
Faculty Work Categorization 
83/84 84/85 85/86 86/87 87/88 88/89 89/90 90/91 
Instr. 63 .76 64.43 65.37 65.0 64.1 62.47 72.52 72.19 
C&G 3.93 3.4 5.23 3.45 4.27 4.91 3.18 3.97 
Res. 10.93 11.31 9.13 11.54 10.94 10.9 3.7 3.18 
AES 21.37 20.86 20.26 20.0 ' 20.69 21.72 20.6 20.66 
Totals 
83/84 84/85 85/86 86/87 87/88 88/89 89/90 90/91 
Instr. 44.47 46.18 42.86 40.53 39.34 36.0 38.71 40.14 
C&G 27.08 24.97 30.7 34.0 37.89 42.17 40.69 38.98 
Res. 9.45 9.67 8.67 9.61 8.19 7.33 5.08 4.7 
AES 18.99 19.18 17.77 15.85 14.58 14.49 15.52 16.18 
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Table 8, Funding category as a percentage of all Support 
occupational titles 
SUPPORT CATEGORIZATIONS 
Merit Work Categorization 
83/84 84/85 85/86 86/87 87/88 88/89 89/90 90/91 
Instr. 31.09 30.76 28.84 29.57 32.03 29.37 33.28 33 .68 
C&G 14.38 16.62 20.22 23.87 21.55 24.81 19.66 18.85 
Res. 13.47 12.89 11.57 10.72 9.81 8.76 9.31 8.66 
AES 41.05 39.73 39.37 35.84 36.6 37.06 37.75 38.81 
PScS Work Categorization 
83/84 84/85 85/86 86/87 87/88 88/89 89/90 90/91 
Instr. 36.02 37.52 35.37 34.53 37.1 33.09 34.35 32.00 
C&G 11.73 12.49 10.67 12.54 11.62 18.57 17.01 25.85 
Res. 10.35 10.67 10.11 9.91 10.3 9.79 8.76 7.53 
AES 41.9 39.31 43.85 43.02 40.98 38.55 39.88 34.61 
Graduate Student Work Categorization 
83/84 84/85 85/86 86/87 87/88 88/89 89/90 90/91 
Instr. 32.7 28.24 25.3 27.09 21.0 16.4 14.03 13.2 
C&G 22.51. 29.49 31.3 35.79 48.3 55.28 53.59 53.61 
Res. d 0 0 0 0 0 0 0 
AES 44.78 42.26 43 .4 37.12 30.7 28.32 32.39 33.19 
Pre and Post Doctoral Work Categorization 
83/84 84/85 85/86 86/87 87/88 88/89 89/90 90/91 
Instr. 0 0 0 0 3.56 0 0 2.15 
C&G 32.2 52.78 50.0 71.43 70.33 60.0 65.32 70.23 
Res. 31.82 0 0 0 0 0 0 0 
AES 35.98 47.22 50.0 28.57 26.11 40.0 34.68 27.61 
Hourly Work Categorization 
83/84 84/85 85/86 86/87 87/88 88/89 89/90 90/91 
Instr. 37.24 27.84 30.1 32.21 27.71 31.01 12.38 17.59 
C&G 44.45 59.55 49.21 53.02 55.34 58.63 76.42 67.44 
Res. 0 0 0 0 0 0 0 0 
AES 18.31 12.6 20.68 14.77 16.95 10.35 11.19 14.98 
Faculty Work Categorization 
83/84 84/85 85/86 86/87 87/88 88/89 89/90 90/91 
Instr. 67.95 67.06 67.07 67.09 67.5 64.64 64.53 63.41 
C&G 2.6 2.39 2.48 2.98 1.67 2.12 4.16 3.34 
Res. 8.98 11.42 10.88 10.9 11.41 12.76 10.4 11.61 
AES 20.47 19.13 19.56 19.02 19.42 20.47 20.91 21.63 
Totals 
83/84 84/85 85/86 86/87 87/88 88/89 89/90 90/91 
Instr. 44.85 43.01 42.78 43.03 42.41 39.3 37.48 36.95 
C&G 13.6 17.87 17.62 20.9 22.66 26.0 27.02 26.61 
Res. 9.23 8.7 8.23 7.89 7.57 7.61 6.81 6.91 
AES 32.32 30.42 31.37 28.18 27.35 27.09 28.69 29.53 
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Table 9. Funding category as a percentage of all Non-Biotech 
occupational titles 
NON-BIOTECH CATEGORIZATIONS 
Merit Work Categorization 
83/84 84/85 85/86 86/87 87/88 88/89 89/90 90/91 
Instr. 72.64 71.45 72.18 70.91 70.17 73.67 74.74 74.35 
C&G 6.94 5.5 6.9 8.97 8.89 9.35 8.14 8.32 
Res. 2.65 2.55 2.39 1.53 1.83 2.21 1.01 0.95 
AES 17.78 20.5 18.53 18.58 19.1 14.76 16.12 16.38 
P&S Work Categorization 
83/84 84/85 85/86 86/87 .87/88 88/89 89/90 90/91 
Instr. 46.7 49.56 45.7 39.91 34.57 41.75 48.16 38,94 
C&G 7.69 6.56 12.92 15.95 25.17 32.69 28.44 34.88 
Res. 9.89 7.35 3.04 4.32 6.98 2.61 2.73 2.2 
AES 35.71 36.52 38.34 39.82 33.27 22.95 20.66 23.98 
Graduate Student Work Categorization 
83/84 84/85 85/86 86/87 87/88 88/89 89/90 90/91 
Instr. 71.17 71.26 68.15 65.09 59.14 57.37 56.83 54.4 
C&G 16.37 17.4 21.02 26.09 29.99 32.72 33.93 34.06 
Res. 6.21 4.84 . 5.0 4.68 5.77 4.81 3.67 4.79 
AES 6.24 6.49 5.83 4.14 5.09 5.1 5.57 6.76 
Pre and Post Doctoral Work Categorization 
83/84 84/85 85/86 86/87 87/88 88/89 89/90 90/91 
Instr. 0.73 3.16 8.85 6.18 8.28 2.97 5.35 9.72 
C&G 58.42 73.16 69.42 77.88 78.14 84.71 86.73 86.1 
Res. 0 0 3.83 1.03 0.33 0.24 0 • 0 
AES 40.85 23.68 17.9 14.91 13.25 12.08 7.92 4.17 
Hourly Work Categorization 
83/84 84/85 85/86 86/87 87/88 88/89 89/90 90/91 
Instr. 25.5 31.39 31.62 30.56 29.51 25.21 20.39 21.11 
C&G 69.37 61.59 63.38 63.17 62.75 64.93 73.09 71.3 
Res, 1.49 0.15 1.37 0.65 1.17 0.73 0.38 0.34 
AES 3.64 6.87 3; 62 5.62 6.58 9.13 6.14 7.25 
Faculty Work Categorization 
83/84 84/85 85/86 86/87 87/88 88/89 89/90 90/91 
Instr. 90.6 90.71 89.73 89.85 89.45 89.54 93.49 93.6 
C&G 2.1 1.82 2.86 2.54 2.52 2.66 3.05 2.55 
Res. 4.62 4.59 4.49 4.78 4.77 4.63 0.14 0.14 
AES 2.68 2.88 2.92 2.84 3.26 3.16 3.31 3.7 
Totals 
83/84 84/85 85/86 86/87 87/88 88/89 89/90 90/91 
Instr. 81.0 80.6 79.55 77.94 75.37 75.15 77.00 75.81 
C&G 7.79 8.13 9.68 11.63 13.24 14.85 15.73 15.81 
Res. 4.72 4.32 4.23 4.19 4.53 4.13 1.16 1.43 
AES 6.5 6.95 6.54 6.24 6.86 5.87 6.12 6.94 
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By again using a comparison of Means (on beginning and 
ending points for the eight years of data), test of 
significance, and Scheffe' Multiple Comparison test, the 
statistical significance of these trends may be analyzed 
(Table 10). 
Table 10. A comparison of beginning and end-point mean 
differences for Graduate Student PTEs, grouped by 
funding category 
Mean Pr>F Scheffe 
Instructional Core -1.4 .29 C-S -0 .67 
Support -0.75 C-N -1 .14 
Non-Biotech -0.29 S-N -0 .46 
C&G Core 4.37 .01* C-S 1 .98 
Support 2.39 C-N 2 .92* 
Non-Biotech 1.46 S-N . .94 




C-S -0 .04 
Support 0.0 C-N 0 .08 
Non-Biotech -.0.12 S-N 0 .12 
AES Core -0.44 .12 C-S -0 .28 
Support -0.16 C-N -0 .46 
Non-Biotech 0.02 S-N -0 .18 
*p <. 05 
This analysis reveals that C&G positions among Graduate 
Students have experienced a substantial and statistically-
significant increase of 4.37 positions per department in the 
Core. The Support and Non-Biotech groupings also experience 
substantive increases, but not to the degree found in the 
Core. While the other funding category analyses failed to 
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reveal significant findings, they clearly indicate trends 
similar to those revealed in Figures 6 and 7 (slight decreases 
in Research and AES PTEs, and substantial decreases in 
Instructional FTEs that are most pronounced among the Core, 
and least pronounced among Non-Biotech departments). 
Among Pre and Post Doctoral employees, all three 
departmental categorizations have experienced dramatic 
increases in the relative level of C&G-funded positions. 
Within the Core, 92.93% of Pre/Post Doctoral positions were 
funded through Contracts and Grants in FY 1990/1991 (up from 
78.11% in FY 1983/1984--Table 7). Among Support Departments, 
70.23% of Pre/Post Doctoral positions were based on C&G funds 
(up from 32.2% in FY 1983/1984--Table 8). Within departments 
unrelated to the biotechnology project, 86.1% of Pre/Post 
Doctoral positions were C&G-related (up from 58.42% in FY 
1983/1984--Table 9). 
A comparison of Means, test of significance, and Scheffe' 
Multiple Comparison test, for Pre/Post Doctoral employees is 
contained in Table 11. Significant findings verify the 
substantial increase in C&G related Pre/Post Doctoral 
positions among the Core, as well as a decrease in Research 
positions for Support and Core Departments. 
Regarding Faculty, it is important to note that their 
activities are somewhat more difficult to classify than 
Graduate Students. For the Faculty, the difference between 
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Instructional and Research PTEs is largely a matter of 
bookkeeping--it is not reflective of a true distinction 
between teaching and research activities. With this in mind, 
it is evident that the official data record of Faculty 
Table 11. A comparison of beginning and end-point mean 
differences for Pre/Post Doctoral PTEs, grouped by 
funding category 
Mean Pr>P Scheffe 
Instructional Core 0.05 .73 C-S 0.05 
Support 0.00 C-N 0.02 
Non-Biotech 0.02 S-N -0.03 
C&G Core 2 .28 .003* C-S 1.68 
Support 0.6 C-N 1.94* 
Non-Biotech 0.39 S-N 0.26 
Research Core -0.15 .03* C-S 0.23 
Support -0.38 C-N -0.15 
Non-Biotech 0.00 S-N -0.38* 
AES Core -0.23 .21 C-S -0.32 
Support 0.09 C-N -0.17 
Non-Biotech -0.06 S-N 0.15 
*p <. 05 
occupational activities has changed little over the eight year 
period under examination for any of the three departmental 
categorizations. The percentage levels hold relatively 
constant for each of the four occupational activity 
categories, for each of the three departmental 
categorizations. 
With this in mind then, it does appear that increases in 
67 
the level of Instructional activity occur within the Core and 
Non-Biotech groupings during the last two years of data. 
However, these increases are largely offset by decreases 
within the Research category. These alterations were caused 
by a recategorization of state funding expenditures by the 
Office of Institutional Research, and did not reflect a true 
switch from Research to Instruction (according to Iowa State 
University's Office of Institutional Research). 
A comparison of Means, test of significance, and Scheffe' 
Multiple Comparison test for Faculty failed to reflect 
significant findings in any funding category. 
It is also important to note that, while the Merit, P&S, 
and Hourly percentages of PTEs failed to reflect the level of 
change present within the Faculty and Graduate Student-
Pre/Post Doctoral categories (as evidenced in Figures 3-5), 
substantial alterations occurred within these categories. For 
example, among Professional and Scientific employees in the 
Core, a drop of approximately 15 percentage points in 
Instructional activity occurred between fiscal years 1983/1984 
to 1988/1989 (Table 7). C&G positions for P&S employees rose 
by about 21 percentage points during the same period. Among 
P&S employees in the Support group, Instructional FTEs dropped 
by about four percentage points over the eight years of the 
data, while C&G increased by about 14 points (Research and AES 
FTEs also declined during the period--Table 8). The Non-
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Biotech P&S category similarly experienced an eight percentage 
point drop in Instruction, and a 27 point increase in C&G PTEs 
(Table 9). 
A comparison of Means, test of significance, and Scheffe' 
Multiple Comparison test, for P&S employees is contained in 
Table 12. 
Table 12. A comparison of beginning and end-point mean 
differences for P&S PTEs, grouped by funding 
category 
Mean Pr>P . Scheffe 
Instructional Core 0.42 .67 C-S 0.28 
Support 0.14 C-N 0.19 
Non-Biotech 0.24 S-N -0.09 
C&G Core 2.18 .0003* C-S 1.95* 
Support 0.22 C-N 1.9* 
Non-Biotech 0.28 S-N -0.05 
Research Core -0.01 .77 C-S -0.02 
Support 0.01 C-N 0.03 
Non-Biotech -0.04 S-N 0.04 
AES Core 0.66 .24 C-S 0.5 
Support 0.16 C-N 0.67 
Non-Biotech -0.01 S-N 0.17 
*p <. 05 
Table 12 indicates a statistically-significant increase 
in C&G positions among P&S employees, with this increase most 
pronounced among the Core. Among Hourly employees, the same 
trend towards an increase in C&G, and a decrease in 
Instruction, was present among all three of the departmental 
categories. The trend was most pronounced among the Support 
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group, and least pronounced among the Non-Biotech group 
(Tables 7-9). A comparison of Means, test of significance, 
and Scheffe' Multiple Comparison test, for Hourly employees is 
contained in Table 13. Once again, the increase in C&G 
positions is found to be statistically significant, and most 
pronounced among the Core. 
Table 13. A comparison of beginning and end-point mean 
differences for Hourly PTEs grouped by funding 
category 
Mean Pr>F Scheffe 
Instructional Core 0.07 .09 C-S 0.4 
Support -0.34 C-N 0.0 
Non-Biotech 0.07 S-N -0.41 
C&G Core 2.05 .02* C-S 0.29 
Support 1.76 C-N 1.65 
Non-Biotech 0.39 S-N 1.36 
Research Core -0.08 .16 C-S -0.08 
Support 0.00 C-N -0.07 
Non-Biotech 0.00 S-N 0.00 
AES Core -0.11 .58 C-S -0.13 
Support 0.01 C-N -0.16 
Non-Biotech 0.05 S-N -0.03 
*p <. 05 
Of the six occupational groupings (Faculty, Graduate 
Students, Merit, P&S, and Hourly), the only one to experience 
an overall increase in Instructional activity was Merit. 
Within the Core category, the Instructional share of Merit 
FTEs increased by approximately five percent. The 
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Instructional share of Support and Non-Biotech Merit PTEs also 
increased slightly (Tables 7-9). A comparison of Means, test 
of significance, and Scheffe' Multiple Comparison test, failed 
to reveal statistically-significant findings among the Merit 
employees. 
An overall analysis of the occupational activity data 
thus reveals that, within the Core, Instructional PTEs reached 
their peak during the 1984/1985 Fiscal Year, when they 
constituted 46.18% of the Core's total occupational activity 
(Pigure 8). This percentage dropped to a low of 3 6% in Piscal 
Year 1988/1989, but has since rebounded to just over 40%. 
Contract and Grant activity has risen dramatically, from a low 
of 24.97% of Core PTEs in 1984/1985 to 38.98% in 1990/1991. 
The Research and Ag Experiment Station shares of Core PTEs 
have declined by approximately 5 and 3 percentage points, 
respectively (Table 7). 
In the Support category (Pigure 9), Instructional 
activity has also dropped significantly, from a peak of 44.85% 
of Support PTEs in 1983/1984, to a low of 36.95% in 1990/1991. 
The Research and Ag Experiment Station share of Support PTEs 
has declined by approximately 2-3 percentage points each. 
Contract and Grant PTEs have approximately doubled, from a low 
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Figure 9. Support FTE totals in terms of fund category percentages 
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And, once again, the same trend towards a decline in 
Instruction and an increase in Contract and Grant activity is 
present in the Non-Biotech category, but to a lesser degree. 
The Instructional share of Non-Biotech PTEs dropped from a 
high of 81% in 1983/1984, to 75.81% in 1990/1991 (a decline of 
just over 6 percentage points). Contract and Grant activity 
has risen from a low of 7.79% of Non-Biotech PTEs in 
1983/1984, to a peak of 15.81% in 1990/1991 (an increase of 
just over 8 percentage points). The percentage of Research 
PTEs has declined by about 3 percentage points over the eight 
year period, while the Ag Experiment Station has held 
relatively constant (Table 9). 
A comparison of Means, test of significance, and Scheffe' 
Multiple Comparison test, for all employees is contained in 
Table 14. The significant increase in C&G positions among the 
Core departments is reflected in this analysis. 
Several basic conclusions are thus apparent from this 
data on occupational type and activity. First, the infusion 
of economic development research funds has had a considerable 
impact upon recipient departments, as displayed by the marked 
increase in research-oriented occupations (such as Graduate 
Students and Pre/Post Docs), and decreases in numbers of 
Paculty. Second, the funds have also had profound impacts in 
terms of the occupational activities in which employees are 
engaged. Again, the trend has been towards a substantial 
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Table 14. A comparison of beginning and end-point mean 
differences for Total PTEs grouped by funding 
category 
Mean Pr>F Scheffe 
Instructional Core .18 .97 C-S 0.43 
Support -0.25 C-N -0.18 
Non-Biotech 0.36 S-N -0.61 
C&G Core 10.41 .004* C-S 4.48 
Support 5.93 C-N 7.74* 
Non-Biotech 2.66 S-N 3.26 
Research Core -1.86 .25 C-S -1.46 
Support -0.4 C-N -0.82 
Non-Biotech -1.03 S-N 0.63 
AES Core -0.53 .82 C-S -0.99 
Support 0.46 C-N -0.54 
Non-Biotech 0.01 S-N 0.45 
Total Core 8.2 .19 C-S 2.47 
Support 5.73 C-N 6.20 
Non-Biotech 2.00 S-N 3.73 
*p <. 05 
increase in Contract and Grant-related research activities, 
and away from Instructional activities. Third, while these 
trends have occurred on a university-wide basis, they have 
tended to be most pronounced among the Core and Support 
recipients of the economic development project funds, and 
least pronounced among departments unrelated to these funds. 
Thus, these figures constitute quantitative evidence of an 
increase in the level of C&G research, and relative decline in 




A second means by which changes in the internal 
structures of the Core and Supporting departments becomes 
evident is in the variety of opinions offered by departmental 
representatives during the interviews mentioned earlier (under 
METHOD OF STUDY). Over the course of these interviews, 
several of the DEOs attempted to convey the qualitative impact 
that these quantitative shifts have had on their departments. 
For example, a Chairperson in one of the Core research 
departments states; 
The most important aspect of the biotechnology funding is 
the competition for start-up funds. We have been able to 
hire good people with the funding, and that definitely 
affects the structure of the department. It also affects 
the nature of the people we hire, so it shifts the 
emphasis of the research they do, and that emphasis has 
shifted dramatically to biotechnology, to the neglect of 
other areas of research. 
The biotechnology money is necessary but not 
sufficient because it restricts the scope of research to 
molecular biology. This may eventually do away with a 
good program on general biology and just leave us with a 
narrower expertise on molecular biology. 
Concern over the changing internal research structures of 
the biotechnology departments was echoed by another Department 
Chair; 
There is a 'have' and 'have-not' community that has 
developed around the biotechnology funding. Even though 
the funding has not been academic, it has had a 
significant role in shaping academic departments. It is 
a loose cannon on our deck... It has shifted 
departments' emphasis to this kind of money, and 
contributed to the reorganization of the biological 
sciences. It also raises questions of the utility of the 
existing structures of departments. 
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Another Chairperson of a Core department underscores 
that, even though this narrowing of research emphases among 
the biological science program at Iowa State may be beneficial 
to his own department, the benefit is indeed of a selective 
nature; 
There is a dichotomy between people doing research at the 
molecular and organismic--or system--levels, and the 
funding has tended to favor the molecular emphasis... The 
funding has had an influence in that it may change the 
description of the positions we have to fill, in order to 
gear it towards that funding, but it's not a problem for 
this department because we fit very well into the 
molecular biology definition. 
In essence then, some of the interviews conducted with 
the executive officers of the Core and Supporting biotech 
departments lend qualitative credence to the quantitative 
trends evidenced in the FTE data: 1) biotechnology research 
may be achieving the ascendancy at the expense of other, more 
broadly-based, areas of research, and; 2) funding-driven 
research demands are significantly altering the traditional 
status quos of these departments (particularly within the 
biotech Core), through targeted faculty selection and 
resulting shifts in instructional and research emphases. 
In addition to the responses received by departmental 
executives and other departmental representatives, the 
biotechnology researchers themselves offered somewhat 
divergent perspectives on the impact that the biotechnology • 
funding has had on their departments. Of the 26 biotechnology 
faculty hired at Iowa State University prior to the 1991-1992 
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academic year, 23 were interviewed by the authors regarding 
their opinions on this, and a variety of other issues (three 
faculty refused to be interviewed). Of those twenty three 
faculty, most were of the opinion that the biotechnology 
project had indeed altered the nature of their departments, 
but in a positive way. Some of the researchers' comments are 
as follows: 
There has been a shift in the emphasis of my department, 
but I see this shift as a good thing. Molecular biology 
is a tool that can be used to study whatever subject you 
want. It was not established at I.S.U. prior to 1986. 
This opposition to molecular biology and 
biotechnology is an antiquated idea. They (referring to 
Non-Biotech faculty) think molecular biology is not 
chemistry, but you can't compete without it. No 
reputable university neglects hiring people who know how 
to do molecular biology. I came here because of people 
doing molecular biology and they can help ny research. 
Biotech is a technique--not a research goal. It's a 
tool to look at the same questions we've always looked 
at, like the electron microscope. It's the questions 
we're asking that are important--not the ways we look at 
them. They're just afraid of change (referring to those 
expressing concerns over the possible shift in 
departments' emphases). 
These concerns are not at all valid. This place had 
no molecular biology before this. It's only enhanced 
things. 
A total of ten of the interviewees were of the opinion 
that structural shifts had occurred in their departments, but 
that these shifts had improved overall departmental quality. 
But, a substantial minority expressed concerns about the 
long-term impact of the project. The following remarks are 
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indicative of these sentiments: 
The impact of the biotech money is a very real danger. 
The research going on is now so cellular and so molecular 
that it's almost too basic to find a direct application. 
It's not serving the constituency it's meant for--the 
farmers. And it's expensive in terms of instruments and 
personnel, and the technical support people they have, 
such as lab technicians. So the State has had to come up 
with astronomical salaries and other funds, and that's 
bad for morale. 
I'm biased. I don't think it (the biotech project) 
has had a beneficial effect. This department is breaking 
up into molecular biology and non-molecular biology... 
If it becomes a sole emphasis, this is a problem. 
Yes, this is redirecting departments. I'm not a 
gene jockey, I'm a (occupation stated). Some hires have 
been based on 'where's the most money to be gotten,' 
rather than 'what's the biggest problem.' 
This university is not in a net growth situation in 
terms of faculty. To the extent that biotechnology 
faculty have been hired, good progress is being made, but 
there is a lack of seed/start-up money for faculty in 
other areas. But this is less a problem with the 
biotechnology program than with not having enough money 
for other areas. 
A total of five interviewees were of the opinion that the 
biotech monies had had an impact on their departments, and 
that this impact was of a negative nature. 
A third theme was that the money had not really had an 
effect on departments: 
There have definitely not been these types of changes in 
our department. The department is hiring on people from 
diverse areas. The potential for problems is there, but 
it hasn't happened yet. 
I would really differ with those who say that this 
is re-directing departments. Molecular biology is just a 
tool. In the modern world, we must apply all the tools 
we have when we do an examination of something. The best 
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scientists use all of the tools that are available to 
them. 
A good scientist must be broadly based. If a 
department just wanted to hire applied people, that would 
be bad. But the biotech people work at very different 
levels. They work together to make a good, general 
department. 
I really don't think it's a problem. I don't like 
to view molecular biology as apart from other science. 
It's a tool and an expensive tool so we need funding for 
it. 
A total of four interviewees were of the opinion that the 
structural impact of the biotech funding was not redirecting 
the emphasis of departments. 
Four of the researchers declined to respond to this 
question. 
Thus, while many DEOs and researchers either deny that 
the biotech funds have had an impact on their departments or 
believe that the impacts that have occurred are of a positive 
nature, a substantial minority also proposes that the 
increased research emphasis may be narrowing the base of 
instructional and research expertise within their departments. 
Another important finding of the interviews with the 
biotech faculty regards the level of teaching activity in 
which they are personally involved. Interviewees were asked, 
'In percentage terms, how is your job balanced between 
teaching and research activities?' On average, the biotech 
faculty spend 72.44% of their time on research activities, 
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while only 27.56% of productive time was devoted to teaching 
activity. 
Summary 
It is evident that this study has revealed several major 
findings : 
1) The economic development biotechnology project has had a 
significant impact on recipient departments, primarily in 
terms of bringing about a marked proportional increase in 
research-oriented occupations (such as graduate students), and 
a proportional decrease in faculty. 
2) The occupational activities of employees have also been 
substantially altered, as evidenced by a dramatic increase in 
Contract and Grant-related research activities, and a decrease 
in Instructional activities. 
3) These trends have tended to be the most pronounced among 
those departments heavily involved in the economic development 
biotechnology project, and least pronounced among non-
participant departments. 
4) Some DEOs and researchers are critical of the.impact that 
the biotech monies have had on their departments, due to the 
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creation of divisions among faculty and an over-concentration 
on issues related to molecular, rather than organismic, 
biology. 
5) While both the raw number and proportional percentage of 
faculty has decreased during the period under examination, a 
growing proportion of remaining faculty are very research-
oriented. Students may therefore be negatively affected not 
only in terms of having fewer faculty in departments, but also 
in terms of having this shrinking number of faculty be far 
more focussed on research than teaching. 
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DISCUSSION AND CONCLUSIONS 
There are several theoretical levels from which these 
issues may be analyzed. On a broad level, a primary 
theoretical perspective which sheds considerable light on the 
implementation, operation, and impact of the biotechnology 
research effort at Iowa State University is Robert Merton's 
concept of 'manifest' and 'latent' functions (Merton, 1968). 
Manifest functions are those outcomes, impacts, or 
results that are intended to occur as the result of a given 
action or activity. For example, in the case of the 
biotechnology research effort at Iowa State University, it was 
previously discussed that the fundamental manifest function of 
this effort has been the stimulation of economic development 
within that State. Another manifest function would be the 
development of a research program in an area that is 
acknowledged to stand at the 'cutting edge' of modern 
scientific technology. 
Latent functions, on the other hand, are those outcomes, 
impacts, or results that are not intended or expected to occur 
as the result of a given action or activity. This is not to 
say that latent functions are of a negative nature; they are 
unexpected or unplanned, but positive in nature. For example, 
according to many of the biotech researchers, the I.S.U. 
program in molecular biology was underdeveloped prior to the 
implementation of the biotechnology research effort. While it 
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was not the manifest intent of the biotech appropriations 
package to resolve this apparent shortcoming at the 
university, it has certainly had that effect. Thus, the 
rectification of some academic inadequacies within the 
University appears to have been brought about by these 
appropriations. 
Another form of latent outcome however, is the 
'dysfunction'--an impact that is both unintended, and of a 
negative nature. Ironically, it appears that the fundamental 
dysfunctions that have resulted from the infusion of biotech 
research dollars at Iowa State have been evidenced among those 
departments that were the primary recipients of the money. 
These dysfunctions lend considerable credence to some of the 
general concerns mentioned earlier in the paper (under The 
Biotechnology Research Effort at Iowa State University). 
One of these concerns was that the increased trend 
towards university reliance on external research funds would 
redirect research efforts towards economic or corporate need, 
rather than academic merit. Clearly, the striking growth of 
C&G positions within the university (in nearly all 
occupational categories) lends quantitative credence to 
concerns over the growing influence of external funds. Some 
of the interviews with DEOs and the biotech researchers also 
lend qualitative credence to the concern (e.g., "Some hires 
have been based on 'where's the most money to be gotten,' 
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rather than 'what's the biggest problem'"). 
A second concern was that the economic development or 
profit-oriented research may be taking place at the expense of 
other areas of necessary research. Concern over these issues 
appears to be somewhat vindicated by the findings of this 
"study, due to the feeling expressed by some DEOs and 
researchers regarding the priority the biotechnology project 
(with its specializing influence) may be taking over the 
traditional needs of a broadly-based program of scientific 
research and education. In quantitative terms, it is clear 
that when overall Faculty PTEs are decreasing, but a growing 
share of the remaining PTEs are allotted towards the biotech 
project. Core Faculty FTE levels are being maintained at the 
expense of more traditional, generalist positions. 
A third issue was that the shift in research emphases 
created by this type of project may negatively affect 
instructional activities by diverting from the amount of time 
faculty are able to put into them, and by altering the nature 
of information that research specialists are able to convey to 
their students. The marked decrease in Instructional FTEs and 
increase in C&G FTEs clearly indicates that research 
activities have taken a numerical priority over instructional 
activities. Interviews with researchers also tend to verify 
the validity of this concern, with the average biotech 
researcher putting approximately three times as much time 
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and/or effort into research as is devoted to teaching. It 
would also stand to reason that the biotechnology faculty are 
not only more research-oriented than their predecessors, but 
also more specialized in terms of the level of instructional 
expertise they possess. 
A fourth concern dealt with how the status of graduate 
students and faculty may be altered by their affiliation with 
profit-oriented research ventures. While this study did not 
focus specific attention on this issue, it is clear that it 
will be of growing importance as more research projects (and 
the dollars that accompany them) become concentrated in the 
hands of fewer and fewer faculty. Also, as the number of 
graduate students involved in these types of projects grow 
dramatically (as has been the case at Iowa State University), 
the question of their current status within the university 
setting will also grow in importance. 
Another dysfunction not discussed earlier involves the 
division of faculty into opposing camps. Clearly, DEOs and 
researchers alike have expressed concerns regarding the intra-
departmental divisions that have arisen since the beginning of 
the biotechnology program at Iowa State. The general nature 
of the antagonism between the biotech 'haves' and 'have-nots' 
is apparent in the comments listed earlier in the paper. 
While the impacts of such a division are difficult to 
quantify, the fact remains that the presence of such 
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antagonisms are not likely to facilitate a positive research 
or instructional work environment. DEOs and other 
administrators must therefore be prepared to dedicate time and 
effort towards the resolution of such divisions, or run the 
risk of encountering a variety of morale-related problems. 
Thus, while some degree of success may have been achieved 
with regard to the manifest functions of I.S.U.'s 
biotechnology research effort (such as keeping the research in 
these departments on the 'cutting edge,' and contributing 
substantially to their on-going budgetary and professional 
needs), it is also clear that latent functions, and 
dysfunctions, have also arisen in the course of this 
implementation, and must be taken into consideration as the 
program continues to develop. 
In terms of taking a more specific theoretical approach 
in analyzing these issues, an organizational theory of 
fundamental relevance in understanding the changing structure 
of Iowa State University (and other universities involved in 
similar ventures) focuses on the issue of strategic management 
and adaptation (Snow et al., 1980; Hrebiniak et al., 1984). 
According to the strategic management approach, 
difficulties in the operational environment of an organization 
force it to adapt by formulating new strategies for operation. 
In order to achieve this, organizational managers assess what 
opportunities and threats are present in the external 
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environment, as well as what strengths and weaknesses exist 
within the organization itself. Once such assessments are 
completed, the best fit between external opportunities and 
internal strengths is determined, and new strategies, 
missions, and goals are formulated with the intent of 
preserving optimal organizational operation. 
With these new organizational missions and goals 
formulated, the organization then moves into the second stage 
of its adaptive process--strategy implementation (Hrebiniak et 
al., 1984). Strategy implementation basically involves 
redistributing organizational resources, and implementing 
operational changes, among the various elements within the 
organization; structures, control systems, human resources, 
technology, and corporate culture (Hrebiniak et al., 1984). 
The proposed result of this resource redistribution and 
operational alteration is the attainment of the adaptive 
pattern of operation deemed desirable in the 'strategy 
formulation' process. 
In the case of Iowa State University, it is clear that 
severe environmental difficulties faced the university as a 
result of budget cutbacks from federal and state sources. 
These cutbacks created the need for an adaptation to maintain 
organizational operation. An external opportunity then became 
apparent to the university, in the form of the growing 
biotechnology industry, and the wide variety of means by which 
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this technology could be applied to the agricultural economy 
(or corporate culture) in the state of Iowa. The pursuit of 
this opportunity also matched closely with the internal 
strengths of the university, in that it possesses a high 
capacity for technological research, as well as the human 
resources to undertake such research. 
A 'best fit' of internal strengths and external 
opportunities thus presented itself to university 
administrators, and the state government's appropriation of 
economic development funds allowed this structural, adjustment, 
and organizational adaptation, to occur. A clear process of 
interaction is thus evident between four of the five 
organizational elements mentioned above: opportunities present 
in the (1) corporate culture resulted in an internal 
reallocation of resources towards (2) technology and (3) human 
resources, which has had the end result of altering (4) 
departmental structures within the university. 
An important organizational problem with this process 
relates to the manner in which the biotechnology project is 
regarded by differing elements among the university. Shanklin 
et al. (1981) describe how the market share and growth 
potential of a venture may influence its receptivity by an 
organization. When a venture involves a new or rapidly-
expanding share of a given market (as is the case with 
biotechnology), it tends to receive a high organizational 
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priority in terms of resource allocation. However, on-going 
ventures in mature markets (such as non-biotechnological 
research efforts in the Core and Support departments) tend to 
be of a lower organizational priority. Often, such efforts 
are used as 'cash cows' to finance newer ventures, or--if they 
fail to bring in substantial or comparable profits--may be 
considered for divestment. 
This issue clearly relates to the apparent division that 
has occurred between many of the faculty in the Core and 
Support departments. DEOs and researchers alike have 
expressed concerns regarding the intra-departmental divisions 
that have arisen since the beginning of the biotechnology 
program at Iowa State. The general nature of the antagonism 
between the biotech 'haves' and 'have-nots' is apparent in the 
comments listed earlier in the paper. 
Neilsen (1968) addresses the fact that scarce resources 
in an environment such as an academic department will tend to 
throw competing groups into conflict with one another. 
Factors related to inequity (e.g., unequal rewards, an unequal 
distribution of power, and the uncertainty that may result 
from such factors) also serve to exacerbate existing conflicts 
(Daft, 1988). In the case of the biotechnology project at 
Iowa State University, such conditions are present in that the 
new biotechnology faculty receive substantial salaries, 
'start-up' funds, and equipment costs from the state, while 
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the older, non-biotechnology faculty members are subject to 
the same budgetary restraints that apply to other members of 
the university who are not involved in 'star' ventures. 
While the impacts of this division are difficult to 
quantify, the fact remains that the presence of such 
antagonisms are not likely to facilitate a positive research 
or instructional work environment. DEOs and other 
administrators must therefore be prepared to dedicate time and 
effort towards the resolution of such divisions, or run the 
risk of encountering a growing body of morale-related 
problems. 
A broader organizational problem relates to the 
previously-mentioned reformulation of strategies, missions, 
and goals that organizations use to adapt to difficulties in 
their operational environment. Once again, it must be pointed 
out that instruction and research are the primary functions of 
the university. And while it is true that the adaptive 
processes implemented by universities such as Iowa State have 
provided financially-strapped departments with the financial 
means .to survive, it may also be narrowing the body of 
teaching and research expertise within these departments. The 
university has therefore survived as an organization by 
adapting to environmental difficulties, but it has been (and 
is being) transformed by this process--with its primary 
functions of teaching and research apparently becoming 
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secondary as a result. 
It is therefore clear that some of the trends evidenced 
in the development of I.S.U.'s biotechnology program--whether 
they be labelled dysfunctional, or the products of adaptation 
to environmental hardship--may well be of a long-term 
detriment to the general functioning of the university. If 
the goals of the biotechnology program therefore work to the 
ultimate detriment of Iowa State University (in terms of 
negatively altering the disciplinary integrity of recipient 
departments, damaging the capacity for instruction, or 
altering the nature and direction of research), some degree of 
debate regarding the full extent and advisability of this 
course of organizational change should be undertaken. 
With these concerns in mind, several questions result 
from the findings of this study. If one of the primary 
purposes of the university is to create new knowledge, when 
does a university administration determine that this creation 
process has become overly influenced by conditional funding 
sources (such as private investments or economic development 
appropriations)? At what point does the nature of research 
become so focussed on one area of specialization that it 
actually serves as a detriment to the general character of a 
department? If another primary purpose of the university is 
to impart the knowledge it creates, at what point does the 
emphasis on research impinge upon the ability to convey 
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knowledge in terms of numbers of personnel allocated to 
perform that function? And, along this same line, at what 
point does the emphasis upon research impinge on the ability 
or motivation displayed by such personnel to carry out the 
instructional function effectively? These are all questions 
that Iowa State University will eventually have to answer as a 
result of its involvement in the biotechnology research 
program, and the overall shift towards research. 
With these questions in mind, it must also be said that 
it is not the intent of this paper to propose that the 
biotechnology project at Iowa State University, or other types 
of economic development projects around the country, are of no 
worth. Projects of this nature may provide many useful 
insights and breakthroughs that are of great importance to the 
long-term health of our economy and society. Indeed, over the 
course of the interviews conducted with the biotechnology 
researchers at Iowa State, the author was very impressed both 
with the quality of the researchers brought into the 
university, and the potential positive impact that their 
research may eventually have. 
However, while the positive aspects of such programs tend 
to receive much attention and fanfare, their possible 
detriments often remain unnoticed or ignored. As such 
programs grow in size and number, we must therefore be wary of 
the fact that there may be negative--as well as positive--
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implications for the universities and states that follow this 
program of economic development. The clear finding of this 
research is that universities participating in such an effort 
must be on guard for the structural changes that may result 
from it. As Jacobson (1991; 1) states: 
Whatever may happen to the overall economy in the months 
ahead... it is already clear that higher education will 
never return to the boom days of the 1980's. At a 
minimum... many institutions--both public and private--
are headed for a probing reassessment and realignment of 
what they can or should be, whom they should serve, and 
how they should attempt to handle all the tasks expected 
of them. 
Universities must therefore come to terms with the nature 
of the economic and political changes facing them. It is true 
that academic activities--namely, teaching and research--may 
be seriously impaired by the kinds of budget cutbacks 
experienced in recent years. Research-oriented, economic 
development funds may thus alleviate the pressures created by 
budgetary restrictions, and allow academic institutions to 
continue operation in the manner to which many of them have 
grown accustomed. However, it must also be realized that 
utilizing universities for purposes such as economic 
development, or altering the motivation, style, and basic 
direction of academic research may create long-term patterns 
within the operation of the university that stray considerably 
from past methods of operation. Whether such deviations are 
of a desirable nature should therefore be debated, and the 
lessons learned through the experiences of universities such 
94 
as Iowa State should serve to clarify matters for both sides 
of this debate. 
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INTRODUCTION 
Over the last several decades, much attention has been 
focussed upon the changing nature of the modern university, 
particularly in terms of its purpose, role, and 
responsibilities in today's research-hungry, business-oriented 
social world. Some have argued for a 'pristine' model of 
university operation, wherein the creation of knowledge 
(through research) is a process which remains unpolluted by 
the influences of the external world. Proponents of such a 
model argue that these external influences may serve to alter 
the nature or character of new knowledge, and also impinge 
upon academic freedom. Others, however, view the university 
in a more utilitarian light, stressing that the knowledge 
created by universities must not only build in some way upon 
past knowledge or achievements to create a general advancement 
in the cumulative body of knowledge in a given field, but also 
be of substantial, practical use in the 'real world.' 
Another debate regarding the operation of the nation's 
universities concerns their financial ability to adequately 
maintain these efforts at the creation of new knowledge 
through research. Over the last ten years, it has become 
increasingly clear that our nation's institutions of higher 
education are operating in a much harsher fiscal environment 
than has existed in previous decades. Shulman (1987) 
addresses how this situation has specifically affected the 
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research abilities of universities; 
According to the U.S. Department of Education, federal 
funding for university research dropped nearly 50 percent 
between 1980 and 1985, the last year for which the 
department kept aggregate totals. This trend is 
especially worrisome since the government still accounts 
for 70 percent of university research funds, (p. 11). 
Clearly, such dramatic cuts in research appropriations 
have the capacity to substantially alter both the level and 
nature of research taking place at our nation's universities. 
Why is this growing trend important? It is important 
because academia benefits in a variety of ways from the 
research it engages in. One fundamental benefit is that 
faculty involved in research supposedly enhance instructional 
quality by being 'current in their fields,' and in touch with 
the more practical applications of a given discipline. Along 
this same line, it should be noted that faculty are not the 
only university personnel who engage in research. Graduate 
and undergraduate students also play an integral part in many 
faculty research projects, and receive valuable training and 
experience from their participation in such efforts. 
Research is also becoming an increasingly important 
determinant of professional advancement for university 
faculty. Shao (1991) states; 
In recent years, hiring and tenure decisions have come to 
be based largely on a professor's ability to generate 
world-class research. The most important criteria in 
tenure decisions remain a professor's publications record . 
and reference letters, mostly from other researchers... 
If you're a mediocre researcher but an excellent teacher, 
you're unlikely to get tenure, (p. 126). 
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Therefore, when faculty reliant upon research for their 
professional advancement face greatly-reduced financial 
support from federal and state governments, they must seek out 
other sources of support to finance their on-going struggle 
for tenure and promotion. 
And, the benefits of academic research are by no means 
limited to academia. Society in general benefits from the 
wide variety of medical, technical, and social innovations 
that result from university research. Society could indeed 
suffer long-term detriments should the research capacities of 
our academic institutions be further altered or restricted in 
the current fiscal environment. 
It is also worth noting that it is not only the research 
activities of universities that have been affected by the 
current fiscal situation. Jacobson (1991) addresses the 
impact budget cuts have had on the instructional abilities of 
our nation's universities; 
Many academic leaders perceive that, even after the 
economy improves, their institutions will confront a 
major challenge involving tradeoffs between student 
access and academic quality. At least one of those 
traditional goals is likely to suffer, officials say, 
because neither state appropriations nor tuition rates 
will grow enough to finance them both as substantially as 
in the past. (p. 1). 
It is therefore clear that both of the primary functions 
of our nation's universities--research and instruction--have 
been negatively affected by this movement towards fiscal 
restraint and budgetary cutbacks. In response to this 
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situation, university administrators have been forced to seek 
alternate sources of replacement funding, in order to maintain 
previous levels of operation. To achieve this, some have 
sought to capitalize on another of the basic benefits that 
research provides academia--a demand-driven source of fiscal 
support. 
Essentially, the research capacity of an academic 
institution is a valuable asset, in that it offers a 
specialized ability to government or industry that may be too 
expensive or difficult to develop independently. A research 
contract thus represents an investment by government or 
industry in the university, since they are paying for a 
service, and expect an eventual profit or benefit in return 
for that payment. The commodification of research facilities 
and personnel can thus result in a much needed source of 
income for financially-strapped universities, and alleviate 
some of the strains caused by budgetary cutbacks. 
Rule (1988) underscores the special lure that this trend 
towards 'self-financing' university operations has taken on in 
recent years; 
Since the 1970s, American higher education as a whole has 
been experiencing a recession, if not a depression. The 
often indiscriminate expansion of the 1960s quickly gave 
way to a period where student populations were falling 
and where government support for research was cut, but 
where operating expenses rose sharply. Under these 
circumstances, the idea of making university functions 
self-financing has taken on a special appeal, (p. 433). 
As a result, Shulman (1987) concludes that, "...leading 
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universities are turning more and more to corporate support as 
federal funding decreases." (p. 11). 
However, not all forms of 'self-financed' research come 
from private corporations. While general research and 
development funds from the federal government have been cut 
dramatically, 'earmarked' funds continue to flow. Earmarked 
research awards are made without a competitive review of the 
merits of a specific research program or project. Earmarked 
research appropriations to colleges and universities have 
increased dramatically over the last four years, from only 
$225 million in FY 1988 to more than $684 million in FY 1992 
(Cordes et al., 1992). Critics accuse earmarking of being 
'pork barrel science,' and claim that its dramatic increase 
over the last four years is linked to both budgetary problems 
on campus, and a desperate attempt to spur economic recovery: 
...the scope of the practice (earmarking)--and the link 
between many of the projects and economic development--
reflects a severe financial squeeze on higher education 
and Congressional concerns about the faltering econoiry. 
(Cordes et al., 1992, p. 1). 
Earmarking may thus represent a congressional attempt to 
'kill two birds with one stone,' by awarding non-competitive 
research monies to financially-strapped universities, while 
channeling research awards into economic development projects. 
Many state governments appear to be using a similar 
technique in dealing with fiscal difficulties, by investing in 
university research--particularly technological research--to 
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inspire economic development. Blumenstyk (1992) states that, 
By the end of the decade (the 1980s) , nearly every state 
had created at least one program that provided grants to 
universities for research with commercial potential... 
In the 1980's, states sort of discovered technology... 
(p. 1). 
So, while general research appropriations from federal 
and state governments remain restricted in the wake of 
widespread budget cutbacks, the hope of quick economic payoffs 
has kept public funds for economic development projects 
(especially technological research) in ample supply. With 
revenues declining and operating costs increasing, many 
universities have therefore 'hired-out' their research 
abilities to private industries or governmental agencies in 
order to maintain fiscal solvency. 
This development is of great interest in light of the 
previously-mentioned debate over the role of the university in 
today's business-oriented social world. In a fiscal 
environment as adverse to academia as the one that has 
prevailed for the last decade or so, it is very difficult (if 
not impossible) for universities to function in a 'pristine' 
mode of operation. How does an institution requiring massive 
amounts of money for its continued operation remain unpolluted 
by the influences of the external world when it must rely on 
the external world for needed funds? 
Clearly, financial difficulties have forced universities 
into a more utilitarian mode of operation, as they 
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increasingly perform the research they are paid to perform 
rather than the research that is necessarily of the highest 
academic merit. Targeted or conditional funds from 
governmental or private sources (e.g., economic development 
and independent research projects, respectively) thus help 
universities maintain present levels of operation, but also 
serve to increase the influence of the suppliers of such funds 
on recipient universities. 
Many view this development as cause for alarm. Shulman 
(1987) states; 
According to Tufts University science historian Sheldon 
Krimsky and others, corporate interests threaten to skew 
research priorities. Krimsky...believes that 'when a 
university has its own for-profit sector, it means that 
the institution has to manage according to very different 
rules.' (p. 11). 
Rule (1988) also expresses concern about the trend, and 
states; 
When universities accommodate themselves too thoroughly 
to the agenda of non-university institutions, they begin 
to lose the qualities that make universities worth having 
in the first place, (p. 434). 
In light of this growing trend (and the alarm with which 
it is viewed), it is the intent of this paper to examine a 
specific case of shifting research and funding patterns at a 
prominent research university. By examining the changes in 
structure and mode of operation at an institution that has 
undergone this cycle of self-financing, it will become 
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possible to ascertain whether the fears expressed by people 
like Shulman and Rule are warranted. 
Biotechnology: A Growing Research Emphasis 
A prime example of the manner in which the trend towards 
economic development research may impact upon the structure 
and operation of universities is evident in the growing 
national effort that has centered upon the development and 
practical application of agricultural biotechnology. Due to 
the promising nature of many preliminary efforts utilizing . 
recombinant DNA technologies (growth hormones, herbicide 
resistance, disease resistance, reproduction enhancement, and 
many others), federal and state governments, as well as a 
variety of private sector interests, have begun to invest 
heavily in research focussing upon genetic engineering and 
agricultural biotechnology. 
In 1988, for example, the federal government was spending 
approximately $2.7 billion dollars annually for basic research 
in biotechnology (Lacy et al., 1988). While only $150 million 
of that money was earmarked specifically for the development 
of agricultural biotechnology, the National Research Council's 
Board on Agriculture recommended in 1988 that this level of 
funding be dramatically increased over a very short period of 
time, to approximately $500 million annually by 1990 (Moses et 
al., 1988). 
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State governments have also increased their funding of 
biotechnology research programs dramatically, and were 
spending a combined total of approximately $150 million 
annually on such projects by 1987 (OTA, 1986) . In comparison 
to the funding expenditures of the federal government, state 
governments are spending a considerably greater portion of 
these funds on the development of agricultural 
biotechnologies. Primary examples of projects established 
with the assistance of these funds are New York State's Center 
for Biotechnology in Agriculture at Cornell University and 
Iowa's Biotechnology Council at Iowa State University (Lacy et 
al., 1988). The goal of such expenditures is most often the 
establishment of research and development centers linking 
industry to universities, with the anticipated result of such 
linkages being the enhancement of economic development in 
these areas. 
In addition to these research expenditures by the federal 
and state governments, biotechnology industries have also 
invested heavily in university research. In 1984, for 
example, biotechnology companies awarded about $120 million in 
contracts and grants to universities (Lacy et al., 1988). As 
a result of these private investments, a variety of 
contractual linkages have also developed between these 
companies and individual faculty, departments, and institutes. 
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The Biotechnology Research Effort at Iowa State University 
The state-supported push for biotechnology research in 
Iowa's university system was begun in 1985, when the Iowa 
Development Commission, at the behest of the Seventy-first 
Iowa General Assembly, allocated the sum of $10 million to the 
state's public Board of Regents, public universities, and/or 
independent colleges. These funds were supplied by revenues 
drawn from the state's lottery program. In fiscal year 1985, 
the Iowa General Assembly allocated $500, 00.0 to Iowa State 
University for the purpose of agricultural biotechnology 
research. Additional appropriations were to follow, with the 
allocation of $3.75 million in 1986, and $4.25 million each 
for fiscal years 1987, 1988, and 1989 (Laws of the Seventy-
first Assembly, 1986 session). 
Research projects and products resulting from these 
appropriations have included the development of new 
biodegradable plastics, technologies for using cholesterol 
reductase to produce animal products with lower cholesterol 
content, and molecular and genetic techniques for the 
isolation of maize genes to control crop yields (among many 
others- Worthy, 1989). 
As has been previously stated, the fundamental goal of 
many biotechnology research efforts—and many private and 
public research efforts in general--is economic development. 
Iowa State's program is no exception to this trend, with the 
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explicitly-stated purpose of the General Assembly's allocation 
being the enhancement of economic development and research and 
development. That goal has remained intact throughout the 
implementation of the program, as evidenced by the remarks of 
the chairman of the oversight committee of the Iowa State 
Biotechnology Council, Walter Fehr: 
With regard to the vision for biotechnology at Iowa State 
University, our ultimate goal is to use the new 
techniques of molecular biology to enhance the economic 
welfare of the state. We believe that this will occur 
through research in three primary areas: (1) the 
development of new products from our traditional 
commodities through bioprocessing; (2) improving the 
efficiency and profitability of crop and livestock 
production; and (3) development of new products and 
processes through the genetic modification of plants, 
animals, and microorganisms. The vision of Iowa State 
University's biotechnology program is strongly influenced 
by the desire to fully utilize the agricultural resources 
of the state for the welfare of its constituents. (Fehr, 
1987). 
In order to bolster the effectiveness of this 
research-centric approach to economic development, technology 
transfer networks have been put in place at I.S.U. to enhance 
the speed and accessibility with which innovations may be 
transferred from the lab to local industries desirous of the 
new biotechnological advancements (e.g., the Eastman Kodak 
fermentation plant in Cedar Rapids, the Cargill biotechnology 
facility in Eddyville, and the Ajinomoto Heartland Lysine 
feed-additive plant, also located in Eddyville- Worthy, 1989) . 
To date, state policy makers appear content with the 
results of the biotechnology-grounded economic development 
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plan. Iowa's General Assembly has extended appropriations for 
the operation of the Biotechnology Council, and for the entire 
program of biotechnology research, beyond the initial 
three-year implementation period. And, in assessing the 
general effectiveness of the project, the state's governor, 
Terry E. Branstad, states; 
Iowa is turning biotech breakthroughs into business 
success stories. Partnerships between private industry 
and Iowa's two world-class research universities are 
resulting in innovative products and economic progress. 
(Worthy, 1989). 
Governor Branstad has even proposed budget increases for 
economic development projects based on university research 
like that taking place at Iowa State (Blumenstyk, 1992) . 
The effort to stimulate economic development through the 
creation of the biotechnology program at I.S.U. therefore 
appears to have met with a substantial degree of success. The 
university system in Iowa has been effectively used as a tool 
to promote this stimulation, and appears likely to continue 
the performance of this function for the foreseeable future. 
In essence, the state of Iowa's effort to stimulate 
economic development through funding university research in 
the ever-growing field of biotechnology serves as a model by 
which other states have, and may, attempt to undertake their 
own research-oriented programs of economic development in the 
future. As has been previously stated, by the end of the 
1980's, nearly every state had at least one program that 
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provided research grants to universities in the hope of 
spurring this kind of economic development. 
However, while state economies may receive a variety of 
benefits from this utilization of the university system, 
concerns have been raised regarding the effect that this 
growing tendency may have upon the universities participating 
in such programs. As Rule (1988) states; 
... what will exploitation of such profitable 
technologies do for--and to--the universities? Even if 
the more extravagant projections for biotechnology prove 
overblown, genetic engineering is bound to be among the 
biggest money-making activities associated with American 
universities in the 1990s. How will pursuit of such 
profits shape institutions supposedly predicated on 
values quite different from profitability? (p. 432). 
Growing numbers of analysts are therefore coming to 
recognize some of the more negative aspects that may accompany 
the increasing influence of public and private economic 
development funding for universities. Leslie Roberts (1983) 
states; 
In the face of declining federal support, universities 
need money for research and instruments. For industry, 
such agreements mean access to the scientific expertise 
that is still centered in the universities and rights to 
any patentable discoveries. And both sides espouse the 
societal good arising from rapid technology transfer. 
There is less agreement, however, on how serious a threat 
corporate funds pose to the integrity of the university, 
(page 159). 
The primary concern about this possible 'threat' involves 
the fear that an over-reliance on external, conditional funds 
(public or private) may diminish the institutional autonomy of 
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universities. This attack on academic autonomy may take a 
variety of forms. 
First, there is concern that the determination of what 
research is done--and how it is done--will come to be based 
more upon corporate/economic development needs than academic 
merit (Càldàrt, 1983). Shulman illustrates the potential for 
abuse that lies in this increased emphasis on economic 
outcomes and corporate needs; 
Although it is unusual for corporations to dictate 
research topics, corporations do discourage certain 
research. John Longwell, a chemical engineer at M.I.T.'s 
Energy Lab, thinks pre-grant discussions with potential 
corporate funders often have such an effect. For 
example, he says Exxon discourages about 20 percent of 
the ideas for new projects for the lab. (Shulman, 1987: 
p. 12) , 
Economic or business concerns may thus take precedence 
over academic merit or the public interest, due to the 
powerful monetary influence that lies behind such concerns. 
Writing with specific regard to the academic impact of 
biotechnology research. Lacy et al. (1988) also stress that 
the growing influence of biotechnology projects in 
universities and colleges may increase the potential for 
conflicts of interest or scientific misconduct resulting from 
the clash between public and private occupational demands. 
A second potential threat to university autonomy is that 
private interests may attempt to restrict the flow of 
information regarding research results (Lacy et al., 1988; 
Caldart, 1983) . Where research findings unencumbered by the 
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control of private funds are free to be made public (e.g., 
through publication in professional journals), research based 
on private funds may be legally restricted due to the 
competitive interests of corporate sponsors. 
The third concern over university autonomy is that long-
term university plans and policies may increasingly be shaped 
by a growing acquiescence to the needs of private investors 
(Caldart, 1983). A possible example of such acquiescence 
could be the alteration of curriculum offerings to more 
adequately fit the needs of the private sector. Rule (1988) 
warns that universities must; 
...ensure that new teaching ventures funded by, or in 
response to, lucrative forms of cooperation with outside 
agencies do not slight the less commercial elements of 
the liberal arts curriculum. If biotechnology firms want 
graduates who will serve as lab technicians and 
researchers, that possibility should hardly be denied to 
students planning careers. But undergraduates enrolling 
in programs conceived in response to such possibilities 
should have the same opportunities, or obligations, to 
study Plato's Republic or Shakespeare's sonnets offered 
to any undergraduate, (p. 435). 
Apart from the specific question of autonomy, Lacy et al. 
(1988) also raise the inter-institutional concern that the 
biotechnology push may result in an over-concentration of 
research funds and scientific talent at a small number of 
universities and colleges. 
Another concern specific to biotechnology research is 
that this industry is new, . and in a very tenuous state. Over 
three-quarters of biotechnology firms continue to lose money. 
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and, in 1988, at least 24 biotechnology companies filed for 
bankruptcy--and five of these were publicly supported (Lacy et 
al., 1988). A 1989 poll (Kumar, 1989) reflects this 
uncertainty by showing that a majority of executives in 
biotechnology companies believe that, within ten years, 
roughly half of the nearly 500 biotechnology companies in the 
United States will fail, merge, or form cost-sharing 
alliances. Over-reliance on a research specialization in such 
a tenuous field (or any one field) may thus present serious 
dangers to those academic departments (and universities in 
general) that allow themselves to become structurally or 
fiscally reliant upon them. 
Apart from the perils of the private sector, it appears 
that universities must also be wary of the publicly-based 
types of economic development funds that have sponsored 
projects such as the biotechnology research at Iowa State 
University. A recent issue of The Chronicle of Higher 
Education states that; 
Many states are losing their ardor for economic-
development programs based on research grants to 
universities. In the last few years several states have 
cut their financing for such research programs and 
shifted funds to projects designed to help small 
businesses and create jobs rapidly. More states are 
considering program cuts this year... state budget 
constraints, changes in political leadership, and a 
growing sense that pouring money into university 
laboratories is not the most efficient or effective way 
to help businesses and create jobs, have all put a damper 
on states' love affairs with the programs. (Blumenstyk, 
1992; p. 1). 
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Thus, the public sector offers little more security than 
the private sector in terms of providing stable, long-term 
financial support for this type of research project. 
The overall trend towards self-financing through state 
and federal economic development funds, or independent 
corporate research projects, may therefore serve to alter the 
makeup of the modern university by creating a greater reliance 
on these conditional types of funds than has been present in 
the past. Concern may also be warranted as to whether this 
more market-driven approach to university research may affect 
the social outcomes of research, and the future capacity for 
universities to undertake a broad base of independent research 
activities. 
An understanding of how such projects affect participant 
universities is thus not only of benefit or relevance to the 
State of Iowa, but to all states engaged in such programs of 
economic development--and all universities participating in 
these programs. In essence, while biotechnology research 
represents but one means by which economic development may be 
attempted by state governments, the process by which such 
projects occur, and the outcomes that result from them, may be 
similar regardless of the specific means at hand (such as 
biotechnology). The utilization of Iowa State University 
serves as a case-study by which the specific effects of such 
efforts may become more fully understood. Therefore, by 
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examining the situation at Iowa State University, it becomes 
possible to determine the likely impacts that biotechnology 
research in particular, and economic development projects in 
general, will have upon participant universities. 
The overriding hypothesis that therefore guides this 
research is that the large infusions of research monies that 
have been received by Iowa State University have altered the 
overall fiscal structure of the university, and that this 
structural alteration has in turn affected other important 
functions of the university, such as the creation of knowledge 
through research. 
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METHOD OF STUDY 
The first necessary step in assessing the impact of the 
biotechnology research effort at Iowa State University was to 
achieve a determination as to exactly which departments could 
be considered the primary beneficiaries of the biotechnology 
funding, which departments benefitted- but to a lesser degree, 
and which received no benefits at all. 
In order to achieve this determination, a technique known 
as 'snowball sampling,' or 'chain referral sampling,' was 
implemented among informed participants in the biotechnology 
research effort at Iowa State University (Kish, 1965: Kotz et 
al., 1982-1988). Under this method of examination, informed 
participants related to a given phenomenon are questioned not 
only with regard to desired information about the specific 
phenomenon under examination, but also in terms of referrals 
that may be given as to other informed participants whose 
knowledge of that phenomenon may be of additional use. Thus, 
the sample begins with a small set of initial elements, and 
ends with a larger set of elements connected with the initial 
set by one or more links of relationships (Kish, 1965: Kotz et 
al., 1982-1988). 
In the Iowa State sample, the initial set of informed 
participants consisted of the Departmental Executive Officers 
(DEOs) of two departments acknowledged to be active in the 
biotechnology research effort (since interviewees were 
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guaranteed confidentiality, names and departments of these 
interviewees shall not be listed). Interviews (conducted by 
phone, or in person, if requested by the interviewee) focussed 
primarily upon two basic questions: 1) 'Which departments 
would you describe as being central to the biotechnology 
research effort at Iowa State University (the 'Core'), and 
which are involved in the biotechnology research effort, but 
to a lesser degree (the 'Support' category); and, 2) 'Could 
you name three other persons familiar enough with the 
biotechnology research program to offer informed opinions on 
this question?' In addition, general comments regarding other 
aspects of the biotechnology research effort (e.g., 
effectiveness of its administration, success in the attainment 
of stated goals, etc.) were welcomed from all interviewees who 
offered them. 
Representatives (for the most part consisting of DEOs) 
were also contacted for all departments named as participants 
in either the Core or Support categories, but for whom a 
specific representative was not named in the course of the 
'snowballing' process. All participating 'Core' and 'Support' 
departments were thus represented by at least one spokesperson 
in the course of the interviews. Ultimately, 22 interviews 
were conducted with DEOs and other departmental 
representatives. 
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As a result of these interviews, twelve departments were 
determined to operate within the Core of the biotechnology 
research effort: Biochemistry/Biophysics, Genetics, Zoology, 
Horticulture, Agronomy, Chemical Engineering, Chemistry, Plant 
Pathology, Botany, Veterinary Microbiology and Preventive 
Medicine, Veterinary Pathology, and Veterinary Anatomy. Nine 
additional departments were determined to function within the 
Support category: Microbiology, Animal Science, Food 
Technology, Food and Nutrition, Forestry, Entomology, 
Veterinary Physiology and Pharmacology, Veterinary Clinical 
Sciences, and the Veterinary Diagnostic Laboratory (see 
Appendix I for departments not included in either the Core or 
Support categories). Six non-academic divisions of the 
University were not included in the analysis (Ames Laboratory, 
Statistics Laboratory, World Food Institute, Computation 
Center, Institute for Physical Research and Technology, and 
Iowa State Water Resources Research Institute). 
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FINDINGS 
With the determination of the Core, Support, and Non-
Biotech departments made, it becomes possible to detect what 
differential impact the large infusions of biotechnology 
research monies have had upon these groupings. The 
determination of these impacts is based upon comprehensive 
records of all university research expenditures for the period 
beginning Fiscal Year (FY) 1983/1984, and ending FY 1989/1990. 
Thus, for purposes of comparison, the first three years of 
this period reflect a time in which no biotechnology funding 
was received by the university, and the last four years 
reflect a period of heavy biotechnology funding, as the 
research effort was implemented (data for this analysis was 
gathered with the cooperation of Iowa State University's 
Office of the Associate Provost for Research). These 
expenditures fall into three separate groupings : General 
Research, Agricultural Experiment Station (AES), and Contracts 
and Grants (C&G). The biotechnology expenditures fall within 
the C&G category (according to Walter Fehr of Iowa State 
University's Biotechnology Council). 
In comparing these three categories, it is evident that 
C&G expenditures have experienced a dramatic increase over the 
seven year period under examination (Figure 1, Table 1). 
C&G expenditures were at their low in the first year of the 
study, amounting to only $18.4 million. However, by the 
0 
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Fi-Ture 1. Academic research expenditures 
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Table 1. Overall academic research expenditures 
Gen. Res. AES C&G Total 
83/84 5553071 11786497 18424670 35764238 
84/85 6590840 13140555 20365497 40096892 
85/86 6496972 11432037 21841883 39770892 
86/87 6994011 11547952 24867641 43409604 
87/88 7639076 14748257 28476857 50864190 
88/89 7876711 14441439 38943678 61261828 
89/90 2664204 16931656 46012676 65608536 
end of the period, they had climbed to a peak of approximately 
$46 mi11ion--amounting to an increase of approximately 250% in 
just seven years. AES expenditures also increased during this 
same period, from about $11.8 million in FY 83/84 to $16.9 
million in FY 89/90. General Research expenditures increased 
slightly for the first six years of the period, and decreased 
sharply in FY 89/90. 
It is also useful to examine these categories in terms of 
the percentages they constitute of the overall research 
expenditures for the university (Figure 2, Table 2). Again, 
we see a dramatic increase in the percentage share of the C&G 
category, from a low of 51.5% of all research expenditures in 
FY 83/84 to a high of 70.1% in FY 89/90. While the dollar 
amount of AES expenditures increased as described in the 
previous paragraph, its percentage of overall expenditures 
actually declined over the seven year period, from 32.9% in FY 
83/84 to 25.8% in FY 89/90. The percentage share of General 
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Figure 2. Funding categories as a percentage 
of the overall academic budget 
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Table 2. Funding categories as a percentage of overall budget 
Gen .. Res. AES C&G Tot. 
83/84 15. 53 32 .96 51 .52 100 
84/85 16. 44 32 .77 50 .79 100 
85/86 16. 34 28 .74 54 .92 100 
86/87 16. 11 26 .60 57 .29 100 
87/88 15. 02 28 .99 55 .99 100 
88/89 12. 86 23 .57 63 .57 100 
.89/90 4. 06 25 .81 70 .13 100 
six years of the period, but decreased from approximately 
12.8% to 4% in FY 89/90. 
Another set of findings arises when these shifts in 
research expenditures are examined within the context of the 
aforementioned biotech departmental categorization. Within 
the Core departments (Table 3, Figure 3), the C&G share of 
research expenditures rises from a low of approximately 54.2% 
in FY 83/84 to a high of 66.5% in FY 89/90. AES expenditures 
hold relatively constant over the seven year period, while 
General Research expenditures also hold relatively constant 
except for a sharp decline of about 6.5 percentage points in 
FY 89/90. 
In the Support category (Table 4, Figure 4), C&G 
expenditures experience an even more dramatic increase than is 
present in the Core category. C&G expenditures steadily 
increase from a low of 42.5% in FY 85/86, to a peak of 
approximately 66% in FY 89/90. The AES share of Support 
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Figure 3. Côre funding source analysis 
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Figure 4. Support funding source analysis 
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Table 3. Core funding source analysis 
% from gen. res. % from AES % from C&G Total 
83/84 17.36 28.48 54.16 100.00 
84/85 16.92 27.34 55.73 99.99 
85/86 15.89 26.22 57.89 100.00 
86/87 16.14 23.54 60.32 100.00 
87/88 15.97 23.91 60.12 100.00 
88/89 14.2 23.4 62.4 100.00 
89/90 7.58 25.92 66.49 99.99 
Table 4. Support funding source analysis 
% from gen. res. % from AES % from C&G Total 
83/84 1.89 55.19 42.91 99.99 
84/85 2.01 54.74 43.24 99.99 
85/86 1.97 • 55.54 42 .49 100.00 
86/87 2 53.06 44.94 100.00 
87/88 1.63 51.99 46.39 100.01 
88/89 1.33 42.84 55.82 99.99 
89/90 0.1 33.89 66.02 100.01 
period, falling from a peak of 55.54% in FY 85/86 to a low of 
approximately 33.9% in FY 89/90. General Research 
expenditures hold relatively constant throughout the period. 
The dramatic increase in C&G funding is also present 
among the Non-Biotech departments (Figure 5, Table 5). C&G 
expenditures constitute only 52.6% of the Non-Biotech research 
expenditures in FY 83/84, but increase to 74.8% by FY 89/90. 
AES decreases from 28.3% of Non-Biotech research expenditures 
in FY 83/84, to 17.3% in FY 89/90. General Research also 
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Figure 5. Non-Biotech funding source analysis 
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Table 5. Non-Biotech funding source analysis 
% from gen. res. % from AES % from C&G Total 
83/84 19.14 28.27 52.59 100.00 
84/85 21.39 29.22 49.39 100.00 
85/86 22.11 21.04 56.85 100.00 
86/87 21.14 19.94 58.92 100.00 
87/88 18.46 25.83 55.71 100.00 
88/89 15.71 17.33 66.96 100.00 
89/90 3.28 21.9 74.83 100.01 
Another perspective on the data may be gained by 
examining these budget fluctuations as fund types rather than 
departmental categories. In other words, rather than looking 
at what percentage C&G funds constituted of total Core 
expenditures, it may be useful to examine what percentage the 
Core constituted of total C&G expenditures. 
The significance of these changes may be tested by 
constructing a comparison of beginning and ending points for 
each of the three funding categories (Table 6). Such a 
comparison is useful in that the first year of data 
(1983/1984) represents a period which saw no biotechnology 
funding, while the last year of data (1989/1990) reflects a 
period in which the.project was well underway. 
In Table 6, the Mean value represents the Mean amount of 
change (+ or -) in the raw number of dollars expended between 
FYs 1983/1984 and 1989/1990 for a given funding category. For 
example, the Mean value of -$44,722 for Core General Research 
Funds represents an average decrease of $44,722 of General 
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Table 6. A comparison of beginning and end-point mean 




















































*p <. 05 
Research Funds per department within the Core over the seven 
years of available data. The Pr>F value represents the 
overall level of significance for these changes. A Scheffe' 
Multiple Comparison was then utilized in order to determine 
the significance of Mean differences for each of the possible 
pairings of departmental categories: Core-Support (C-S); Core-
Non-Biotech (C-N), and; Support-Non-Biotech (S-N) (Agresti and 
Finlay, 1986). 
This general analysis yields statistically significant 
results only for the overall research expenditures of the 
university. In this category, it is demonstrated that, over 
the seven years of available data. Core research expenditures 
have increased by an average of $636,961 per department. 
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Support expenditures have increased by an even more dramatic 
$710,131 per department. Non-Biotech departments have 
averaged an increase of only $208,181 per department. And, 
while changes within the other funding categories were not 
found to be statistically significant (due to high 
variability), the dramatic increase in C&G funds for the Core 
and Support Departments is worth noting. 
Another important aspect of the data is revealed when the 
three biotech categorizations are compared with one another, 
in terms of the percentage that each category constitutes of 
overall research expenditures (Figure 6, Table 7). These 
figures show that the percentages have fluctuated considerably 
during the six year period under examination, with Core 
expenditures steadily increasing in the three years prior to 
the appropriation of biotechnology funding, holding relatively 
constant in the first year of the program, and declining 
rapidly in the second, third, and fourth years of the program. 
Thus, while the per-department levels of research expenditures 
have increased in the manner described in Table 6, the 
percentage that the Core constitutes of overall research 
expenditures has actually declined considerably since the 
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Figure 6. Core, Support, and Non-Biotech percentages 
of the total budget 
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Table 7. Core, Support, and Non-Biotech percentages of total 
budget 
Core Support Non i-Biotech Total 
83/84 37 .23 17 .12 45. 65 100 
84/85 38 .31 16 .74 44. 95 100 
85/86 40 .00 16 .32 43. 68 100 
86/87 40 .42 15 .72 43. 86 100 
87/88 37 .65 14 .87 47. 48 100 
88/89 34 .81 16 .18 49. 01 100 
89/90 • 33 .89 21 .24 44. 88 100.01 
The decline of research expenditures is even more 
dramatic with the introduction of a 'hypothetical alternative' 
scenario, in which research expenditures are examined as if 
biotechnology funding had not been appropriated during the 
1986-1989 period (Figure 6--complete information for FY 89/90 
appropriations is not yet available). These findings thus 
indicate that general expenditures have not only decreased on 
the whole for the Core departments during this period, but 
that non-biotechnological research has undergone a dramatic 
decline as well, from a high of 40.03% of expenditures in 
fiscal year 1985/1986, to a low of 34.13% in fiscal year 
1987/1988. Much of this decline, then, is attributable to the 
absence of substantial increases in General Research and AES 
expenditures during the entire period under examination 
(Figure 3). As is evident, while C&G expenditures (again, the 
funding category which reflects the infusion of biotechnology 
money) have increased considerably, the percentage of 
expenditures attributable to General Research and AES sources 
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has declined to a comparable degree. The university therefore 
becomes more dependent on money from external sources, as 
research funds from sources internal to the university 
continue to decline. So, while increases in research 
expenditures attributable to biotechnology funding have been 
considerable, levels of funding from the university have held 
relatively constant, resulting in an overall decline in the 
percentage such monies contribute to total university research 
expenditures. 
The specific result of these developments for the Core 
departments has been the creation of a substantial capacity to 
undertake biotechnology research, and an apparently-dramatic 
decrease in the ability (at least, in financial terms) to 
undertake other forms of non-biotechnological research. And, 
while the increased biotechnology expenditures have offset 
this general decline in Core expenditures to an extent, they 
have not been substantive enough to prevent an overall decline 
in the proportional budgetary level of representation that 
these departments held in the years prior to the establishment 
of the biotechnology research effort. 
A second means by which changes in the fiscal structures 
of the Core and Supporting departments becomes evident is in 
the variety of opinions offered during interviews with 
departmental representatives. Over the course of these 
interviews, several of the DEOs attempted to convey the 
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qualitative impact that these quantitative, monetary shifts 
have had upon their departments. 
For example, a Chairperson in one of the Core research 
•departments states; 
The most important aspect of the biotechnology funding is 
the competition for start-up funds. We have been able to 
hire good people with the funding, and that definitely 
affects the structure of the department. It also affects 
the nature of the people we hire, so it shifts the 
emphasis of the research they do, and that emphasis has 
shifted dramatically to biotechnology, to the neglect of 
other areas of research. 
The biotechnology money is necessary but not 
sufficient because it restricts the scope of research to 
molecular biology. This may eventually do away with a 
good program on general biology and just leave us with a 
narrower expertise on molecular biology. 
Concern over the changing internal research structures of 
the biotechnology departments was echoed by another Department 
Chair; 
There is a 'have' and 'have-not' community that has 
developed around the biotechnology funding. Even though 
the funding has not been academic, it has had a 
significant role in shaping academic departments. It is 
a loose cannon on our deck... It has shifted 
departments' emphasis to this kind of money, and 
contributed to the reorganization of the biological 
sciences. It also raises questions of the utility of the 
existing structures of departments. 
Another Chairperson of a Core department underscores 
that, even though this narrowing of research emphases among 
the biological science program at Iowa State may be a benefit 
to his own department, the benefit is indeed of a selective 
nature; 
There is a dichotomy between people doing research at the 
molecular and organismic--or system--levels, and the 
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funding has tended to favor the molecular emphasis... The 
funding has had an influence in that it may change the 
description of the positions we have to fill, in order to 
gear it towards that funding, but it's not a problem for 
this department because we fit very well into the 
molecular biology definition. 
In essence then, the interviews conducted with the 
executive officers of the Core and Supporting biotech 
departments lend some qualitative credence to the quantitative 
trends evidenced in the research expenditure data: 
biotechnology research may be achieving the ascendancy at the 
expense of other, more broadly-based, areas of research; 
research demands are significantly altering the traditional 
status quos of these departments (particularly within the 
biotech Core), in terms of faculty selection, the impact of 
these selections upon traditional departmental makeup, and the 
impact that this shifting makeup will have upon the overall 
research and instructional emphases of departments. 
In addition to the responses received by departmental 
executives and other departmental representatives, the 
biotechnology researchers themselves offered somewhat 
divergent perspectives on the impact that the biotechnology 
funding has had on their departments. Of the 26 biotechnology 
faculty hired at Iowa State University prior to the 1991/1992 
academic year, 23 were interviewed by the author regarding 
their opinions on this, and a variety of other issues (three 
faculty refused to be interviewed). Of those twenty three 
faculty, most were of the opinion that the biotechnology 
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project had indeed altered the nature of their departments, 
but in a positive way. Some of the researchers' comments are 
as follows: 
The biological sciences are developing a more molecular 
orientation. I think it's very good that this is 
happening. That's where biology is going... Iowa State 
had no molecular biologists before 1986. It's really 
necessary that Iowa State increase in this area if it 
wants to keep its place in the world... It's easier to 
get a grant in molecular biology than other areas, and I 
think other areas get pissed off at molecular biologists 
because of this. 
This university was way behind in molecular biology, 
and this (the biotechnology funding) has helped to catch 
it up. This is where the exciting science will happen 
over the next ten years... My department is not overly 
focussed on molecular biology. 
Biotechnology funds have hired people we would not 
have otherwise been able to hire. It's something that 
was needed. It brought molecular biology onto campus. 
There are certain areas of science clearly at the 
forefront. If you want to stay in the lead, you have to 
keep up. The biotech money has allowed us to do this. 
This is just a case of sour grapes. Some scientists 
are failing to keep up with the science of the '90s, and 
are not using an integrated approach. If they are not 
willing to use an integrated approach, they can't get the 
money. They are using the science of 25 years ago, and 
they feel that time has passed them by. 
A total of ten of the interviewees were of the opinion 
that structural shifts had occurred in their departments, but 
that these shifts had improved overall departmental quality. 
But, a substantial minority expressed concerns about the 
long-term impact of the project. The following remarks are 
indicative of these sentiments: 
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The impact of the biotech money is a very real danger. 
The research going on is now so cellular and so molecular 
that it's almost too basic to find a direct application. 
It's not serving the constituency it's meant for--the 
farmers. And it's expensive in terms of instruments and 
personnel, and the technical support people they have, 
such as lab technicians. So the State has had to come up 
with astronomical salaries and other funds, and that's 
bad for morale. 
I'm biased. I don't think it (the biotech project) 
has had a beneficial effect. This department is breaking 
up into molecular biology and non-molecular biology... 
If it becomes a sole emphasis, this is a problem. 
Yes, this is redirecting departments. I'm not a 
gene jockey, I'm a (occupation stated). Some hires have 
been based on 'where's the most money to be gotten,' 
rather than 'what's the biggest problem.' 
This university is not in a net growth situation in 
terms of faculty. To the extent that biotechnology 
faculty have been hired, good progress is being made, but 
there is a lack of seed/start-up money for faculty in 
other areas. But this is less a problem with the 
biotechnology program than with not having enough money 
for other areas. 
A total of five interviewees were of the opinion that the 
biotech monies had impacted their departments, and that this 
impact was of a negative nature. 
A third theme was that the money had not really had an 
effect on departments: 
There have definitely not been these types of changes in 
our department. The department is hiring on people from 
diverse areas. The potential for problems is there, but 
it hasn't happened yet. 
I would really differ with those who say that this 
is re-directing departments. Molecular biology is just a 
tool. In the modern world, we must apply all the tools 
we have when we do an examination of something. The best 
scientists use all of the tools that are available to 
them. 
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A good scientist must be broadly based. If a 
department just wanted to hire applied people, that would 
be bad. But the biotech people work at very different 
levels. They work together to make a good, general 
department. 
I really don't think it's a problem. I don't like 
to view molecular biology as apart from other science. 
It's a tool and an expensive tool so we need funding for 
it. 
Four interviewees were of the opinion that the biotech 
monies had not substantially altered the emphasis of their 
departments. Four of the researchers declined to respond to 
this question. 
Thus, while many DEOs and researchers either deny that 
the biotech funds have had an impact on their departments or 
believe that the impacts that have occurred are of a positive 
nature, a substantial minority also proposes that the 
increased research emphasis may be narrowing the base of 
research expertise within their departments (due to the 
perception that the biotechnology faculty possess a more 
specialized professional focus). 
Having said this, it is also important to note that the 
vast majority of researchers view the biotech 'seed' monies as 
being very successful in helping them to bring in additional 
external research monies. Nineteen of the 23 interviewees 
stated that, based on their own personal experiences, the 
monies had been very successful in this regard; 
Yes--the seed monies to faculty have definitely been a 
success. Most faculty have already more than paid for 
themselves, and from this point on it'll only get better. 
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But I don't know if it's really had any impact on the 
economy of the state. 
Putting together federal and private funds, I've 
brought in two times as much as I was given for the 
start-up. Yes, for me it's been very successful. 
In my case, I received $150,000 in start-up funds, 
and brought in about $700,000 in return. I think all of 
the biotech faculty have received outside funding. 
Two researchers stated that they were too new to be able 
to accurately answer the question, while two others expressed 
the view that the monies for the most part "provided pork" to 
older faculty--but that they personally had put start-up 
monies to good use. 
In summary, it is evident that this study has revealed 
several major findings: 
1) C&G expenditures, reflective of external sources of 
research funding, have experienced dramatic increases in all 
departmental categorizations over the last seven years. These 
increases have occurred in terms of raw dollar amounts, as 
well as the percentage that such funds constitute of overall 
university research expenditures. Departments throughout the 
university have thus developed a greatly increased reliance 
upon external 'contract and grant' funding for their 
operation. 
2) Ironically, the Core departments' overall share of 
university research expenditures has decreased since the 
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beginning of the biotech program, indicating a possible 
administrative overestimation of external returns on the 
biotech funds. 
3) Core departments have also experienced a significantly 
reduced level of funding for non-biotech related research. 
While the receipt of the economic development funds has helped 
to cushion the impact of this decrease, it also increases the 
likelihood that Core departments may become structurally 
transformed as a result of these monies. This tendency may 
lead to a much higher level of financial dependence by Core 
departments on the biotech research and monies. 
4) There is substantial agreement with the perception that 
some structural transformation has already occurred among 
departments participating in the biotech research effort. 
Many feel the structural changes are positive in nature, in 
that previously-neglected research areas or techniques have 
become highly developed and sophisticated. However, a 
substantial minority of DEOs and researchers are critical of 
the impact that the biotech monies have had on their 
departments, in terms of the creation of divisions among 
faculty and an over-concentration on issues related to 
molecular, rather than organismic, biology. 
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5) The vast majority of researchers view the economic 
development 'seed' monies as being very successful at helping 
them to bring in additional external sources of private and 
public funds. 
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DISCUSSION AND CONCLUSIONS 
A broad theoretical perspective which sheds considerable 
light on the implementation and operation of the biotechnology 
research effort at Iowa State University- and its impacts- is 
Robert Merton's notion of 'manifest' and 'latent' functions 
(Merton, 1968). 
Manifest functions are those outcomes, impacts, or 
results that are intended to occur as the result of a given 
action or activity. For example, in the case of the 
biotechnology research effort at Iowa State University, it was 
previously discussed that the fundamental manifest function of 
this effort has been the stimulation of economic development 
within that state. Another would be the development of a 
research program in an area that is acknowledged to stand at 
the 'cutting edge' of modern scientific technology. 
Latent functions, on the other hand, are those outcomes, 
impacts, or results that are not intended or expected to occur 
as the result of a given action or activity. This is not to 
say that latent functions are of a negative nature; they are 
unexpected or unplanned, but of a positive nature. For 
example, according to many of the biotech researchers, the 
I.S.U. program in molecular biology was underdeveloped prior 
to the implementation of the biotechnology research effort. 
While it was not the manifest intent of the biotech 
appropriations package to resolve this apparent shortcoming at 
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Iowa State, it has certainly had that effect. Thus, the 
rectification of some structural inadequacies within the 
university appears to have been brought about by these 
appropriations. 
Another form of latent outcome however, is the 
'dysfunction'--an impact that is both unintended, and of a 
negative nature. Ironically, it appears that the fundamental 
dysfunctions that have resulted from the infusion of biotech 
research dollars at Iowa State have been evidenced among those 
departments that were the primary recipients of the money. 
While it is true that these monies have indeed kept the 
research in these departments on the 'cutting edge,' and 
contributed substantively to meeting their on-going budgetary 
and professional needs, it also appears that it may have had a 
variety of negative results for recipient departments. 
A primary problem appears to be that the infusion of 
biotechnology research monies may have enabled the university 
administration to cut other, non-biotech research funds to 
recipient departments (particularly within the Core). Funding 
for non-biotechnology research and personnel in these 
departments has thus decreased considerably during the initial 
three-year implementation of the research effort, as alternate 
sources of non-biotechnology replacement funding have 
apparently not been received to any substantial degree (Figure 
6, Table 7). So, while departments have benefitted to a 
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degree from the receipt of the biotech funds, non-biotech 
funding has decreased dramatically. The concerns voiced by 
some DEOs and researchers regarding the narrowing focus of 
Core departments thus appears to have found quantitative 
grounding in the findings of this study. 
A second possible problem is that there may have been an 
overestimation in the anticipated amount of external funds 
that would result from the biotech project (at least, in the 
short term). Two elements of the data lead to this possible 
conclusion. First, there has been a steady decline in total 
biotechnology' research expenditures during the three-year 
implementation period (from $2,640,001 in FY 86/87, to 
$2,300,000 in FY 87/88, to $1,019,720 in FY 88/89--according 
to Glenda Webber, former Program Assistant with the I.S.U. 
Biotechnology Council). Second, the Core's proportion of 
overall academic research expenditures has decreased steadily 
during the first four years of the program. 
In addition to these specific issues, it is useful to 
examine the relevance these findings hold in terms of the 
general concerns (university autonomy, financial over-reliance 
on economic development or private funds, etc.) mentioned 
earlier in the paper. Clearly, the increased reliance on C&G 
funds indicates that concerns over corporate influence on, and 
the flow of information from, university laboratories will 
grow in importance as the research program develops. It must 
149 
be remembered that the seed monies of the biotech program at 
Iowa State have only just taken root. As research efforts 
develop and more corporate monies flow in to support these 
efforts, faculty and administration alike will increasingly 
have to deal with this issue. 
A more immediate concern may be the growing reliance of 
universities on these tenuous types of funds. Earlier, it was 
mentioned that a growing number of states have become 
increasingly skeptical of the link between university research 
and economic development. Blumenstyk (1992) raises this issue 
with specific regard for the situation in Iowa; 
Some states, including New Jersey and Texas, still 
strongly support their research programs and have 
substantially maintained their financing. And some 
governors, notably Iowa's Terry Branstad, a Republican, 
are proposing budget increases for economic development 
based on university research. But examples of 
disenchantment abound... the states' research-oriented 
programs are suffering because the payoffs are too 
distant, and the programs lack techniques to measure 
their effectiveness in the short term. They also have 
depended too heavily on support from the governors who 
created them... (p. 24, 25). 
So, while the Governor of Iowa remains a strong ally of 
this approach to research and development, it is clear that he 
is a member of a shrinking minority. Universities benefitting 
from such programs must therefore be wary not only of the 
market fluctuations related to specialized research efforts, 
but also of the political fluctuations that could terminate 
support for such efforts. 
On a similar note, it bears mentioning that the 
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biotechnology program at Iowa State has been closely 
associated with the 'earmarking' of federal appropriations 
discussed earlier. In fiscal year 1992 alone, the Department 
of Agriculture awarded $2,865 million to Iowa State's Midwest 
Plant Biotechnology Consortium (to be shared with 17 other 
universities) and $1,953 million, also for an Iowa State 
biotechnology consortium to be shared with the University of 
Iowa and the Iowa Department of Economic Development (Cordes 
et al., 1992). In light of growing political concern with 
earmarking, a heightened reliance on this type of money may 
also put those dependent upon it in a precarious financial 
position. 
Another dysfunction that was not discussed earlier 
involves the division of faculty into opposing camps. 
Clearly, DEOs and researchers alike have expressed concerns 
regarding the intra-departmental divisions that have arisen 
since the beginning of the biotechnology program at Iowa 
State. The general nature of the antagonism between the 
biotech 'haves' and 'have-nots' is apparent in the comments 
listed earlier in the paper. While the impacts of such a 
division are difficult to quantify, the fact remains that the 
presence of such antagonisms are not likely to facilitate a 
positive work environment. DEOs and other administrators must 
therefore be prepared to dedicate time and effort towards the 
resolution of such divisions, or run the risk of encountering 
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a variety of morale-related problems. 
Thus, while some degree of success may have been achieved 
with regard to the manifest functions of I.S.U.'s 
biotechnology research effort, it is also clear that latent 
functions, and dysfunctions, have also arisen in the course of 
this implementation, and must be taken into consideration as 
the program continues to develop. 
In terms of taking a more specific theoretical approach 
in analyzing these issues, an organizational theory of 
fundamental relevance in understanding the changing structure 
of Iowa State University (and other universities involved in 
similar ventures) focuses on the issue of strategic management 
and adaptation (Snow et al., 1980; Hrebiniak et al., 1984). 
According to the strategic management approach, 
difficulties in the operational environment of an organization 
force it to adapt by formulating new strategies for operation. 
In order to achieve this, organizational managers assess what 
opportunities and threats are present in the external 
environment, as well as what strengths and weaknesses exist 
within the organization itself. Once such assessments are 
completed, the best fit between external opportunities and 
internal strengths is determined, and new strategies, 
missions, and goals are formulated with the intent of 
preserving optimal organizational operation. 
With these new organizational missions and goals 
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formulated, the organization then moves into the second stage 
of its adaptive process--strategy implementation (Hrebiniak et 
al., 1984). Strategy implementation basically involves 
redistributing organizational resources, and implementing 
operational changes, among the various elements within the 
organization; structures, control systems, human resources, 
technology, and corporate culture (Hrebiniak et al., 1984). 
The proposed result of this resource redistribution and 
operational alteration is the attainment of the adaptive 
pattern of operation deemed desirable in the 'strategy 
formulation' process. 
In the case of Iowa State University, it is clear that 
severe environmental difficulties faced the university as a 
result of budget cutbacks from federal and state sources. 
These cutbacks created the need for an adaptation to maintain 
organizational operation. An external opportunity then became 
apparent to the university, in the form of the growing 
biotechnology industry, and the wide variety of means by which 
this technology could be applied to the agricultural economy 
(or corporate culture) in the state of Iowa. The pursuit of 
this opportunity also matched closely with the internal 
strengths of the university, in that it possesses a high 
capacity for technological research, as well as the human 
resources to undertake such research. 
A 'best fit' of internal strengths and external 
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opportunities thus presented itself to university 
administrators, and the state government's appropriation of 
economic development funds allowed this structural adjustment, 
and organizational adaptation, to occur. A clear process of 
interaction is thus evident between four of the five 
organizational elements mentioned above: opportunities present 
in the (1) corporate culture resulted in an internal 
reallocation of resources towards (2) technology and (3) human 
resources, which has had the end result of altering (4) 
departmental structures within the university. 
An important organizational problem with this process 
relates to the manner in which the biotechnology project is 
regarded by differing elements among the university. Shanklin 
et al. (1981) describe how the market share and growth 
potential of a venture may influence its receptivity by an 
organization. When a venture involves a new or rapidly-
expanding share of a given market (as is the case with 
biotechnology), it tends to receive a high organizational 
priority in terms of resource allocation. However, on-going 
ventures in mature markets (such as non-biotechnological 
research efforts in the Core and Support departments) tend to 
be of a lower organizational priority. Often, such efforts 
are used as 'cash cows' to finance newer ventures, or--if they 
fail to bring in substantial or comparable profits--may be 
considered for divestment. 
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This issue clearly relates to the apparent division that 
has occurred between many of the faculty in the Core and 
Support departments. DEOs and researchers alike have 
expressed concerns regarding the intra-departmental divisions 
that have arisen since the beginning of the biotechnology 
program at Iowa State. The general nature of the antagonism 
between the biotech 'haves' and 'have-nots' is apparent in the 
comments listed earlier in the paper. 
Neilsen (1968) addresses the fact that scarce resources 
in an environment such as an academic department will tend to 
throw competing groups into conflict with one another. 
Factors related to inequity (e.g., unequal rewards, an unequal 
distribution of power, and the uncertainty that may result 
from such factors) also serve to exacerbate existing conflicts 
(Daft, 1988). In the case of the biotechnology project at 
Iowa State University, such conditions are present in that the 
new biotechnology faculty receive substantial salaries, 
'start-up' funds, and equipment costs from the state, while 
the older, non-biotechnology faculty members are subject to 
the same budgetary restraints that apply to other members of 
the university who are not involved in 'star' ventures. 
While the impacts of this division are difficult to 
quantify, the fact remains that the presence of such 
antagonisms are not likely to facilitate a positive research 
or instructional work environment, DEOs and other 
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administrators must therefore be prepared to dedicate time and 
effort towards the resolution of such divisions, or run the 
risk of encountering a growing body of morale-related 
problems. 
A broader organizational problem relates to the 
previously-mentioned reformulation of strategies, missions, 
and goals that organizations use to adapt to difficulties in 
their operational environment. Once again, it must be pointed 
out that instruction and research are the primary functions of 
the university. And while it is true that the adaptive 
processes implemented by universities such as Iowa State have 
provided financially-strapped departments with the financial 
means to survive, it may also be narrowing the body of 
teaching and research expertise within these departments. The 
university has therefore survived as an organization by 
adapting to environmental difficulties, but it has been (and 
is being) transformed by this process--with its primary 
functions of teaching and research apparently becoming 
secondary as a result. 
It is therefore clear that some of the trends evidenced 
in the development of I.S.U.'s biotechnology program--whether 
they be labelled dysfunctional, or the products of adaptation 
to environmental hardship--may well be of a long-term 
detriment to the general functioning of the university. If 
the goals of the biotechnology program therefore work to the 
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ultimate detriment of Iowa State University (in terms of 
negatively altering the disciplinary integrity of recipient 
departments, damaging the capacity for instruction, or 
altering the nature and direction of research), some degree of 
debate regarding the full extent and advisability of this 
course of organizational change should be undertaken. 
Therefore, with these concerns in mind, several questions 
result from the findings of this study. If one of the primary 
purposes of the university is to create new knowledge, when 
does a university administration determine that this creation 
process has become overly influenced, restricted and/or 
specialized by forces external to the university? At what 
point do participating departments become altered by external 
forces to such a degree that they no longer meet the needs 
they were originally intended to meet? And, if universities 
are to become increasingly reliant upon external research 
monies (public or private) for their operation, does this 
reliance present a danger if the projects and their funding 
are focussed in an area, on an industry, or from a source that 
is itself in a tenuous state? In other words, is it wise to 
tie the operation of our public universities this closely to 
the fluctuations and uncertainties of the marketplace or the 
ballot box? 
With these questions in mind, it must also be said that 
it is not the intent of this paper to propose that the 
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biotechnology project at Iowa State University, or other types 
of economic development projects around the country, are of no 
worth. Projects of this nature may provide many useful 
insights and breakthroughs that are of great importance to the 
long-term health of our econoijny and society. Indeed, over the 
course of the interviews conducted with the biotechnology 
researchers at Iowa State, the author was very impressed both 
with the quality of the researchers brought into the 
University, and the potential positive outcomes that their 
research may eventually create. 
However, while the positive aspects of such programs tend 
to receive much attention and fanfare, their possible 
detriments often remain unnoticed or ignored. As such 
programs grow in size and number, we must therefore be wary of 
the fact that there may be negative--as well as positive--
implications for the universities and states that follow this 
program of economic development. The clear finding of this 
research is that universities participating in such an effort 
must be on guard for the structural changes that may result 
from it. Jacobson (1991) states: 
Whatever may happen to the overall economy in the months 
ahead... it is already clear that higher education will 
never return to the boom days of the 1980's. At a 
minimum. .. many institutions--both public and private--
are headed for a probing reassessment and realignment of 
what they can or should be, whom they should serve, and 
how they should attempt to handle all the tasks expected 
of them. (p. 1). 
Universities must therefore come to terms with the nature 
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of the economic and political changes facing them. It is true 
that academic research may be seriously impaired by the kinds 
of budget cutbacks experienced in recent years. Economic 
development and corporate funds may thus alleviate the 
pressures created by budgetary restrictions, and allow 
academic institutions to continue operation in the manner to 
which many of them have grown accustomed. However, it must 
also be realized that utilizing universities for purposes such 
as economic development, or altering the motivation, style, 
and basic direction of academic research may create long-term 
patterns within the operation of the university that stray 
considerably from past methods of operation. Whether such 
deviations are of a desirable nature should therefore be 
debated, and the lessons learned through the experiences of 
universities such as Iowa State should be taken into account 
by others involved in, or considering involvement in, a 
similar course of action. 
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INTRODUCTION 
Academic institutions have traditionally been charged 
with two basic instructional functions in our society; the 
provision of quality education, and the provision of adequate 
access to quality education. However, recent restrictions on 
both federal and state funding for universities may severely 
hamper their ability to continue performing these functions 
adequately. A recent issue of the Chronicle of Higher 
Education states: 
Many academic leaders perceive that, even after the 
economy improves, their institutions will confront a 
major challenge involving tradeoffs between student 
access and academic quality. At least one of those 
traditional goals is likely to suffer, officials say, 
because neither state appropriations nor tuition rates 
will grow enough to finance them both as substantially as 
in the past. (Jacobson, 1991, p. 1). 
It is proposed that these problematic 'tradeoffs' may 
take a wide variety of forms, including enrollment caps, cuts 
in faculty, larger class sizes, fewer course offerings, 
tuition increases, cuts in student services, and others 
(Jacobson, 1991). In essence, due to the current fiscal 
situation around the country, colleges and universities must 
be prepared to either limit their current accessibility to 
students, or risk decreasing the quality of instruction that 
is offered to them. 
Apart from instruction, another important function of our 
institutions of higher education is the creation of knowledge 
through research. As has been the case with instruction, many 
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universities have experienced considerable difficulty 
regarding their financial ability to adequately maintain 
research efforts. Shulman (1987) addresses how this situation 
has affected the research abilities of universities; 
According to the U.S. Department of Education, federal 
funding for university research dropped nearly 50 percent 
between 1980 and 1985, the last year for 'which the 
department kept aggregate totals. This trend is 
especially worrisome since the government still accounts 
for 70 percent of university research funds, (p. 11). 
Clearly, such dramatic cuts in research appropriations 
have the capacity to substantially alter both the level and 
nature of research taking place at our nation's universities. 
Why is this growing trend important? It is important 
because academia benefits in a variety of ways from the 
research it engages in. One fundamental benefit is that 
faculty involved in research supposedly enhance instructional 
quality by being 'current in their fields,' and in touch with 
the more practical applications of a given discipline. Along 
this same line, it should be noted that faculty are not the 
only university personnel who engage in research. Graduate 
and undergraduate students also play an integral part in many 
faculty research projects, and receive valuable training and 
experience from their participation in such efforts. 
Research is also becoming an increasingly important 
determinant of professional advancement for university 
faculty. Shao (1991) states; 
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In recent years, hiring and tenure decisions have come to 
be based largely on a professor's ability to generate 
world-class research. The most important criteria in 
tenure decisions remain a professor's publications record 
and reference letters, mostly from other researchers... 
If you're a mediocre researcher but an excellent teacher, 
you're unlikely to get tenure, (p. 126). 
When faculty reliant upon research for their professional 
advancement face greatly-reduced financial support from 
federal and state governments, they must therefore seek out 
other sources of support to finance their on-going struggle 
for tenure and promotion. 
It is also important to note that the benefits of 
academic research are by no means limited to academia. 
Society in general benefits from the wide variety of medical, 
technical, and social innovations that result from university 
research. Society could indeed suffer long-term detriments 
should the research capacities of our academic institutions be 
further altered or restricted in the current fiscal 
environment. 
It is therefore clear that both of the primary functions 
of our nation's universities--research and instruction--have 
been negatively affected by this movement towards fiscal 
restraint and budgetary cutbacks. In response to this 
situation, university administrators have been forced to seek 
alternate sources of replacement funding, in order to maintain 
previous levels of operation. To achieve this, some have 
sought to capitalize on another of the basic benefits that 
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research provides academia—a demand-driven source of fiscal 
support. 
Essentially, the research capacity of an academic 
institution is a valuable asset, in that it offers a 
specialized ability to government or industry that may be too 
expensive or difficult to develop independently. A research 
contract thus represents an investment by government or 
industry in the university, since they are paying for a 
service, and expect an eventual profit or benefit in return 
for that payment. The commodification of research facilities 
and personnel can thus result in a much needed source of 
income for financially-strapped universities, and alleviate 
some of the strains caused by budgetary cutbacks. 
Rule (1988) underscores the special lure that this trend 
towards 'self-financing' university operations has taken on in 
recent years; 
Since the 1970s, American higher education as a whole has 
been experiencing a recession, if not a depression. The 
often indiscriminate expansion of the 1960s quickly gave 
way to a period where student populations were falling 
and where government support for research was cut, but 
where operating expenses rose sharply. Under these 
circumstances, the idea of making university functions 
self-financing has taken on a special appeal, (p. 433). 
Shulman (1987) concludes that, "...leading universities 
are turning more and more to corporate support as federal 
funding decreases." (p. 11). 
However, not all forms of 'self-financed' research come 
from private corporations. While general research and 
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development funds from the federal government have been cut 
substantially, 'earmarked' funds continue to flow. Earmarked 
research awards are made without a competitive review of the 
merits of a specific research program or project. Earmarked 
research appropriations to colleges and universities have 
increased dramatically over the last four years, from only 
$225 million in FY 1988 to more than $684 million in FY 1992 
(Cordes et al., 1992). 
Critics accuse earmarking of being 'pork barrel science,' 
and claim that its dramatic increase over the last four years 
is linked to both budgetary problems on campus, and a 
desperate attempt to spur economic recovery: 
...the scope of the practice (earmarking)—and the link 
between many of the projects and economic development--
reflects a severe financial squeeze on higher education 
and Congressional concerns about the faltering economy. 
(Cordes et al., 1992, p. 1). 
Earmarking may thus represent a congressional attempt to 
'kill two birds with one stone,' by awarding non-competitive 
research monies to financially-strapped universities, while 
channeling research awards into economic development projects. 
State governments have also turned towards investing in 
university research--particularly technological research--to 
inspire economic development. Blumenstyk (1992) states that. 
By the end of the decade (the 1980s), nearly every state 
had created at least one program that provided grants to 
universities for research with commercial potential... 
In the 1980's, states sort of discovered technology... 
(p. 1). 
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So, while federal and state appropriations for 
instructional uses remain largely restricted due to concern 
over tax and tuition rates, the hope of quick economic payoffs 
has kept public funds for targeted research (especially 
technological research) in ample supply. With revenues 
declining and operating costs increasing, many universities 
have therefore been forced to 'hire-out' their research 
abilities to private industries or governmental agencies in 
order to maintain fiscal solvency. However, while such 
arrangements may be effective at maintaining a given level of 
operation for financially-strapped universities and 
departments, uncertainty exists as to what impact they will 
have on the style of operation for these entities. It is the 
intent of this paper to examine this issue. 
Biotechnology: A Growing Research Emphasis 
A prime example of the manner in which the trend towards 
research enhancement may impact upon the structure and 
operation of universities is evident in the effort to develop 
practical applications for agricultural biotechnology. Due to 
the promising nature of many preliminary efforts utilizing 
recombinant DNA technologies (growth hormones, herbicide 
resistance, disease resistance, reproduction enhancement, and 
many others), federal and state governments, as well as a 
variety of private sector interests, have begun to invest 
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heavily in research focussing upon genetic engineering and 
agricultural biotechnology. In 1988, for example, the federal 
government was spending approximately $2.7 billion dollars 
annually for basic research in biotechnology (Lacy et al., 
1988). While only $150 million of that money was earmarked 
specifically for the development of agricultural 
biotechnology, the National Research Council's Board on 
Agriculture recommended in 1988 that this level of funding be 
dramatically increased over a very short period of time, to 
approximately $500 million annually by 1990 (Moses et al., 
1988) . 
State governments have also increased their funding of 
biotechnology research programs dramatically, and were 
spending a combined total of approximately $150 million 
annually on such projects by 1987 (OTA, 1986). And, in 
comparison to the funding expenditures of the federal 
government, state governments are spending a considerably 
greater portion of these funds on the development of 
agricultural biotechnologies. Prime examples of projects 
established with these funds are New York State's Center for 
Biotechnology in Agriculture at Cornell University and Iowa's 
Biotechnology Council at Iowa State University (Lacy et al., 
1988) . The hoped-for result of such expenditures is most 
often the establishment of research and development centers 
linking industry to universities. The anticipated result of 
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such linkages is the enhancement of economic development. 
In addition to research expenditures by federal and state 
governments, biotechnology industries have also invested 
heavily in university research. In 1984 for example, 
biotechnology companies awarded about $120 million in 
contracts and grants to universities (Lacy et al., 1988). As 
a result of these private investments, a variety of 
contractual linkages have also developed between these 
companies and individual faculty, departments, and institutes. 
The Biotechnology Research Effort at Iowa State University 
The state-supported push for biotechnology research in 
Iowa's university system was begun in 1985, when the Iowa 
Development Commission, at the behest of the Seventy-first 
Iowa General Assembly, allocated the sum of $10 million to the 
state's public Board of Regents, public universities, and/or 
independent colleges. These funds were supplied by revenues 
drawn from the State's lottery program. In fiscal year 1985, 
the Iowa General Assembly allocated $500,000 to Iowa State 
University for the purpose of agricultural biotechnology 
research. Additional appropriations were to follow, with the 
allocation of $3.75 million in 1986, and $4.25 million each 
for fiscal years 1987, 1988, and 1989 (for a total of $17 
million in the first three years of the program- Shelley et 
al., 1990). 
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Research projects and products resulting from these 
appropriations have included the development of new 
biodegradable plastics, technologies for using cholesterol 
reductase to produce animal products with lower cholesterol 
content, and molecular and genetic techniques for the 
isolation of maize genes to control crop yields (among many 
others- Worthy, 1989). 
As has been previously stated, the fundamental goal of 
many biotechnology research efforts--and many private and 
public research efforts in general--is economic development. 
Iowa State's program is no exception to this trend, with the 
explicitly-stated purpose of the General Assembly's allocation 
being the enhancement of economic development. That goal has 
remained intact throughout the implementation of the program, 
as evidenced by the remarks of Walter Fehr, Chairman of the 
Oversight Committee of the Iowa State Biotechnology Council: 
With regard to the vision for biotechnology at Iowa State 
University, our ultimate goal is to use the new 
techniques of molecular biology to enhance the economic 
welfare of the state. We believe that this will occur 
through research in three primary areas: (1) the 
development of new products from our traditional 
commodities through bioprocessing; (2) improving the 
efficiency and profitability of crop and livestock 
production; and (3) development of new products and 
processes through the genetic modification of plants, 
animals, and microorganisms. The vision of Iowa State 
University's biotechnology program is strongly influenced 
by the desire to fully utilize the agricultural resources 
of the state for the welfare of its constituents. (Fehr, 
1987) . 
In order to bolster the effectiveness of this 
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research-centric approach to economic development, technology 
transfer networks have also been put in place at I.S.U. These 
networks are designed to enhance the speed and accessibility 
with which innovations may be transferred from the lab to 
local industries desirous of. the new biotechnological 
advancements (e.g., the Eastman Kodak fermentation plant in 
Cedar Rapids, the Cargill biotechnology facility in Eddyville, 
and the Ajinomoto Heartland Lysine feed-additive plant, also 
located in Eddyville- Worthy, 1989) . 
To date, state policy makers appear content with the 
results of the biotechnology-grounded economic development 
plan. Iowa's General Assembly has extended appropriations for 
the operation of the Biotechnology Council, and for the entire 
program of biotechnology research, beyond the initial 
three-year implementation period. And, in assessing the 
general effectiveness of the project, the state's governor, 
Terry E. Branstad, states, 
Iowa is turning biotech breakthroughs into business 
success stories. Partnerships between private industry 
and Iowa's two world-class research universities are 
resulting in innovative products and economic progress. 
(Worthy, 1989). 
And, Governor Branstad has even proposed budget increases 
for economic development projects based on university research 
like that taking place at Iowa State (Blumenstyk, 1992). 
The effort to stimulate economic development through the 
creation of the biotechnology program at I.S.U. therefore 
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appears to have met with a substantial degree of success.' The 
university system in Iowa has been effectively used as a tool 
to promote this stimulation, and appears likely to continue 
the performance of this function for the foreseeable future. 
In essence then, the state of Iowa's effort to stimulate 
economic development through funding university research in 
the ever-growing field of biotechnology serves as a model by 
which other states have, and may, attempt to undertake their 
own research-oriented programs of economic development in the 
future. As has been previously stated, by the end of the 
1980's, nearly every state had at least one program that 
provided research grants to universities in the hope of 
spurring this kind of economic development. 
However, while state economies may receive a variety of 
benefits from this utilization of the university system, 
concerns have been raised regarding the effect that this 
growing tendency may have upon the universities themselves. 
Shulman (1987) states; 
According to Tufts University science historian Sheldon 
Krimsky and others, corporate interests threaten to skew 
research priorities. Krimsky...believes that 'when a 
university has its own for-profit sector, it means that 
the institution has to manage according to very different 
rules.' (p. 11). 
Rule (1988) also expresses concern about the trend, and 
states; 
... . what will exploitation of such profitable 
technologies do for--and to--the universities? Even if 
the more extravagant projections for biotechnology prove 
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overblown, genetic engineering is bound to be among the 
biggest money-making activities' associated with American 
universities in the 1990s. How will pursuit of such 
profits shape institutions supposedly predicated on 
values quite different from profitability? 
...when universities accommodate themselves too 
thoroughly to the agenda of non-university institutions, 
they begin to lose the qualities that make universities 
worth having in the first place, (p. 432, 434). 
Growing numbers of analysts are therefore coming to 
recognize some of the more negative aspects that may accompany 
the increasing influence of economic development and private 
funding for research in universities. Leslie Roberts (1983) 
states; 
In the face of declining federal support, universities 
need money for research and instruments. For industry, 
such agreements mean access to the scientific expertise 
that is still centered in the universities and rights to 
any patentable discoveries. And both sides espouse the 
societal good arising from rapid technology transfer. 
There is less agreement, however, on how serious a threat 
corporate funds pose to the integrity of the university, 
(page 159). 
A primary concern about this possible 'threat' involves 
the fear that an over-reliance on external, conditional funds 
(public or private) may diminish the institutional autonomy of 
universities. This attack on academic autonomy may take a 
variety of forms. 
First, there is concern that the determination of what 
research is done--and how it is done--will come to be based 
more upon corporate/economic development needs than academic 
merit (Caldart, 1983). The following excerpt illustrates the 
potential for abuse that lies in this increased emphasis on 
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economic outcomes and corporate needs; 
Although it is unusual for corporations to dictate 
research topics, corporations do discourage certain 
research. John Longwell, a chemical engineer at M.I.T.'s 
Energy Lab, thinks pre-grant discussions with potential 
corporate funders often have such an effect. For 
example, he says Exxon discourages about 20 percent of 
the ideas for new projects for the lab. (Shulman, 1987: 
p. 12). 
Economic or business concerns may thus take precedence 
over academic merit or the public interest, due to the 
powerful monetary influence that lies behind such concerns. 
Writing with specific regard to the academic impact of 
biotechnology research. Lacy et al. (1988) also stress that 
the growing influence of biotechnology projects in 
universities and colleges may increase the potential for 
conflicts of interest or scientific misconduct resulting from 
the clash between public and private occupational demands. 
A second proposed threat to university autonomy is that 
private interests may attempt to restrict the flow of 
information regarding research results (Lacy et al., 1988; 
Caldart, 1983). Where research findings unencumbered by the 
control of private funds are free to be made public (e.g., 
through publication in professional journals), research based 
on private funds may be legally restricted due to the 
competitive interests of corporate sponsors. 
The third concern over university autonomy is that long-
term university plans and policies may increasingly be shaped 
by a growing acquiescence to the needs of private investors 
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(Caldart, 1983) . A possible example of such acquiescence 
could be the alteration of curriculum offerings to more 
adequately fit the needs of the private sector. Rule (1988) 
warns that universities must; 
...ensure that new teaching ventures funded by, or in 
response to, lucrative forms of cooperation with outside 
agencies do not slight the less commercial elements of 
the liberal arts curriculum. If biotechnology firms want 
graduates who will serve as lab technicians and 
researchers, that possibility should hardly be denied to 
students planning careers. But undergraduates enrolling 
in programs conceived in response to such possibilities 
should have the same opportunities, or obligations, to 
study Plato's Republic or Shakespeare's sonnets offered 
to any undergraduate, (p. 435). 
Apart from the specific question of autonomy, a fourth 
set of concerns relates to how the status of graduate students 
and faculty may be altered by their affiliation with profit-
oriented research ventures. Rule (1988) states; 
How is the university to treat faculty and students 
associated with such 'profit centers'? As ordinary 
university citizens, subject to the same rules as others 
in terms of promotion, tenure, teaching and academic 
freedom (for faculty) and grading, distribution 
requirements, fellowships and progress toward degrees 
(for students)? Can the university act as investment 
manager toward an organization consisting of its own 
people, while still maintaining its role as a university? 
Unable to answer in the affirmative. President Bok of 
Harvard, at the urging of his faculty, declined in 1980 
to institute such a corporate experiment there, (p. 433). 
In essence, universities will increasingly be faced with 
the question of whether the more 'profitable' faculty and 
graduate students will be held to the same standards and 
rigors as those of a less business-oriented character. 
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A fourth set of concerns relates to the impact that the 
growing emphasis on research may have on the instructional 
abilities and capacities of academic institutions. Using 
Stanford University as an example, Maria Shad (1991) describes 
how research responsibilities tend to take precedence over 
instructional duties; 
Grants represent 28% of the school's research and 
instruction budget and make stars of the people who win 
them. Faculty can even 'buy out' of teaching by using 
grants to pay part of their salaries. Temporary teachers 
pick up the slack, (p. 126). 
Rule (1988) examines this issue not only with regard to 
the general priority research appears to take over teaching, 
but also with regard to the way in which shifting research 
emphases may eventually result in shifting teaching emphases; 
One form of responsibility incumbent on universities is 
to make available to students a wide array of 
intellectual possibilities. University collaboration 
with outside agencies may lead to distortion of such 
possibilities. There is the danger that curricula may be 
skewed toward the profitable, rather than the profound. 
Faculty absorbed in lucrative research ventures may be 
unwilling or unable to help students consider research 
problems whose merits are strictly intellectual. And all 
this may be true without conscious intent on the part of 
faculty, (p. 434). 
Lending possible credence to this concern is the fact 
that curriculum offerings are being altered around the 
country, both to accommodate the needs of the burgeoning 
biotechnology industries (in order to provide them with 
trained personnel), as well as to serve as a vent through 
which the expertise of the growing number of university 
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biotechnologists may find curricular release. Each year, 
growing numbers of universities, colleges, and institutes have 
incorporated courses in biotechnology into their curricular 
offerings, and have established undergraduate majors in 
biotechnplogical fields (Amatniek, 1983) . 
The push towards research may therefore affect 
instructional activities in two basic ways; by diverting from 
the amount of time or effort faculty are able to put into 
them, and by altering the nature or body of information.that 
research specialists are willing or able to convey to their 
students. 
A fifth, related concern raised by Lacy et al., (1988), 
concerns the possibility that the expansion in biotechnology 
research may result in the neglect of research into other 
important disciplinary and methodological perspectives. For 
example, scientists may become so focussed on molecular 
methods of reproduction enhancement that more traditional 
forms of plant or animal breeding (which may be more cost 
effective and efficient than biotechnological methods) become 
underutilized and increasingly unexplored. Thus, economic 
development or profit-oriented research may not only redirect 
existing research efforts (the first primary concern), but 
also re-direct them at the expense of other areas of necessary 
research (the second fundamental concern). 
Another concern specific to biotechnology research is 
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that this industry is new, and in a very tenuous state. Over 
three-quarters of biotechnology firms continue to lose money, 
and, in 1988, at least 24 biotechnology companies filed for 
bankruptcy--and five of these were publicly supported (Lacy et 
al., 1988). Also reflecting this uncertainty was a 1989 poll 
(Kumar, 1989) showing that a majority of executives in 
biotechnology companies believe that, within ten years, 
roughly half of the nearly 500 biotechnology companies in the 
United States will fail, merge, or form cost-sharing 
alliances. Over-reliance on a research specialization in such 
a tenuous field (or any one field) may thus present serious 
dangers to those academic departments (and universities in 
general) that allow themselves to become structurally or 
fiscally reliant upon them. 
Apart from the perils of the private sector, it appears 
that universities must also be wary of the publicly-based 
types of economic development funds that have sponsored 
projects such as the biotechnology research at Iowa State 
University. A recent issue of The Chronicle of Higher 
Education states; 
Many states are losing their ardor for economic-
development programs based on research grants to 
universities. In the last few years several states have 
cut their financing for such research programs and 
shifted funds to projects designed to help small 
businesses and create jobs rapidly. More states are 
considering program cuts this year... state budget 
constraints, changes in political leadership, and a 
growing sense that pouring money into university 
laboratories is not the most efficient or effective way 
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to help businesses and create jobs, have all put a damper 
on states' love affairs with the programs. (Blumenstyk, 
1992; p. 1). 
Thus, the public sector offers little more security than 
the private sector in terms of providing stable, long-term 
financial support for this type of research project. 
And, lastly. Lacy et al. (1988) also raise the inter-
institutional concern that the biotechnology push may result 
in an over-concentration of research funds and scientific 
talent at a small number of universities and colleges. 
The overall trend towards 'self-financing' university 
operation through the attainment of private or public economic 
development research funds may therefore serve to alter the 
makeup of the modern university by placing a heavier emphasis 
on research-oriented activities than has been present in the 
past. Concern may also be warranted as to whether this more 
market-driven approach to university research may affect the 
social outcomes of research, and the future capacity for 
universities to adequately fulfill instructional 
responsibilities, as well as undertake a broad base of 
independent, 'no strings attached' research activities (among 
a wide variety of other concerns). 
An understanding of how economic development projects 
impact upon participant universities is thus not only of 
benefit or relevance to the State of Iowa, but to all states 
engaged in such programs--and all universities participating 
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in these programs. The overriding hypotheses that therefore 
guide this research are; 1) The large infusions of research 
monies related to the biotechnology project have altered the 
fiscal and occupational structure of the university, and; 2) 
this recent alteration in operational emphasis has in turn 
altered the ability of the university to perform the 
instructional and research functions it was originally 
intended to perform. 
By examining the situation at Iowa State University, it 
becomes possible to determine the likely impacts that 
biotechnology research in particular—and economic development 
research projects in general--will have upon participant 
universities. In essence, while biotechnology research 
represents but one means by which economic development may be 
attempted by state governments, the processes by which such 
projects occur, and the outcomes that result from them, may be 
similar regardless of the specific means at hand (such as 
biotechnology). The utilization of Iowa State University 
therefore serves as a case-study by which the specific effects 
of such efforts may become more fully understood. 
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METHOD OF STUDY 
The first step necessary in assessing the impact of the 
biotechnology research effort on Iowa State University was to 
determine: 1) which departments should be considered the 
primary beneficiaries of the biotechnology funding; 2) which 
departments benefitted--but to a lesser degree, and; 3) which 
received no benefits at all. 
In order to achieve this determination, a technique known 
as 'snowball sampling,' or 'chain referral sampling,' was 
implemented among informed participants in the biotechnology 
research effort at Iowa State University. Under this method 
of examination, informed participants are questioned not only 
with regard to their own knowledge of a given phenomenon, but 
also regarding their knowledge of other informed participants 
who may possess information relevant to the phenomenon. Thus, 
the sample begins with a small set of elements, and ends with 
a larger set of elements that are in some way connected to the 
initial set (Encyclopedia of Statistical Sciences, c.1982-
1988) . 
In the Iowa State sample, the initial set of informed 
participants consisted of the Departmental Executive Officers 
(DECS) of two departments acknowledged to be active in the 
biotechnology research effort (since interviewees were 
guaranteed confidentiality, names and departments of these 
interviewees shall not be listed). Interviews (conducted by 
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phone, or in person, if requested by the interviewee) focussed 
primarily upon two basic questions; 1) 'Which departments 
would you describe as being central to the biotechnology 
research effort at Iowa State University (the 'Core'), and 
which are involved in the biotechnology research effort, but 
in a more supportive role (the 'Support' departments), and; 2) 
'Could you name three other persons familiar enough with the 
biotechnology research program to offer informed opinions on 
this question?' In addition, general comments regarding other 
aspects of the biotechnology research effort (e.g., 
effectiveness of its administration, success in the attainment 
of stated goals, etc.) were welcomed from all interviewees who 
offered them. 
Representatives (for the most part consisting of DEOs) 
were also contacted for all departments named as participants 
in either the Core or Supporting groups, but for whom a 
specific representative was not named in the course of the 
'snowballing' process. All participating Core and Support 
departments were thus represented by at least one spokesperson 
over the course of the interviews. Ultimately, 22 interviews 
were conducted with DEOs and other departmental 
representatives. 
As a result of these interviews, twelve departments were 
determined to operate within the Core of the biotechnology 
research effort; Biochemistry/Biophysics, Genetics, Zoology, 
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Horticulture, Agronomy, Chemical Engineering, Chemistry, Plant 
Pathology, Botany, Veterinary Microbiology and Preventive 
Medicine, Veterinary Pathology, and Veterinary Anatomy. Nine 
additional departments were determined to function within the 
Support group: Microbiology, Animal Science, Food Technology, 
Food and Nutrition, Forestry, Entomology, Veterinary 
Physiology and Pharmacology, Veterinary Clinical Sciences, and 
the Veterinary Diagnostic Laboratory (see Appendix I for 
departments not included in either the Core or Support 
categories). Due to this project's focus on the academic 
impacts of the biotechnology research project, six non-
academic divisions of the University were not included in the 
analysis (Ames Laboratory, Statistics Laboratory, World Food 
Institute, Computation Center, Institute for Physical Research 




With the determination of the Core, Support, and Non-
Biotech departments made, it becomes possible to detect what 
differential impact the large infusions of biotechnology 
research monies have had upon these groupings. The 
determination of these impacts is based upon comprehensive 
records of all university research expenditures for the period 
beginning Fiscal Year (FY) 1983/1984, and ending FY 1989/1990. 
Thus, for purposes of comparison, the first three years of 
this period reflect a time in which no biotechnology funding 
was received by the university, and the last four years 
reflect a period of heavy biotechnology funding, as the 
research effort was implemented (data for this analysis was 
gathered with the cooperation of Iowa State University's 
Office of the Associate Provost for Research), These 
expenditures fall into three separate groupings : General 
Research, Agricultural Experiment Station (AES), and Contracts 
and Grants (C&G). The biotechnology expenditures fall within 
the C&G category. 
In comparing these three categories, it is evident that 
C&G expenditures have experienced a dramatic increase over the 
seven year period under examination (Figure 1, Table 1). C&G 
expenditures were at their low in the first year of the study, 
amounting to only $18.4 million. However, by the end of the 
period, they had climbed to a peak of approximately $46 
83/84 84/85 85/86 86/87 87/88 88/89 89/90 
Year 
General Research AES C&G 
Figure 1. Academic research expenditures 
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million—amounting to an increase of approximately 250% in 
just seven years. AES expenditures also increased during this 
same period, from about $11.8 million in FY 83/84 to $16.9 
million in FY 89/90. General Research expenditures increased 
slightly for the first six years of the period, and decreased 
sharply in FY 89/90. 
Table 1. Overall academic research expenditures 
Gen. Res. AES C&G Total 
83/84 5553071 11786497 18424670 35764238 
84/85 6590840 13140555 20365497 40096892 
85/86 6496972 11432037 21841883 39770892 
86/87 6994011 11547952 24867641 43409604 
87/88 7639076 14748257 28476857 50864190 
88/89 7876711 14441439 38943678 61261828 
89/90 2664204 16931656 46012676 65608536 
It is also useful to examine these categories in terms of 
the percentages they constitute of the overall research 
expenditures for the university (Figure 2, Table 2). 
Table 2. Funding categories as a percentage of overall budget 
Gen .. Res. AES C&G Tot. 
83/84 15. 53 32 .96 51 .52 100 
84/85 16. 44 32 .77 50 .79 100 
85/86 16. 34 28 .74 54 .92 100 
86/87 16. 11 26 .60 57 .29 100 
87/88 15. 02 28 .99 55 .99 100 
88/89 12. 86 23 .57 63 .57 100 










83/84 84/85 85/86 86/87 87/88 88/89 89/90 
Year 
General Research —AES C&G 
Figure 2. Funding categories as a percentage 
of the overall academic budget 
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Again, we see a dramatic increase in the percentage share 
of the C&G category, from a low of 51.5% of all research 
expenditures in FY 83/84 to a high of 70.1% in FY 89/90. 
While the dollar amount of AES expenditures increased as 
described in the previous paragraph, its percentage of overall 
expenditures actually declined over the seven year period, 
from 32.9% in FY 83/84 to 25.8% in FY 89/90. The percentage 
share of General Research expenditures held relatively 
constant for the first six years of the period, but decreased 
from approximately 12.8% to 4% in FY 89/90. 
Another set of findings arises when these shifts in 
research expenditures are examined within the context of the 
aforementioned biotech departmental categorization. Within 
the Core departments (Figure 3, Table 3), the C&G share of 
research expenditures rises from a low of approximately 54.2% 
in FY 83/84 to a high of 66.5% in FY 89/90. AES expenditures 
hold relatively constant over the seven year period, while 
General Research expenditures also hold relatively constant 
except for a sharp decline of about 6.5% in FY 89/90. 
In the Support category (Figure 4, Table 4), C&G 
expenditures experience an even more dramatic increase than is 
present in the Core category. C&G expenditures steadily 
increase from a low of 42.5% in FY 85/86, to a peak of 
approximately 66% in FY 89/90. The AES share of Support 
83/84 84/85 85/86 86/87 87/88 88/89 89/90 
Year 
General Research —I— AES C&G 
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Figure 4. Support funding source analysis 
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Table 3. Core funding source analysis 
% from gen. res. % from AES % from C&G Total 
83/84 17.36 28.48 54.16 100.00 
84/85 16.92 27.34 55.73 99.99 
85/86 15.89 26.22 57.89 100.00 
86/87 16.14 23.54 60.32 100.00 
87/88 15.97 23.91 60.12 100.00 
88/89 14.2 23.4 62.4 100.00 
89/90 7.58 25.92 66.49 99.99 
expenditures experiences a dramatic decline during this same 
period, falling from a peak of 55.54% in FY 85/86 to a low of 
approximately 33.9% in FY 89/90. General Research 
expenditures hold relatively constant throughout the period.. 
Table 4. Support funding source analysis 
% from gen. res. % from AES % from C&G Total 
83/84 1.89 55.19 42.91 99.99 
84/85 2.01 54.74 43.24 99.99 
85/86 1.97 55.54 42.49 100.00 
86/87 2 53.06 44.94 100.00 
87/88 1.63 51.99 46.39 100.01 
88/89 1.33 42.84 55.82 99.99 
89/90 0.1 33.89 66.02 100.01 
The dramatic increase in C&G funding is also present 
among the Non-Biotech departments (Figure 5, Table 5). C&G 
expenditures constitute only 52.6% of the Non-Biotech research 
expenditures in FY 83/84, but increase to 74.8% by FY 89/90. 
AES decreases from 28.3% of Non-Biotech research expenditures 
in FY 83/84, to 17.3% in FY 89/90. General Research also 
declines dramatically, from 19.1% in FY 83/84 to 3.3% in 
89/90. 
83/84 84/85 85/86 86/87 87/88 88/89 89/90 
Year 
General Research -H— AES C&G 
Figure 5. Non-Biotech funding source analysis 
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Table 5. Non-Biotech funding source analysis 
% from gen. res. % from AES % from C&G Total 
83/84 19.14 28.27 52.59 100.00 
84/85 21.39 29.22 49.39 100.00 
85/86 22.11 21.04 56.85 100.00 
86/87 21.14 19:94 58.92 100.00 
87/88 18.46 25.83 55.71 100.00 
88/89 15.71 17.33 66.96 100.00 
89/90 3.28 21.9 74.83 100.01 
Another perspective on the data may be gained by 
examining these budget fluctuations from the perspective of 
the fund type rather than the departmental categories. In 
other words, rather than looking at what percentage C&G funds 
constituted of total Core expenditures, it may be useful to 
examine what percentage the Core constituted of total C&G 
expenditures. 
The significance of these changes may be tested by 
constructing a comparison of beginning and ending points for 
each of the three funding categories (Table 6). Such a 
comparison is useful in that the first year of data 
(1983/1984) represents a period which saw no biotechnology 
funding, while the last year of data (1989/1990) reflects a 
period in which the project was well underway. 
In Table 6, the Mean value represents the Mean amount of 
change (+ or -) in the raw number of dollars expended between 
FYs 1983/1984 and 1989/1990 for a given funding category. For 
example, the Mean value of -$44,722 for Core General Research 
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Funds represents an average decrease of $44,722 of General 
Research Funds per department within the Core over the seven 
years of available data. The Pr>F value represents the 
overall level of significance for these changes. A Scheffe' 
Table 6. A comparison of beginning and end-point mean 
differences by funding category 
Mean Pr>F Scheffe 
Gen. Core -$44,722 .63 C-S -$35,421 
Res. Support -$9,301 C-N -$10,429 
Non-Biotech -$34,293 S-N $24,992 
C&G Core $540,840 .09 C-S -$56,541 
Support $597,381 C-N $327,427 
Non-Biotech $213,413 S-N $383,968 
AES Core $140,843 .18 C-S $18,792 
Support $122,051 C-N $111,783 
Non-Biotech $29,060 S-N $92,991 
Total Core $636,961 .03* C-S -$73,171 
Support $710,131 C-N $428,780 
Non-Biotech $208,181 S-N $501,951 
*p <. 05 
Multiple Comparison was then utilized in order to determine 
the significance of Mean differences for each of the possible 
pairings of departmental categories; Core-Support (C-S); Core-
Non-Biotech (C-N), and; Support-Non-Biotech (S-N) (Agresti and 
Finlay, 1986). 
This general analysis yields statistically significant 
results only for the overall research expenditures of the 
university. In this category, it is demonstrated that, over 
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the seven years of available data. Core research expenditures 
have increased by an average of $636,961 per department. 
Support expenditures have increased by an even more dramatic 
$710,131 per department. Non-Biotech departments have 
averaged an increase of only $208,181 per department. And, 
while changes within the other funding categories were not 
found to be statistically significant (due to high 
variability), the dramatic increase in C&G funds for the Core 
and Support Departments is worth noting. 
Another important aspect of the data is revealed when the 
three biotech categorizations are compared with one another, 
in terms of the percentage that each category constitutes of 
overall research expenditures (Figure 6, Table 7). These 
Table 7. Core, Support, and Non-Biotech percentages of total 
budget 
Core Support Non-Biotech Total 
83/84 37.23 17.12 45.65 100 
84/85 38.31 16.74 44.95 100 
85/86 40.00 16.32 43.68 100 
86/87 40.42 15.72 43.86 100 
87/88 37.65 14.87 47.48 100 
88/89 34.81 16.18 49 .01 100 
89/90 33.89 21.24 44.88 100.01 
figures show that the percentages have fluctuated considerably 
during the six year period under examination, with Core 
expenditures steadily increasing in the three years prior to 
the appropriation of biotechnology funding, holding relatively 
10 
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Figure 6. Core, Support, and Non-Biotech percentages 
of the total budget 
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constant in the first year of the program, and declining 
rapidly in the second, third, and fourth years of the program. 
The decline of research expenditures is even more 
dramatic with the introduction of a 'hypothetical alternative' 
scenario, in which research expenditures are examined as if 
biotechnology funding had not been appropriated during the 
1986-1989 period (Figure 6—complete information for FY 89/90 
appropriations is not yet available). Indication is thus 
present that general expenditures have not only decreased on 
the whole for the Core departments during this period, but 
that non-biotechnological research has undergone a dramatic 
decline as well, from a high of 40.03% of expenditures in 
fiscal year 1985/1986, to a low of 34.13% in fiscal year 
1987/1988. 
Much of this decline then, is attributable to the absence 
of substantial increases in General Research and AES 
expenditures during the entire period under examination 
(Figure 3). As is evident, while C&G expenditures (again, the 
funding category which reflects the infusion of biotechnology 
money) have increased considerably, the percentage of 
expenditures attributable to General Research and AES sources 
has declined to a comparable degree. The university therefore 
becomes more dependent on money from external sources, as 
research funds from sources internal to the university 
continue to decline. 
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Thus, while increases in research expenditures 
attributable to biotechnology funding have been considerable, 
levels of funding from the university have held relatively 
constant, resulting in an overall decline in the percentage 
such monies contribute to total university research 
expenditures. 
The specific result of these developments for the Core 
departments has been the creation of a substantial capacity to 
undertake biotechnology research, and an apparently-dramatic 
decrease in the ability (at least, in financial terms) to. 
undertake other forms of non-biotechnological research. And, 
while the increased biotechnology expenditures have offset 
this general decline in Core expenditures to an extent, they 
have not been substantive enough to prevent an overall decline 
in the proportional budgetary level of representation that 
these departments held in the years prior to the establishment 
of the biotechnology research effort. 
A second means by which the impacts of the biotechnology 
research project become evident is through the quantitative 
shifts that have occurred in 'full time equivalency' (FTE) job 
categorizations within the individual departments of the 
university. Comprehensive listings of these FTE 
categorizations were collected for the eight-year period from 
fiscal years 1983/1984 to 1990/1991, and were obtained with 
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the cooperation of Iowa State University's Office of 
Institutional Research. 
Under this system of employment categorization, 
occupational positions are grouped into several broad funding 
categories. Four of these categories are relevant to this 
study; Instruction, Contracts and Grants (C&G), Research, and 
Agricultural Experiment Station (AES). Within these broad 
categorizations, positions are more specifically grouped in 
terms of employee type; Merit, Professional and Scientific 
(P&S), Graduate Student, Pre- and Post-Doctoral, Hourly, and 
Faculty. 
In terms of these specific employee types, the raw 
numbers for the entire university reveal an overall decrease 
in the number of Faculty over the eight year period under 
examination (Figure 7). Faculty FTEs were at a peak of 
1558.62 positions in fiscal year 1985/1986, but dropped to 
1478.12 positions by 1990/1991 (a net loss of approximately 80 
positions). On the other hand, the combined number of 
Graduate Student and Pre/Post Doctoral FTEs rose from a low of 
689.62 in 1984/1985 to 864.22 by 1990/1991 (a net gain of just 
under 175 positions). P&S and Hourly FTEs also rose 
significantly, with P&S FTEs increasing by approximately 100 
positions, and Hourly FTEs increasing by just under 70 
positions. Raw numbers of Merit FTEs held relatively constant 
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Figure 7. ETE totals 
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Table 8. Raw numbers of university PTEs grouped by 
occupational category 
83/84 84/85 85/86 86/87 87/88 88/89 89/90 90/91 
Merit 477.5 455.8 476.7 490.0 482.8 443.3 467.8 474.8 
P&S 121.0 138.9 142.3 147.0 164.9 177.1 202.1 220.6 
Grad. 629.3 623.2 674.1 721.0 724.7 731.2 747.3 765.7 
P/Doc 67.2 66.4 . 65.7 77.3 89.5 96.4 117.0 98.6 
Hourly 148.0 165.0 166.3 182.0 191.2 224.5 222.6 216.2 
Fac. 1506.0 1529.0 1559.0 1546.0 1489.0 1464.9 1496.4 1478.1 
Total 2949.0 2979.0. 3084.0 3163.0 3142.0 3137.3 3253.2 3253.9 
Grad & 
P/doc 696.5 689.6 739.9 798.0 814.2 827.6 864.3 864.2 
These data thus reveal that Faculty PTEs--as a percentage 
of total FTEs--have declined considerably during the eight 
year period under study (Pigure 8). Faculty positions 
constituted 51.34% of PTEs in FY 1984/1985, but steadily 
declined to represent 45.42% of PTEs by FY 1990/1991 (a drop 
of about 6 percentage points). Conversely, Graduate Students 
and Pre/Post Doctoral employees constituted only 23.15% of 
total PTEs in 1984/1985, but rose to represent 26.56% of 
overall PTEs by FY 1990/1991 (a gain of about 3.5 percentage 
points). Hourly and P&S employees also increased slightly in 
comparison to the other occupational categories (approximately 
1.5 and 2.5 percentage points, respectively), while Merit 
employees decreased slightly (approximately 1.5 points--Table 
9) . 
83/84 84/85 85/86 86/87 87/88 88/89 ( 9/90 90/91 
Year 
Merit -4- P&S Grads. & Pdocs 
L_] Hourly Faculty 
Figure 8. Percentage of PTE totals by occupational 
category 
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Table 9. Occupational categories as a percentage of total PTEs 
83/84 84/85 85/86 86/87 87/88 88/89 89/90 90/91 
Merit 16.19 15.3 15.46 15.5 15.36 14.13 14.38 14.59 
P&S 4.10 4.66 4.61 4.66 5.25 5.65 6.21 6.78 
Grad 21.34 20.92 21.86 22.8 23.06 23.31 22.97 23.53 
P/Doc 2.28 2.23 2.13 2.44 2.85 3.07 3.6 3.03 
Hourly 5.02 5.54 5.39 5.76 6.09 7.15 6.84 6.64 
Fac. 51.07 51.34 50.54 48.9 47.39 46.69 46. 45.43 
Total% 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 
Grad & 
Pdoc% 23.62 23.15 23.99 25.2 25.91 26.38 26.57 26.56 
While these findings indicate the occurrence of some 
alteration in the overall occupational structure of the 
University, an even more important set of findings occurs when 
these fluctuations are examined in the context of the 
aforementioned biotech departmental categorization. Within 
the Core (Figure 9), Graduate Student and Pre/Post Doctoral 
PTEs increased by approximately five percent (in relation to 
total Core PTEs), from a low of 27.87% in fiscal year 
1984/1985 (the year prior to the implementation of the 
biotechnology research effort) to 32.87% in 1990/1991. During 
this same period, the Faculty share of PTEs declined by 6.76 
percentage points, from a high of 34.12% in 1984/1985, to a 
low of 27.36% in 1989/1990. The P&S share of PTEs also rose 
by approximately three percent during this period, while the 
Merit share declined by approximately 3.5 percentage points 
over the eight years under study. The Hourly share of Core 
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Figure 9. Core PTE breakdown 
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Table 10. Occupational categories as a percentage of total 
Core FTEs 
Core PTE Breakdown 
83/84 84/85 85/86 86/87 87/88 88/89 89/90 90/91 
Grad 24.7 22.97 25.27 •26.77 27.15 26.04 25.45 25.81 
Pdoc 5.16 4.9 5.04 5.83 6.1 6.61 7.69 7.06 
P&S 6.85 8.0 8.14 8.14 9.11 10.61 11.32 11.14 
Merit 18.65 18.85 18.11 18.07 17.52 14.95 14.83 15.01 
Hourly 11.75 11.15 11.53 11.19 11.67 14.33 13.35 12.92 
Fac. 32.88 34.12 31.89 30.0 28.44 27.46 27 .36 28.05 
Total 99.99 99.99 99.98 100.00 99.99 100.00 100.00 99.99 
Grads & 
Pdocs 29.86 27.87 30.31 32.6 33.25 32.65 33.14 32.87 
A similar trend is evident within the Support departments 
(Figure 10). Graduate Student and Pre/Post Doctoral FTEs rise 
steadily from a low of 16.62% in 1985/1986 (the first year of 
the biotechnology funding) to 22.51% in 1990/1991. During 
this same period, Faculty FTEs steadily decreased from a high 
of 37.74% in 1985/1986 to a low of 32.61% in 1990/1991. Other 
occupational categories remain relatively stable (Table 11). 
This same trend occurs in departments unrelated to the 
biotechnology research effort, though to a lesser degree 
(Figure 11). The comparative level of Graduate Student and 
Pre/Post Doctoral FTEs rise by a total of 2.89 percentage 
points during the eight-year period. Faculty FTEs fall by 5.54 
percentage points, and other categories hold relatively 
constant (Table 12). 
The significance of these changes may be tested by 
constructing a comparison of beginning and ending points for 
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Figure 10. Support ETE breakdown 
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Figure 11. Non-Biotech PTE breakdown 
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Table 11. Occupational categories as a percentage of total 
Support PTEs 
Support FTE Breakdown 
83/84 84/85 85/86 86/87 87/88 88/89 89/90 90/91 
Grad. 15.78 15.18 14.54 14.47 15.85 17.19 17.29 18.53 
Pdoc. 3.68 3.41 2.08 2.38 2.79 2.02 3.93 3.98 
P&S 7.68 7.18 7.86 7.85 7.7 7.99 7 .93 9.02 
Merit 28.83 28.76 28.75 28.74 26.53 27.24 27.54 28.24 
Hourly 6.38 8.43 9.02 9.57 10.5 10.73 9.17 7.61 
Fac. 37.65 37.03 37.74 36.99 36.61 34.82 34.14 32.61 
Tot. 100.00 99.99 99.99 100.00 99.98 99.99 100.00 99.99 
Grads & 
Pdocs 19.46 18.59 16.62 16.85 18.64 19.21 21.22 22.51 
Table 12. Occupational categories as a percentage of total 
Non-Biotech PTEs 
Non-biotech FTE Breakdown 
83/84 84/85 85/86 86/87 87/88 88/89 89/90 90/91 
Grad. 21.09 21.29 21.85 22.73 22.71 23.29 23.13 23.68 
Pdoc. 0.89 1.0 1.04 1.11 1.53 1.74 1.8 1.19 
P&S 2.34 2.92 2.65 2.7 3.21 3.04 3.68 4.53 
Merit 12.79 11.33 11.99 12.03 12.43 11.25 11.4 11.48 
Hourly 2.12 2.88 2.34 2.91 2.99 3.35 3.59 3.89 
Fac. 60.76 60.58 60.14 58.52 57.12 57.32 56.4 55.22 
Totals 99.99 100.00 100.01 100.00 99.99 99.99 100.00 99.99 
Grad & 
Pdocs 21.98 22.29 22.89 23.84 24.24 25.03 24.93 24.87 
case with the budgetary information, such a comparison is 
useful in that the first year of data (1983/1984) represents a 
period which saw no biotechnology funding, while the last year 
of data (1990/1991) reflects a period in which the project was 
well underway. 
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Table 13. A comparison of beginning and end-point mean 
differences between Core, Support, and Non-
Biotechnology occupational categories 
Mean Pr>F Scheffe 
Graduate Core 2.47 .47 C-S .99 
Support 1.48 C-N 1.4 
Non-Biotech 1.06 S-N .42 
Pre/Post Doc Core 1.95 .02* C-S 1.64 
Support .31 C-N 1.64* 
Non-Biotech .3 S-N .00 
Faculty Core -. 62 .86 C-S -1.44 
Support .81 C-N -.46 
Non-Biotech . -.16 S-N .97 
P&S Core 3.25 .0008* C-S 2.71* 
. Support .54 C-N 2 .78* 
Non-Biotech .47 S-N .07 
Merit Core -.77 .30 C-S -1.93 
Support 1.15 C-N -.59 
Non-Biotech -.18 S-N 1.34 
Hourly Core 1.93 .11 C-S .49 
Support 1.45 C-N 1.42 
Non-Biotech .51 S-N .93 
*p <. 05 
In Table 13, the Mean value represents the Mean amount of 
change (+ or -) in the raw number of PTEs between FYs 
1983/1984 and 1990/1991 for a given occupational category. 
For example, the Mean value of 2.47 for Core Graduate Students 
represents an average increase of 2.47 FTEs per department 
within the Core over the eight years of available data. The 
Pr>F value represents the overall level of significance for 
these changes. A Scheffe' Multiple Comparison was then 
utilized in order to determine the significance of Mean 
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differences for each of the possible pairings of departmental 
categories; Core-Support (C-S); Core-Non-Biotech (C-N) , and; 
Support-Non-Biotech (S-N) (Agresti and Finlay, 1986) . 
This general analysis yields statistically significant 
results for two of the occupational categories. Pre/Post 
Doctoral employees have increased substantially within the 
Core Departments (1.95 per department), and moderately within 
the Support and Non-Biotech departments (.31 and .3, 
respectively). Also, P&S employees have increased 
dramatically within the Core (3.25 PTEs per department, on 
average), and moderately within the Support and Non-Biotech 
groupings (.54 and .47, respectively). And, while the other 
analyses of occupational groupings were not found to be 
statistically significant (due to high variability) some of 
the findings do tend to lend credence to the trends described 
in Figures 9-11 (e.g., a substantial increase in Graduate 
Students per department, with the increase most pronounced 
among the Core, and least pronounced among the Non-
Biotechnology Departments). 
Beyond this basic analysis of the five occupational 
groupings, it is important to remember that each of these 
groupings may be further analyzed in terms of the occupational 
activity (Instruction, C&G, Research, and AES) that a given 
employee is engaged in. For example, it is clear that the 
Graduate Student share of FTEs has increased in all three of 
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the biotech categorizations. However, it is still unclear 
whether these graduate students are engaged in instructional 
or research activities. The data on professional activity is 
therefore useful in answering this question, and reveals some 
interesting trends. 
As has been stated, within the Core categorization, the 
relative level of Graduate Student and Pre/Post Doctoral FTEs 
has increased by five percent. Faculty have decreased by 
nearly seven percent, and other occupational categories have 
held fairly constant. These trends appear even more dramatic 
in light of the occupational activity data. Among Core 
Graduate Students (Figure 12), there was a 20% drop in the 
proportional share of Graduate Students involved in 
Instructional activity between fiscal years 1984/1985 and 
1989/1990. This same period saw an increase of over 2 6% in 
C&G related-activities for graduate students (a category 
reflective of the biotechnology funding). Research and Ag 
Experiment Station activities both declined slightly (Table 
14) . 
0 
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Figure 12. Graduate PTE categorization (Gore) 
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Table 14. Funding category as a percentage of all Core 
occupational titles 
CORE CATEGORIZATIONS 
Merit Work Categorization 
83/84 84/85 85/86 86/87 87/88 88/89 89/90 90/91 
Instr. 37.11 40.12 36.6 35.05 37,02 38.68 40.6 42.35 
C&G 21.82 19.19 22.71 27.45 27.5 21.14 20,01 8.47 
Res. 17.13 16.94 16.17 15,56 15.0 16.02 15,06 14,8 
AES 23.93 23.75 24.52 21,94 20.48 24.16 24,33 24.38 
P&S Work Categorization 
83/84 84/85 85/86 86/87 87/88 88/89 89/90 90/91 
Instr. 41.02 39.16 38.21 35,22 31,08 26.59 27.63 28,82 
C&G 25.26 24.82 27.82 32.11 34.55 46.1 45,19 41,01 
Res. 13.93 15.04 15.62 15.81 13,81 8.04 7.12 6,24 
AES 19.79 20.97 18.35 16.86 20.56 19.26 20,06 23.93 
Graduate Student Work Categorization 
83/84 84/85 85/86 86/87 87/88 88/89 89/90 90/91 
Instr. 52,82 55.28 44.22 41.06 41,1 37,2 34.98 36.97 
C&G 28.35 26.05 40.23 45.5 47.19 49,82 52.36 49.18 
Res. 3.46 4.82 3.74 4.41 3,59 3,86 2.65 2,11 
AES 15.36 13.85 11.8 9,03 8.12 9,12 10.00 11,74 
Pre and Post Doctoral Work Categorization 
83/84 84/85 85/86 86/87 87/88 88/89 89/90 90/91 
Instr. 0.91 0 5.28 4.32 2,03 3,62 1,54 1,83 
C&G 78.11 86.31 69.66 75,13 88,71 93.67 94,59 92.93 
Res. 7.65 1.44 5,94 9.19 3.55 1,36 1,16 1,32 
AES 13.33 12.25 19.13 11,35 5,71 1.36 2.7 3,92 
Hourly Work Categorization 
83/84 84/85 85/86 86/87 87/88 88/89 89/90 90/91 
Instr. 5.73 7.16 6.89 5.26 4,36 2,22 5.18 5,01 
C&G 76.21 71.65 77.98 78.94 89,8 94,96 83.49 87.22 
Res. 3.91 2.1 2.71 2.95 0 0 1.98 1,92 
AES 14.15 19.09 12.42 12,84 5,84 2,82 9.35 5,85 
Faculty Work Categorization 
83/84 84/85 85/86 86/87 87/88 88/89 89/90 90/91 
Instr. 63.76 64.43 65.37 65.0 64.1 62,47 72,52 72.19 
C&G 3.93 3.4 5.23 3.45 4,27 4,91 3,18 3.97 
Res. 10.93 11.31 9.13 11.54 10,94 10,9 3,7 3,18 
AES 21.37 20.86 20.26 20.0 20.69 21.72 20,6 20,66 
Totals 
83/84 84/85 85/86 86/87 87/88 88/89 89/90 90/91 
Instr. 44.47 46.18 42.86 40.53 39,34 36.0 38,71 40,14 
C&G 27.08 24.97 30.7 34.0 37,89 42.17 40,69 38.98 
Res. 9.45 9.67 8.67 9.61 8.19 7,33 5.08 4.7 
AES 18.99 19.18 17.77 15,85 14.58 14,49 15.52 16.18 
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Similar trends are also present in the Support 
departments (Figure 13), which reveal a proportional increase 
of 31% in C&G related activities, and a 19.5% drop in 
Instructional activities. AES positions also declined by 
approximately 11.5% (there were no Graduate Student Research 
PTEs in the Support group—Table 15). 
A similar trend, though less pronounced, was found among 
the Non-Biotech departments. The Instructional share of PTEs 
for Graduate Students declined by approximately 16.7% in 
comparison to the other occupational categories, while the C&G 
portion of PTEs increased by approximately 17.7%, AES and 
Research PTEs held relatively constant (Table 16). 
By again using a comparison of Means (on beginning and 
ending points for the eight years of data), test of 
significance, and Scheffe' Multiple Comparison test, the 
statistical significance of these trends may be analyzed 
(Table 17). 
This analysis reveals that C&G positions among Graduate 
Students have experienced a substantial and statistically-
significant increase of 4.37 positions per department in the 
Core. The Support and Non-Biotech groupings also experience 
substantive increases, but not to the degree found in the 
Core. While the other funding category analyses failed to 
reveal significant findings, they clearly indicate trends 
similar to those revealed in Pigures 12 and 13 (slight 
10 
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Figure 13. Graduate PTE categorization (Support) 
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Table 15. Funding category as a percentage of all Support 
occupational titles 
SUPPORT CATEGORIZATIONS 
Merit Work Categorization 
83/84 84/85 85/86 86/87 87/88 88/89 89/90 90/91 
Instr. 31.09 30.76 28.84 29.57 32.03 29.37 33 .28 33.68 
C&G 14.38 16.62 20.22 23.87 21.55 24.81 19.66 18.85 
Res. 13.47 12.89 11.57 10.72 9.81 8.76 9.31 8.66 
AES 41.05 39.73 39.37 35.84 36.6 37.06 37.75 38.81 
P&S Work Categorization 
83/84 84/85 85/86 86/87 87/88 88/89 89/90 90/91 
Instr. 36.02 37.52 35.37 34,53 37.1 33.09 34.35 32.00 
C&G 11.73 12.49 10.67 12.54 11.62 18.57 17.01 25.85 
Res. 10.35 10.67 10.11 9.91 10.3 9.79 8.76 7.53 
AES 41.9 39.31 43.85 43.02 40.98 38.55 39.88 34.61 
Graduate Student Work Categorization 
83/84 84/85 85/86 86/87 87/88 88/89 89/90 90/91 
Instr. 32.7 28.24 25.3 27.09 21.0 16.4 14.03 13.2 
C&G 22.51 29.49 31.3 35.79 48.3 55.28 53.59 53.61 
Res. 0 0 0 0 0 0 0 0 • 
AES 44.78 42.26 43.4 37.12 30.7 28.32 32.39 33.19 
Pre and Post Doctoral Work Categorization 
.83/84 84/85 85/86 86/87 87/88 88/89 89/90 90/91 
Instr. 0 0 0 0 3.56 0 0 2.15 
C&G 32.2 52.78 50.0 71.43 70.33 60.0 65.32 70.23 
Res. 31.82 0 0 0 0 0 0 0 
AES 35.98 47.22 50.0 28.57 26.11 40.0 34.68 27.61 
Hourly Work Categorization 
83/84 84/85 85/86 86/87 87/88 88/89 89/90 90/91 
Instr. 37.24 27.84 30.1 32.21 27.71 31.01 12.38 17.59 
C&G 44.45 59.55 49.21 53.02 55.34 58.63 76.42 67.44 
Res. 0 0 0 0 0 0 0 0 
AES 18.31 12.6 20.68 14.77 16.95 10.35 11.19 14.98 
Faculty Work Categorization 
83/84 84/85 85/86 86/87 87/88 88/89 89/90 90/91 
Instr. 67.95 67.06 67.07 67.09 67.5 64.64 64.53 63.41 
C&G 2.6 2.39 2.48 2.98 1.67 2.12 4.16 3.34 
Res. 8.98 11.42 10.88 10.9 11.41 12.76 10.4 11.61 
AES 20.47 19.13 19.56 19.02 19.42 20.47 20.91 21.63 
Totals 
83/84 84/85 85/86 86/87 87/88 88/89 89/90 90/91 
Instr. 44.85 43.01 42.78 43.03 42.41 39.3 37.48 36.95 
C&G 13.6 17.87 17.62 20.9 22.66 26.0 27.02 26.61 
Res. 9.23 8.7 8.23 7.89 7.57 7.61 6.81 6.91 
AES 32.32 30.42 31.37 28.18 27.35 27.09 28.69 29.53 
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Table 16. Funding category as a percentage of all Non-Biotech 
occupational titles 
NON-BIOTECH CATEGORIZATIONS 
Merit Work Categorization 
83/84 84/85 85/86 86/87 87/88 88/89 89/90 90/91 
Instr. 72.64 71.45 72.18 70.91 70.17 73.67 74.74 74.35 
C&G 6.94 5.5 6.9 8.97 8.89 9.35 8.14 8.32 
Res. 2.65 2.55 2.39 1.53 1.83 2.21 1.01 0.95 
AES 17.78 20.5 18.53 18.58 19.1 14.76 16.12 16.38 
P&S Work Categorization 
83/84 84/85 85/86 86/87 87/88 . 88/89 89/90 90/91 
Instr. 46.7 49.56 45.7 39.91 34.57 41.75 48.16 38.94 
C&G 7.69 6.56 12.92 15.95 25.17 32.69 28.44 34.88 
Res. 9.89 7.35 3.04 4.32 6.98 2.61 2.73 2.2 
AES 35.71 36.52 38.34 39.82 33.27 22.95 20.66 23.98 
Graduate Student Work Categorization 
83/84 84/85 85/86 86/87 87/88 88/89 89/90 90/91 
Instr. 71.17 71.26 68.15 65.09 59.14 57.37 56.83 54.4 
C&G 16.37 17.4 21.02 26.09 29.99 32.72 33.93 34.06 
Res. 6.21 4.84 5.0 4.68 5.77 4.81 3.67 4.79 
AES 6.24 6.49 5.83 4.14 5.09 5.1 5.57 6.76 
Pre and Post Doctoral Work Categorization 
83/84 84/85 85/86 86/87 87/88 88/89 89/90 90/91 
Instr. 0.73 3.16 8.85 6.18 8.28 2.97 5.35 9.72 
C&G 58.42 73.16 69.42 77.88 78.14 84.71 86.73 86.1 
Res. 0 0 3.83 1.03 0.33 0.24 0 0 
AES 40.85 23.68 17.9 14.91 13.25 12.08 7.92 4.17 
Hourly Work Categorization 
83/84 84/85 85/86 86/87 87/88 88/89 89/90 90/91 
Instr. 25.5 31.39 31.62 30.56 29.51 25.21 20.39 21.11 
C&G 69.37 61.59 63.38 63.17 62.75 64.93 73.09 71.3 
Res. 1.49 0.15 1.37 0.65 1.17 0.73 0.38 0.34 
AES 3.64 6.87 3.62 5.62 6.58 9.13 6.14 7.25 
Faculty Work Categorization 
83/84 84/85 85/86 86/87 87/88 88/89 89/90 90/91 
Instr. 90.6 90.71 89.73 89.85 89.45 89.54 93.49 93.6 
C&G 2.1 1.82 2.86 2.54 2.52 2.66 3.05 2.55 
Res. 4.62 4.59 4.49 4.78 4.77 4.63 0.14 0.14 
AES 2.68 2.88 2.92 2.84 3.26 3.16 3.31 3 .7 
Totals 
83/84 84/85 85/86 86/87 87/88 88/89 89/90 90/91 
Instr. 81.0 80.6 79.55 77,94 75.37 75.15 77.00 75.81 
C&G 7.79 8.13 9.68 11.63 13.24 14.85 15.73 15.81 
Res. 4.72 4.32 4.23 4.19 4.53 4.13 1.16 1.43 
AES 6.5 6.95 6.54 6.24 6.86 5.87 6.12 6.94 
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Table 17. A comparison of beginning and end-point mean 
differences for Graduate Student PTEs, grouped by-
funding category 
Mean Pr>F Scheffe 
Instructional Core -1.4 .29 C-S -0.67 
Support -0.75 C-N -1.14 
Non-Biotech -0.29 S-N -0.46 
C&G Core 4.37 .01* C-S 1.98 
Support 2.39 C-N 2.92* 
Non-Biotech 1.46 S-N .94 
Research Core -0.04 .80 C-S -0.04 
Support 0.0 C-N 0.08 
Non-Biotech -0.12 S-N 0.12 
AES Core -0.44 .12 C-S -0.28 
Support -0.16 C-N -0.46 
Non-Biotech• 0.02 S-N -0.18 
*p <. 05 
decreases in Research and AES PTEs, and substantial decreases 
in Instructional PTEs that are most pronounced among the Core, 
and least pronounced among Non-Biotech departments). 
Among Pre and Post Doctoral employees, all three 
departmental categorizations have experienced dramatic 
increases in the relative level of C&G-funded positions. 
Within the Core, 92.93% of Pre/Post Doctoral positions were 
funded through Contracts and Grants in FY 1990/1991 (up from 
78.11% in PY 1983/1984--Table 14). Among Support Departments, 
70.23% of Pre/Post Doctoral positions were based on C&G funds 
(up from 32.2% in PY 1983/1984--Table 15). And, within 
departments unrelated to the biotechnology project, 86.1% of 
Pre/Post Doctoral positions were C&G-related (up from 58.42% 
in FY 1983/1984--Table 16). 
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Table 18. A comparison of beginning and end-point mean 
differences for Pre/Post Doctoral PTEs, grouped by 
funding category 
Mean Pr>F Scheffe 
Instructional Core 0.05 .73 c-s 0.05 
Support 0.00 C-N 0.02 
Non-Biotech 0.02 S-N -0.03 
C&G Core 2.28 .003* c-s 1.68 
Support 0.6 C-N 1.94* 
Non-Biotech 0.39 S-N 0.26 
Research Core -0.15 .03* C-s 0.23 
Support -0.38 C-N -0.15 
Non-Biotech 0.00 S-N -0.38* 
AES Core -0.23 .21 C-s -0.32 
Support 0.09 C-N -0.17 
Non-Biotech -0.06 S-N 0.15 
*p <. 05 
A comparison of Means, test of significance, and Scheffe' 
Multiple Comparison test, for Pre/Post Doctoral employees is 
contained in Table 18. 
The substantial increase in C&G related Pre/Post Doctoral 
positions among the Core is found to be statistically 
significant, as is the decrease in Research positions for 
Support and Core Departments. 
Regarding Faculty, it is important to note that their 
activities are somewhat more difficult to classify than 
Graduate Students. For the Faculty, the difference between 
Instructional and Research FTEs is largely a matter of 
bookkeeping--it is not reflective of a true distinction 
between teaching and research activities. With this in mind, 
it is evident that the official data record of Faculty 
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occupational activities has changed little over the eight year 
period under examination for any of the three departmental 
categorizations. The percentage levels hold relatively 
constant for each of the four occupational activity 
categories, for each of the three departmental 
categorizations. 
With this in mind then, it does appear that increases in 
the level of Instructional activity occur within the Core and 
Non-Biotech groupings during the last two years of data. 
However, these increases are largely offset by decreases 
within the Research category. These alterations were caused 
by a recategorization of state funding expenditures by the 
Office of Institutional Research, and did not reflect a true 
switch from Research to Instruction (according to Iowa State 
University's Office of Institutional Research). 
A comparison of Means, test of significance, and Scheffe' 
Multiple Comparison test for Faculty failed to reflect 
significant findings in any funding category. 
It is also important to note that, while the Merit, P&S, 
and Hourly percentages of PTEs failed to reflect the level of 
overall change present within the Faculty and Graduate 
Student-Pre/Post Doctoral categories (as evidenced in Figures 
10-12), substantial alterations occurred within these 
categories. For example, among Professional and Scientific 
employees in the Core, a proportional drop of approximately 
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15% in Instructional activity occurred between fiscal years 
1983/1984 to 1988/1989 (Table 14). The proportion of C&G 
positions for P&S employees rose by about 21% during the same 
period. Among P&S employees in the Support group. 
Instructional PTEs dropped by about four percentage points 
over the eight years of the data, while C&G increased by about 
14 percentage points (Research and AES PTEs also declined 
during the period--Table 15). The Non-Biotech P&S category 
similarly experienced an eight percentage point drop in 
Instruction, and a 27% increase in C&G PTEs (Table 16). 
A comparison of Means, test of significance, and Scheffe' 
Multiple Comparison test, for P&S employees is contained in 
Table 19. 
Table 19 indicates a statistically-significant increase 
in C&G positions among P&S employees, with this increase most 
pronounced among the Core. 
Among Hourly employees, the same trend towards an 
increase in C&G, and a decrease in Instruction, was present 
among all three of the departmental categories. The trend was 
most pronounced among the Support group, and least pronounced 
among the Non-Biotech group (Tables 14-16). 
A comparison of Means, test of significance, and Scheffe' 
Multiple Comparison test, for Hourly employees is contained in 
Table 20. Once again, the increase in C&G positions is found 
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Table 19. A comparison of beginning and end-point mean 
differences for P&S PTEs, grouped by funding 
category 
Mean Pr>F Scheffe 




































*p <. 05 
to be statistically significant, and most pronounced among the 
Core. 
Of the six occupational groupings (Paculty, Graduate 
Students, Merit, P&S, and Hourly), the only one to experience 
an overall increase in Instructional activity was Merit. 
Within the Core category, the Instructional share of Merit 
PTEs increased by approximately five percent. The 
Instructional share of Support and Non-Biotech Merit PTEs also 
increased slightly (Tables 14-16). A comparison of Means, 
test of significance, and Scheffe' Multiple Comparison test, 
failed to reveal statistically-significant findings among the 
Merit employees. 
An overall analysis of the occupational activity data 
thus reveals that, within the Core, Instructional PTEs reached 
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Table 20. A comparison of beginning and end-point mean 
differences for Hourly PTEs, grouped by funding 
category 
Mean Pr>F Scheffe 




































*p <• 05 
their peak during the 1984/1985 Fiscal Year, when they 
constituted 46.18% of the Core's total occupational activity 
(Figure 14). This percentage dropped to a low of 36% in 
Fiscal Year 1988/1989, but has since rebounded to just over 
40%. Contract and Grant activity has risen dramatically, from 
a low of 24.97% of Core PTEs in 1984/1985 to 38.98% in 
1990/1991. The Research and Ag Experiment Station shares of 
Core PTEs have declined by approximately 5% and 3%, 
respectively (Table 14). 
In the Support category (Figure 15), Instructional 
activity has also dropped significantly, from a peak of 44.85% 
of Support PTEs in 1983/1984, to a low of 36.95% in 1990/1991. 
The Research and Ag Experiment Station share of Support PTEs 
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Figure 14. Gore PTE totals in terms of fund category 
percentages 
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Figure 15. SupportPTE totals in terms of fund category 
percentages 
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Contract and Grant PTEs have approximately doubled, from a low 
of 13.6% of Support PTEs in 1983/1984 to 26.61% in 1990/1991 
(Table 15). 
And, once again, the same trend towards a decline in 
Instruction and an increase in Contract and Grant activity is 
present in the Non-Biotech category, but to a lesser degree 
(Pigure 16). The Instructional share of Non-Biotech PTEs 
dropped from a high of 81% in 1983/1984, to 75.81% in 
1990/1991 (a decline of just over 6 percentage points). 
Contract and Grant activity has risen from a low of 7.79% of 
Non-Biotech PTEs in 1983/1984, to a peak of 15.81% in 
1990/1991 (an increase of just over 8 percentage points). The 
percentage of Research PTEs has declined by about 3 percentage 
points over the eight year period, while the Ag Experiment 
Station has held relatively constant (Table 16). 
A comparison of Means, test of significance, and Scheffe' 
Multiple Comparison test, for all employees is contained in 
Table 21. This Table reflects a statistically significant 
increase of 10.41 C&G positions per department within the 
Core. 
Several basic conclusions are thus apparent from this 
data on occupational type and activity. Pirst, the infusion 
of economic development research funds has had a considerable 
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Table 21. A comparison of beginning and end-point mean 
differences for Total PTEs, grouped by funding 
category 
Mean Pr>F Scheffe 













































*p <• 05 
increase in research-oriented occupations (such as Graduate 
• Students and Pre/Post Docs), and decreases in numbers of 
Faculty. Second, the funds have, also had profound impacts in . 
terms of the occupational activities that employees are 
engaged in. The trend has been towards a substantial increase 
in Contract and Grant-related research activities, and away 
from Instructional activities. And, third, while these trends 
have occurred on a university-wide basis, they have tended to 
be most pronounced among the Core and Support recipients of 
the economic development project funds, and least pronounced 
among departments unrelated to these funds. These figures 
constitute quantitative evidence of an increase in the level 
of C&G research, and relative decline in the level of 
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Instruction, taking place at Iowa State University. 
A third means by which changes in the internal structures 
of the Core and Supporting departments becomes evident is in 
the variety of opinions offered by departmental 
representatives during the interviews mentioned earlier (under 
METHOD OF STUDY). Over the course of these interviews, 
several of the DEOs attempted to convey the qualitative impact 
that these quantitative shifts have had on their departments. 
For example, a Chairperson in one of the Core research 
departments states; 
The most important aspect of the biotechnology funding is 
the competition for start-up funds. We have been able to 
hire good people with the funding, and that definitely 
affects the structure of the department. It also affects 
the nature of the people we hire, so it shifts the 
emphasis of the research they do, and that emphasis has 
shifted dramatically to biotechnology, to the neglect of 
other areas of research. 
The biotechnology money is necessary but not 
sufficient because it restricts the scope of research to 
molecular biology. This may eventually do away with a 
good program on general biology and just leave us with a 
narrower expertise on molecular biology. 
Concern over the changing internal research structures of 
the biotechnology departments was echoed by another Department 
Chair; 
There is a 'have' and 'have-not' community that has 
developed around the biotechnology funding. Even though 
the funding has not been academic, it has had a 
significant role in shaping academic departments. It is 
a loose cannon on our deck... It has shifted 
departments' emphasis to this kind of money, and 
contributed to the reorganization of the biological 
sciences. It also raises questions of the utility of the 
existing structures of departments. 
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Another Chairperson of a Core department underscores 
that, even though this narrowing of research emphases among 
the biological science program at Iowa State may be beneficial 
to his own department, the benefit is indeed of a selective 
nature; 
There is a dichotomy between people doing research at the 
molecular and organismic--or system--levels, and the 
funding has tended to favor the molecular emphasis... The 
funding has had an influence in that it may change the 
description of the positions we have to fill, in order to 
gear it towards that funding, but it's not a problem for 
this department because we fit very well into the 
molecular biology definition. 
In essence, then, some of the interviews conducted with 
the executive officers of the Core and Supporting biotech 
departments lend qualitative credence to the quantitative 
trends evidenced in the PTE data; 1) biotechnology research 
may be achieving the ascendancy at the expense of other, more 
broadly-based, areas of research, and; 2) funding-driven 
research demands are significantly altering the traditional 
status quos of these departments (particularly within the 
biotech Core), through targeted faculty selection and 
resulting shifts in instructional and research emphases. 
In addition to the responses received by departmental 
executives and other departmental representatives, the 
biotechnology researchers themselves offered somewhat 
divergent perspectives on the impact that the biotechnology 
funding has had on their departments. Of the 26 biotechnology 
faculty hired at Iowa State University prior to the 1991-1992 
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academic year, 23 were interviewed by the authors regarding 
their opinions on this, and a variety of other issues (three 
faculty refused to be interviewed). Of those twenty three 
faculty, most were of the opinion that the biotechnology 
project had indeed altered the nature of their departments, 
but in a positive way. Some of the researchers' comments are 
as follows: 
There has been a shift in the emphasis of my department, 
but I see this shift as a good thing. Molecular biology 
is a tool that can be used to study whatever subject you 
want. It was not established at I.S.U. prior to 1986. 
This opposition to molecular biology and 
biotechnology is an antiquated idea. They (referring to 
Non-Biotech faculty) think molecular biology is not 
chemistry, but you can't compete without it. No 
reputable university neglects hiring people who know how 
to do molecular biology. I came here because of people 
doing molecular biology and they can help my research. 
Biotech is a technique--not a research goal. It's a 
tool to look at the same questions we've always looked 
at, like the electron microscope. It's the questions 
we're asking that are important--not the ways we look at 
them. They're just afraid of change (referring to those 
expressing concerns over the possible shift in 
departments' emphases). 
These concerns are not at all valid. This place had 
no molecular biology before this. It's only enhanced 
things. 
The biological sciences are developing a more 
molecular orientation. I think it's very good that this 
is happening. That's where biology is going... Iowa 
State had no molecular biologists before 1986. It's 
really necessary that Iowa State increase in this area if 
it wants to keep its place in the world... It's easier 
to get a grant in molecular biology than other areas, and 
I think other areas get pissed off at molecular 
biologists because of this. 
This university was way behind in molecular biology. 
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and this (the biotechnology funding) has helped to catch 
it up. This is where the exciting science will happen 
over the next ten years... My department is not overly 
focussed on molecular biology. 
Biotechnology funds have hired people we would not 
have otherwise been able to hire. It's something that 
was needed. It brought molecular biology onto campus. 
There are certain areas of science clearly at the 
forefront. If you want to stay in the lead, you have to 
keep up. The biotech money has allowed us to do this. 
This is just a case of sour grapes. Some scientists 
are failing to keep up with the science of the '90s, and 
are not using an integrated approach. If they are not 
willing to use an integrated approach, they can't get the 
money. They are using the science of 25 years ago, and 
they feel that time has passed them by. 
A total of ten of the interviewees were of the opinion 
that structural shifts had occurred in their departments, but 
that these shifts had improved overall departmental quality. 
But, a substantial minority expressed concerns about the 
long-term impact of the project. The following remarks are 
indicative of these sentiments: 
The impact of the biotech money is a very real danger. 
The research going on is now so cellular and so molecular 
that it's almost too basic to find a direct application. 
It's not serving the constituency it's meant for--the 
farmers. And it's expensive in terms of instruments and 
personnel, and the technical support people they have, 
such as lab technicians. So the State has had to come up 
with astronomical salaries and other funds, and that's 
bad for morale. 
I'm biased. I don't think it (the biotech project) 
has had a beneficial effect. This department is breaking 
up into molecular biology and non-molecular biology... 
If it becomes a sole emphasis, this is a problem. 
Yes, this is redirecting departments. I'm not a 
gene jockey, I'm a (occupation stated). Some hires have 
been based on 'where's the most money to be gotten,' 
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rather than 'what's the biggest problem.' 
This university is not in a net growth situation in 
terms of faculty. To the extent that biotechnology 
faculty have been hired, good progress is being made, but 
there is a lack of seed/start-up money for faculty in 
other areas. But this is less a problem with the 
biotechnology program than with not having enough money 
for other areas. 
A total of five interviewees were of the opinion that the 
biotech monies had impacted their departments, and that this 
impact was of a negative nature. 
A third theme was that the money had not really had an 
effect on departments: 
There have definitely not been these types of changes in 
our department. The department is hiring on people from 
diverse areas. The potential for problems is there, but 
it hasn't happened yet. 
I would really differ with those who say that this 
is re-directing departments. Molecular biology is just a 
tool. In the modern world, we must apply all the tools 
we have when we do an examination of something. The best 
scientists use all of the tools that are available to 
them. 
A good scientist must be broadly based. If a 
department just wanted to hire applied people, that would 
be bad. But the biotech people work at very different 
levels. They work together to make a good, general 
department. 
I really don't think it's a problem. I don't like 
to view molecular biology as apart from other science. 
It's a tool and an expensive tool so we need funding for 
it. 
A total of four interviewees were of the opinion that the 
structural impact of the biotech funding was not redirecting 
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the emphasis of departments. 
Four of the researchers declined to respond to this 
question. 
Thus, while many DEOs and researchers either deny that 
the biotech funds have had an impact on their departments or 
believe that the impacts that have occurred are of a positive 
nature, a substantial minority also proposes that the 
increased research emphasis may be narrowing the base of 
instructional and research expertise within their departments. 
Another important finding of the interviews with the 
biotech faculty regards the level of teaching activity in 
which they are personally involved. Interviewees were asked, 
'In percentage terms, how is your job balanced between 
teaching and research activities?' On average, the biotech 
faculty spend 72.44% of their time on research activities, 
while only 27.56% of productive time was devoted to teaching 
activity. 
Having said this, it is also important to note that the 
vast majority of researchers view the biotech 'seed' monies as 
being very successful in helping them to bring in additional 
external research monies. Nineteen of the 23 interviewees 
stated that, based on their own personal experiences, the 
monies had been very successful in this regard; 
Yes--the seed monies to faculty have definitely been a 
success. Most faculty have already more than paid for 
themselves, and from this point on it'll only get better. 
But I don't know if it's really had any impact on the 
239 
economy of the state. 
Putting together federal and private funds, I've 
brought in two times as much as I was given for the 
start-up. Yes, for me it's been very successful. 
In my case, I received $150,000 in start-up funds, 
and brought in about $700,000 in return. I think all of 
the biotech faculty have received outside funding. 
Two researchers stated that they were too new to be able 
to accurately answer the question, while two others expressed 
the view that the monies for the most part "provided pork" to 
older faculty--but that they personally had put start-up 
monies to good use. 
In summary then, it is evident that this study has 
revealed several major findings: 
1) C&G expenditures, reflective of external sources of 
research funding, have experienced dramatic increases in all 
departmental categorizations over the last seven years. These 
increases have occurred in terms of raw dollar amounts, as 
well as the percentage that such funds constitute of overall 
university research expenditures. Departments throughout the 
university have thus developed a greatly increased reliance 
upon external 'contract and grant' funding for their 
operation. 
2) Ironically, the Core departments' overall share of 
university research expenditures has decreased since the 
240 
beginning of the biotech program, indicating a possible 
administrative overestimation of external returns on the 
biotech funds. 
3) Core departments have also experienced a significantly 
reduced level of funding for non-biotech related research. 
While the receipt of the economic development funds has helped 
to cushion the impact of this decrease, it also increases the 
likelihood that Core departments may become structurally 
transformed as a result of these monies. This tendency may 
lead to a much higher level of financial dependence by Core 
departments on the biotech research and monies. 
4) The economic development biotechnology project has had a 
significant impact on recipient departments, primarily in 
terms of bringing about a marked proportional increase in 
research-oriented occupations (such as graduate students), and 
a proportional decrease in faculty. 
5) The occupational activities of employees have also been 
substantially altered, as evidenced by a dramatic increase in 
Contract and Grant-related research activities, and a decrease 
in Instructional activities. 
6) These trends have tended to be the most pronounced among 
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those departments heavily involved in the economic development 
biotechnology project, and least pronounced among non-
participant departments. 
7) There is substantial agreement with the perception that 
some structural transformation has already occurred among 
departments participating in the biotech research effort. 
Many feel the structural changes are positive in nature, in 
that previously-neglected research areas or techniques have 
become highly developed and sophisticated. However, a 
substantial minority of DEOs and researchers are critical of 
the impact that the biotech monies have had on their 
departments, in terms of the creation of divisions among 
faculty and an over-concentration on issues related to 
molecular, rather than organismic, biology. 
8) While both the raw number and proportional percentage of 
faculty has decreased during the period under examination, a 
growing proportion of remaining faculty are very research-
oriented. Students may therefore be negatively affected not 
only in terms of having fewer faculty in departments, but also 
in terms of having this shrinking number of faculty be far 
more focussed on research than teaching. 
9) The vast majority of researchers view the economic 
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development 'seed' monies as being very successful at helping 
them to bring in additional external sources of private and 
public funds. 
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DISCUSSION AND CONCLUSIONS 
There are several theoretical levels from which these 
issues may be analyzed. On a broad level, a primary 
theoretical perspective which sheds considerable light on the 
implementation, operation, and impact of the biotechnology 
research effort at Iowa State University is Robert Merton's 
concept of 'manifest' and 'latent' functions (Merton, 1968). 
Manifest functions are those outcomes, impacts, or 
results that are intended to occur as the result of a given 
action or activity. For example, in the case of the 
biotechnology research effort at Iowa State University, it was 
previously discussed that the fundamental manifest function of 
this effort has been the stimulation of economic development 
within that State. Another manifest function would be the 
development of a research program in an area that is 
acknowledged to stand at the 'cutting edge' of modern 
scientific technology. 
Latent functions, on the other hand, are those outcomes, 
impacts, or results that are not intended or expected to occur 
as the result of a given action or activity. This is not to 
say that latent functions are of a negative nature; they are 
unexpected or unplanned, but positive in nature. For example, 
according to many of the biotech researchers, the I.S.U. 
program in molecular biology was underdeveloped prior to the 
implementation of the biotechnology research effort. While it 
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was not the manifest intent of the biotech appropriations 
package to resolve this apparent shortcoming at the 
university, it has certainly had that effect. Thus, the 
rectification of some structural inadequacies within the 
University appears to have been brought about by these 
appropriations. 
Another form of latent outcome however, is the 
'dysfunction'--an impact that is both unintended, and of a 
negative nature. Ironically, it appears that the fundamental 
dysfunctions that have resulted from the infusion of biotech 
research dollars at Iowa State have been evidenced among those 
departments that were the primary recipients of the money. 
While it is true that these monies have indeed kept the 
research in these departments on the 'cutting edge,' and 
contributed substantively to meeting their on-going budgetary 
and professional needs, it also appears that it may have had a 
variety of negative results for recipient departments. 
A primary problem appears to be that the infusion of 
biotechnology research monies may have enabled the university 
administration to cut other, non-biotech research funds to 
recipient departments (particularly within the Core). Funding 
for non-biotechnology research and personnel in these 
departments has thus decreased considerably during the initial 
three-year implementation of the research effort, as alternate 
sources of non-biotechnology replacement funding have 
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apparently not been received to any substantial degree (Figure 
6, Table 6). So, while departments have benefitted to a 
degree from the receipt of the biotech funds, non-biotech 
funding has decreased dramatically. The concerns voiced by 
some DEOs and researchers regarding the narrowing focus of 
Core departments thus appears to have found quantitative 
grounding in the findings of this study. 
A second possible problem is that there may have been an 
overestimation in the anticipated amount of external funds . 
that would result from the biotech project (at least, in the 
short term) . Two elements of the data lead to this possible 
conclusion. First, there has been a steady decline in total 
biotechnology research expenditures during the three-year 
implementation period (from $2,640,001 in FY 86/87, to 
$2,300,000 in FY 87/88, to $1,019,720 in FY 88/89--according 
to Glenda Webber, former Program Assistant with the I.S.U. 
Biotechnology Council). Second, the Core's proportion of 
overall academic research expenditures has decreased steadily 
during the first four years of the program. This may be 
attributable to a re-direction of general university funds 
away from the Core departments, due to their receipt of the 
biotechnology funds. 
Another dysfunction involves the division of faculty into 
opposing camps. Clearly, DEOs and researchers alike have 
expressed concerns regarding the intra-departmental divisions 
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that have arisen since the beginning of the biotechnology 
program at Iowa State. The general nature of the antagonism 
between the biotech 'haves' and 'have-nots' is apparent in the 
comments listed earlier in the paper. While the impacts of 
such a division are difficult to quantify, the fact remains 
that the presence of such antagonisms are not likely to 
facilitate a positive research or instructional work 
environment. DEOs and other administrators must therefore be 
prepared to dedicate time and effort towards the resolution of 
such divisions, or run the risk of encountering a variety of 
morale-related problems. 
In addition to these issues, it is useful to examine the 
relevance these findings hold in terms of the general concerns 
(university autonomy, financial over-reliance on economic 
development or private funds, etc.) mentioned earlier in the 
paper (under The Biotechnology Research Effort at Iowa State 
University). One of these concerns was that the increased 
trend towards university reliance on external research funds 
would redirect research efforts towards economic or corporate 
need, rather than academic merit. Clearly, the striking 
growth of C&G positions within the university (in nearly all 
occupational categories) lends quantitative credence to 
concerns over the growing influence of external funds. Some 
of the interviews with DEOs and the biotech researchers also 
lend qualitative credence to the concern (e.g., "Some hires 
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have been based on 'where's the most money to be gotten,' 
rather than 'what's the biggest problem'"). 
Another concern was that private interests may attempt to 
restrict the flow of information regarding research results. 
Clearly, the increased reliance on C&G funds indicates that 
concerns over corporate influence on, and the flow of 
information from, university laboratories will grow in 
importance as the research program develops. It must be 
remembered that the seed monies of the biotech program at Iowa 
State have only just taken root. As research efforts develop 
and more corporate monies flow in to support these efforts, 
faculty and administration alike will increasingly have to 
deal with this issue. 
A third concern of a more immediate nature may be the 
growing reliance of universities on these tenuous types of 
funds. Earlier, it was mentioned that a growing number of 
states have become increasingly skeptical of the link between 
university research and economic development. Blumenstyk 
(1992) raises this issue with specific regard for the 
situation in Iowa; 
Some states, including New Jersey and Texas, still 
strongly support their research programs and have 
substantially maintained their financing. And some 
governors, notably Iowa's Terry Branstad, a Republican, 
are proposing budget increases for economic development 
based on university research. But examples of 
disenchantment abound... the states' research-oriented 
programs are suffering because the payoffs are too 
distant, and the programs lack techniques to measure 
their effectiveness in the short term. They also have 
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depended too heavily on support from the governors who 
created them... (p. 24, 25). 
So, while the Governor of Iowa remains a strong ally of 
this approach to research and development, it is clear that he 
is a member of a shrinking minority. Universities benefitting 
from such programs must therefore be wary not only of the 
market fluctuations related to specialized research efforts, 
but also of the political fluctuations that could terminate 
support for such efforts. 
On a similar note, it bears mentioning that the 
biotechnology program at Iowa State has been closely 
associated with the 'earmarking' of federal appropriations 
discussed earlier. In fiscal year 1992 alone, the Department 
of Agriculture awarded $2,865 million to Iowa State's Midwest 
Plant Biotechnology Consortium (to be shared with 17 other 
universities) and $1,953 million, also for an Iowa State 
biotechnology consortium to be shared with the University of 
Iowa and the Iowa Department of Economic Development (Cordes 
et al., 1992). In light of growing political concern with 
earmarking, a heightened reliance on this type of money may 
also put those dependent upon it in a precarious financial 
position. 
A fourth concern was that the shift in research emphases 
created by this type of project may negatively affect 
instructional activities by diverting from the amount of time 
faculty are able to put into them, and by altering the nature 
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of information that research specialists are able to convey to 
their students. The marked decrease in Instructional PTEs and 
increase in C&G PTEs clearly indicates that research 
activities have taken a numerical priority over instructional 
activities. Interviews with researchers also tend to verify 
the validity of this concern, with the average biotech 
researcher putting approximately three times as much time 
and/or effort into research as is devoted to teaching. It 
would also stand to reason that the biotechnology faculty are 
not only more research-oriented than their predecessors, but 
also more specialized in terms of the level of instructional 
expertise they possess. 
A fifth concern dealt with how the status of graduate 
students and faculty may be altered by their affiliation with 
profit-oriented research ventures. While this study did not 
focus specific attention on this issue, it is clear that it 
will be of growing importance as more research projects (and 
the dollars that accompany them) become concentrated in the 
hands of fewer and fewer faculty. Also, as the number of 
graduate students involved in these types of projects grow 
dramatically (as has been the case at Iowa State University), 
the question of their current status within the university 
setting will also grow in importance. 
And, lastly, a sixth concern was that the economic 
development or profit-oriented research may be taking place at 
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the expense of other areas of necessary research. Concern 
over these issues appears to be somewhat vindicated by the 
findings of this study, due to the feeling expressed by some 
DEOs and researchers regarding the priority the biotechnology 
project (with its specializing influence) may be taking over 
the traditional needs of a broadly-based program of scientific 
research and education. And, in quantitative terms, it is 
clear that when overall Faculty PTEs are decreasing, but a 
growing share of the remaining PTEs are allotted towards the 
biotech project. Core Paculty PTE levels are being maintained 
at the expense of more traditional, generalist positions. 
Thus, while some degree of success may have been achieved 
with regard to the manifest functions of I.S.U.'s 
biotechnology research effort (such as keeping the research in 
these departments on the 'cutting edge,' and contributing 
substantially to their on-going budgetary and professional 
needs), it is also clear that latent functions, and 
dysfunctions, have also arisen in the course of this 
implementation, and must be taken into consideration as the 
program continues to develop. 
In terms of taking a more specific theoretical approach 
in analyzing these issues, an organizational theory of 
fundamental relevance in understanding the changing structure 
of Iowa State University (and other universities involved in 
similar ventures) focuses on the issue of strategic management 
251 
and adaptation (Snow et al., 1980; Hrebiniak et al., 1984). 
According to the strategic management approach, 
difficulties in the operational environment of an organization 
force it to adapt by formulating new strategies for operation. 
In order to achieve this, organizational managers assess what 
opportunities and threats are present in the external 
environment, as well as what strengths and weaknesses exist 
within the organization itself. Once such assessments are 
completed, the best fit between external opportunities and 
internal strengths is determined, and new strategies, 
missions, and goals are formulated with the intent of 
preserving optimal organizational operation. 
With these new organizational missions and goals 
formulated, the organization then moves into the second stage 
of its adaptive process--strategy implementation (Hrebiniak et 
al., 1984). Strategy implementation basically involves 
redistributing organizational resources, and implementing 
operational changes, among the various elements within the 
organization; structures, control systems, human resources, 
technology, and corporate culture (Hrebiniak et al., 1984). 
The proposed result of this resource redistribution and 
operational alteration is the attainment of the adaptive 
pattern of operation deemed desirable in the 'strategy 
formulation' process. 
In the case of Iowa State University, it is clear that 
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severe environmental difficulties faced the university as a 
result of budget cutbacks from federal and state sources. 
These cutbacks created the need for an adaptation to maintain 
organizational operation. An external opportunity then became 
apparent to the university, in the form of the growing 
biotechnology industry, and the wide variety of means by which 
this technology could be applied to the agricultural economy 
(or corporate culture) in the state of Iowa. The pursuit of 
this opportunity also matched closely with the internal 
strengths of the university, in that it possesses a high 
capacity for technological research, as well as the human 
resources to undertake such research. 
A 'best fit' of internal strengths and external 
opportunities thus presented itself to university 
administrators, and the state government's appropriation of 
economic development funds allowed this structural adjustment, 
and organizational adaptation, to occur. A clear process of 
interaction is thus evident between four of the five 
organizational elements mentioned above: opportunities present 
in the (1) corporate culture resulted in an internal 
reallocation of resources towards (2) technology and (3) human 
resources, which has had the end result of altering (4) 
departmental structures within the university. 
An important organizational problem with this process 
relates to the manner in which the biotechnology project is 
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regarded by differing elements among the university. Shanklin 
et al. (1981) describe how the market share and growth 
potential of a venture may influence its receptivity by an 
organization. When a venture involves a new or rapidly-
expanding share of a given market (as is the case with 
biotechnology), it tends to receive a high organizational 
priority in terms of resource allocation. However, on-going 
ventures in mature markets (such as non-biotechnological 
research efforts in the Core and Support departments) tend to 
be of a lower organizational priority. Often, such efforts 
are used as 'cash cows' to finance newer ventures, or--if they 
fail to bring in substantial or comparable profits--may be 
considered for divestment. 
This issue clearly relates to the apparent division that 
has occurred between many of the faculty in the Core and 
Support departments. DEOs and researchers alike have 
expressed concerns regarding the intra-departmental divisions 
that have arisen since the beginning of the biotechnology 
program at Iowa State. The general nature of the antagonism 
between the biotech 'haves' and 'have-nots' is apparent in the 
comments listed earlier in the paper. 
Neilsen (1968) addresses the fact that scarce resources 
in an environment such as an academic department will tend to 
throw competing groups into conflict with one another. 
Factors related to inequity (e.g., unequal rewards, an unequal 
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distribution of power, and the uncertainty that may result 
from such factors) also serve to exacerbate existing conflicts 
(Daft, 1988) . In the case of the biotechnology project at 
Iowa State University, such conditions are present in that the 
new biotechnology faculty receive substantial salaries, 
'start-up' funds, and equipment costs from the state, while 
the older, non-biotechnology faculty members are subject to 
the same budgetary restraints that apply to other members of 
the university who are not involved in 'star' ventures. 
While the impacts of this division are difficult to 
quantify, the fact remains that the presence of such 
antagonisms are not likely to facilitate a positive research 
or instructional work environment. DEOs and other 
administrators must therefore be prepared to dedicate time and 
effort towards the resolution of such divisions, or run the 
risk of encountering a growing body of morale-related 
problems. 
A broader organizational problem relates to the 
previously-mentioned reformulation of strategies, missions, 
and goals that organizations use to adapt to difficulties in 
their operational environment. Once again, it must be pointed 
out that instruction and research are the primary functions of 
the university. And while it is true that the adaptive 
processes implemented by universities such as Iowa State have 
provided financially-strapped departments with the financial 
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means to survive, it may also be narrowing the body of 
teaching and research expertise within these departments. The 
university has therefore survived as an organization by 
adapting to environmental difficulties, but it has been (and 
is being) transformed by this process--with its primary 
functions of teaching and research apparently becoming 
secondary as a result. 
It is therefore clear that some of the trends evidenced 
in the development of I.S.U.'s biotechnology program--whether 
they be labelled dysfunctional, or the products of adaptation 
to environmental hardship--may well be of a long-term 
detriment to the general functioning of the university. If 
the goals of the biotechnology program therefore work to the 
ultimate detriment of Iowa State University (in terms of 
negatively altering the disciplinary integrity of recipient 
departments, damaging the capacity for instruction, or 
altering the nature and direction of research), some degree of 
debate regarding the full extent and advisability of this 
course of organizational change should be undertaken. 
Therefore, with these concerns in mind, several questions 
result from the findings of this study: 
1) If one of the primary purposes of the university is to 
create new knowledge, when does a university administration 
determine that this creation process has become overly 
influenced, restricted and/or specialized by conditional 
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funding sources external to the university (such as private 
investments or economic development appropriations)? 
2) At what point does the nature of research become so 
focussed on one area of specialization that it actually serves 
as a detriment to the general character of a department? 
3) At what point do participating departments become altered 
by external forces to such a degree that they no longer meet 
the needs they were originally intended to meet? 
4) If another primary purpose of the university is to impart 
the knowledge it creates, at what point does the emphasis on 
research impinge upon the ability to convey knowledge in terms 
of numbers of personnel allocated to perform that function? 
5) Along this same line, at what point does the emphasis upon 
research impinge on the ability or motivation displayed by 
such personnel to carry out the instructional function 
effectively? 
6) And, if universities are to become increasingly reliant 
upon external research monies {public or private) for their 
operation, does this reliance present a danger if the projects 
and their funding are focussed in an area, on an industry, or 
from a source that is itself in a tenuous state? In other 
words, is it wise to tie the operation of our public 
universities this closely to the fluctuations and 
uncertainties of the marketplace or the ballot box? 
These are all questions that Iowa State University will 
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eventually have to answer as a result of its involvement in 
the biotechnology research program, and the overall shift 
towards research. 
With these questions in mind, it must also be said that 
it is not the intent of this paper to propose that the 
biotechnology project at Iowa State University, or other types 
of economic development projects around the country, are of no 
worth. Projects of this nature may provide many useful 
insights and breakthroughs that are of great importance to the 
long-term health of our economy and society. Indeed, over the 
course of the interviews conducted with the biotechnology 
researchers at Iowa State, the author was very impressed both 
with the quality of the researchers brought into the 
university, and the potential positive impact that their 
research may eventually have. 
However, while the positive aspects of such programs tend 
to receive much attention and fanfare, their possible 
detriments often remain unnoticed or ignored. As such 
programs grow in size and number, we must therefore be wary of 
the fact that there may be negative--as well as positive--
implications for the universities and states that follow this 
program of economic development. The clear finding of this 
research is that universities participating in such an effort 
must be on guard for the structural changes that may result 
from it. As Jacobson (1991) states: 
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Whatever may happen to the overall economy in the mont'hs 
ahead... it is already clear that higher education will 
never return to the boom days of the 1980's. At a 
minimum... many institutions--both public and private--
are headed for a probing reassessment and realignment of 
what they can or should be, whom they should serve, and 
how they should attempt to handle all the tasks expected 
of them. (p. 1). 
Universities must therefore come to terms with the nature 
of the economic and political changes facing them. It is true 
that academic activities--namely, teaching and research--may 
be seriously impaired by the kinds of budget cutbacks 
experienced in recent years. Research-oriented, economic 
development funds may thus alleviate the pressures created by 
budgetary restrictions, and allow academic institutions to 
continue operation in the manner to which many of them have 
grown accustomed. However, it must also be realized that 
utilizing universities for purposes such as economic 
development, or altering the motivation, style, and basic 
direction of academic research may create long-term patterns 
within the operation of the university that stray considerably 
from past methods of operation. Whether such deviations are 
of a desirable nature should therefore be debated, and the 
lessons learned through the experiences of universities such 
as Iowa State should serve to clarify matters for both sides 
of this debate. 
259 
REFERENCES 
Agresti, Alan, and B. Finlay 
1986 Statistical Methods for the Social Sciences. San 
Francisco: Dellen Publishing Company. 
Amatniek, Joan C. 
1983 "College Biotechnology Programs on the Rise." 
Bio/technology 4 (No. 8): 467-468. ' 
Bagnall, Roger S. and J. Hench 
1983 "Are We Prepared for the Technological Revolution in 
Scholarly Research?" Change (July/August): 38-42. 
Begley, Ronald 
1992 "U.S. Research Budget Applauded, but with Caveats." 
Chemical.Week 150 (Feb. 12): 7. 
Berlowitz, Laurence, R. Zdanis, J. Crowley, and J, Vaughn 
1981 "Instrumentation Needs of Research Universities." 
Science 211 (March 6): 1013-1018. 
Blumenstyk, Goldie 
1992 "States Re-Evaluate Industrial Collaborations Built 
Around Research Grants to Universities." The 
Chronicle of Higher Education XXXVIII (No. 25): 1, 
24-25. 
Caldart, Charles 
1983 "Industry Investment in University Research." 
Science, Technology, and Human Values 8 (No. 2): 
24-32. 
Champion, Dean J. 
1975 The Sociology of Organizations. New York: 
McGraw-Hill. 
Cordes, Colleen and J. Goodman 
1992 "Congress Earmarked a Record $684-Million for Non-
Competitive Projects on Campuses." The Chronicle of 
Higher Education XXXVIII (No. 32, April 15): 1, 26, 
31. 
Cuiliton, Barbara J. 
1983 "Academe and Industry Debate Partnership." Science 
219 (January 14): 150-151/ 
260 
Curry, James and M. Kenney 
1990 "Land-grant university-industry.relationships in 
biotechnology; A comparison with the non-land-grant 
research universities." Rural Sociology 55: 44-57. 
Fehr, Walter 
1987 Letter to Dr. David Kline, Chairman of the Iowa 
State University Bioethics Committee. Dated 9/16. 
Hrebiniak, Lawrence G. and W. Joyce 
1984 Implementing Strategy. New York: Macmillan. 
Iowa, State of 
1986 Laws of the Seventy-First General Assembly. Chapter 
1207: 295-296. 
Jacobson, Robert L. 
1991 "Academic Leaders Predict Major Changes for Higher 
Education in Recession's Wake." The Chronicle of 
Higher Education XXXVIII (No. 13, Nov. 20): 1, 35-
36. 
Jaspers, Karl 
1959 The Idea of the University. Boston: Beacon Hill 
Press. 
Juma, Calestous 
1989 "The Gene Hunters: Biotechnology and the Scramble 
for Seeds." Princeton University Press. 
Kish, Leslie 
1965 Survey Sampling. New York: Wiley Press. 
Kotz, Samuel, and N. Johnson (eds) 
1982-88 The Encyclopedia of Statistical Sciences. New York: 
Wiley Press. 
Kumar, A. 
1989 "Clouds gather over the biotech industry." Wall 
Street Journal (Jan. 30): Bl, B5. 
Lacy, William B., and L. Busch 
1989 "Changing division of labor between the university 
and industry: The case of agricultural 
biotechnology.": 21-50 in J. Molnar and H. Kinnucan 
(eds.) Biotechnology and the New Agricultural 
Revolution, American Association for the Advancement 
of Science Symposium Series. Boulder: Westview 
Press. 
261 
Lacy, William B., L. Lacy and L. Busch 
1988 "Agricultural Biotechnology Research; Practices, 
Consequences, and Policy Recommendations." 
Agriculture and Human Values 5 (No. 3): 3-14. 
Lamont, Ann 
1989 "The Chase for Venture Dollars." Bio/technology 7 
(No. 10): 1026-1028. 
Landis, Phillip S. 
1988 "Industry and academia; A vital interface." 
CHEMTECH 18 (No. 3): 156-159 
Lomasky, Loren E. 
1988 "Public money, private gain." CHEMTECH 18 (No. 12): 
716-718. 
Lundeen, Robert W. 
1988 "Private initiatives in public policy." CHEMTECH 18 
(No. 4); 214-217. 
McGourty, Christine 
1989 "NIH restricts university links with industry." 
Nature 341 (No. 6239); 173. 
Merton, Robert K. 
1968 Social Theory and Social Structure. New York: Free 
Press. 
Moses, P.B., J.E. Tavares, and C.E. Hess 
1988 "Funding agricultural biotechnology research." 
Bio/technology 6 (No. 2):. 144-148. 
Neilsen, Eric H.. 
1968 "Understanding and Managing Intergroup Conflict." 
Administrative Science Quarterly 12: 296-320. 
Omenn, Gilbert 
1982 "Re-Energizing the Research University." 
Environment 24 (No. 6): 49-51. 
Pisano, Gary 
1990 "The R&D Boundaries of the Firm; An Empirical 
Analysis." Administrative Science Quarterly 35: 
153-176. 
Rauch, Lee 
1989 "Surviving the Funding Gap." Bio/technology 7 (No. 
5): 435-442. 
262 
Reichel, Brian J., P. Lasley, W. Woodman, and M. Shelley, II 
1988 ."Economic Development and Biotechnology: Public 
Policy Response to the Farm Crisis in Iowa," 
Agriculture and Human Values V (No. 3): 15-25. 
Ritzer, George 
1983 Sociological Theory. New York: Alfred A. Knopf. 
Roberts, Edward and D. Peters 
1981 "commercial innovation from university faculty." 
Research Policy 10: 108-126. 
Roberts, Leslie 
1983 "Reconciling Academic Ideals with Financial 
Realities." Bioscience 33 (No. 3): 159-162. 
Rosenberg, Stewart B. 
1988 "Foundations Offer Funding Opportunities." 
Bio/technology 6 (No. 6): 502. 
Rule, James B. 
1988 "Biotechnology: Big Money Comes to the University." 
Dissent (Fall): 430-436. 
Seabrook, Jeremy 
1991 "Biotech Bondage." New Statesman and Society 4 (May 
10): 17. 
Shanklin, William L. and J. Ryans, Jr. 
1981 "Is the International Cash Cow Really a Prize 
Heifer?" Business Horizon 24: 10-16. 
Shao, Maria 
1991 "How Stanford is pushing Profs back to the 
Classroom." Business Week (No. 3214): 126. 
Shelley, Mack C., II, W. Woodman, B. Reichel, and P. Lasley 
1988 "On the Role of Universities and Biotechnology in 
Economic Development and Public Policy." Policy 
Studies Journal 17 (Fall): 156-168. 
Shulman, Seth 
1987 "Academia, Inc." Technology Review 90 (No. 8): 11-
12. 
Snow, Charles C. and L. Hrebiniak 
1980 "Strategy, Distinctive Competence, and 
Organizational Performance." Administrative Science 
Quarterly 25: 317-335. 
263 
Spalding, B.J. 
1988 "Industry will bolster U.S. R&D." Chemical Week 142 
(No. 1, 2): 7-9. 
Stevens, Charles J. 
1981 "Preventing Unnecessary Intrusions on University 
Autonomy: A Proposed Academic Freedom Privilege." 
California Law Review 69: 1538-1568. 
1982 "Universities, profit and research." Nature 296 
{March 4): 1. 
U.S. Congress, Office of Technology Assessment 
1986 Technology, Public Policy, and the Changing 
Structure of American Agriculture, OTA-F-285, 
Washington, D.C.: U.S. Government Printing Office, 
March. 
Worthy, Ward 
1989 "Iowa Tries to Capitalize on Biotechnology R&D 
Capabilities." Chemical and Engineering News 67 




(by college and department title) 
AG=College of Agriculture 
BS=College of Business 
DS=College of Design 
ED=College of Education 
FCS=College of Family and 
Consumer Science 
AG Economics 
AG Ag Education 
AG Ag Engineering 
AG Animal Ecology 
AG Center for Agriculture and 
Rural Development 
AG Family and Consumer Science 
AG Food Crops Center 
AG Journalism 
AG Meat Export Center 
AG Meat Irradiation Center 
AG Seed Science Center 
AG Sociology and Anthropology 







BS Transportation and 
Logistics 
DS Architecture 
DS Art and Design 
DS Community and Regional 
Planning 
DS Landscape Architecture 
ED Elementary Education 
ED Industrial Education 
ED Physical Education 
ED Professional Studies 
ED Secondary Education 
ED Research and Statistics 
EG Aerospace Engineering 
EG Biomedical Engineering 
EG Bridge Engineering Center 
EG Civil and Construction 
Engineering 
EG EECpE 
EG=College of Engineering 
SH=College of Science and 
Humanities 
VM=College of Veterinary 
Medicine 
EG Engineering Science and 
Mechanics 
EG Freshman Engineering 
EG Industrial Engineering 
EG Material Science and 
Engineering 
EG Mechanical Engineering 
EG Nuclear Engineering 
FCS Child Development 
FCS FCS Education 
FCS Family Environment 
FCS HRIM 
FCS Textiles and Clothing 
SH Computer Science 
SH Earth Sciences 
SH Economics 
SH English 
SH Foreign Language and 
Literature 
SH History 






SH Political Science 
SH Psychology 
SH Sociology and Anthropology 
SH Speech Communication 
SH Statistics 
VM Biomedical Engineering 
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INTRODUCTION 
Ever since the 1950s, there has been a global attempt to 
heighten agricultural productivity through the "intensification" 
of farming methods. Means of achieving this intensification 
include production specialization, organizational 
centralization, and the utilization of production-enhancing 
technologies, such as chemicals or feed additives (Sainsbury, 
1979). Agricultural production has thus undergone a 
modernization process not unlike that experienced by non-
agricultural sectors of the economy, whereby increased 
production and consumption yields higher profits for producers, 
as well as lower prices and a higher availability of goods for 
consumers. 
A new variable in this growing trend has been the invention 
and dissemination of products utilizing recombinant DNA (rDNA) 
technology. Though this technology is relatively new, it has 
already contributed to production enhancement in a variety of 
ways. One fundamental application of rDNA technology involves 
heightening the capacity of plants and/or animals to create 
useable goods. Probably the most important example of such an 
application has been the creation of Bovine Somatotropin, or 
bST--a drug designed to enhance milk production in cows. A 
study conducted at Cornell University by a group of economists 
and animal scientists suggested that milk production could be 
heightened by at much as 25% in cows treated with BGH (Hansel, 
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1986). A report by the Office of Technology Assessment (1986) 
also projected a 25.6% increase in milk production after the 
adoption of bST, and predicted that almost all farmers would 
eventually come to use the hormone (OTA, 1986) . 
While this particular application of agricultural 
biotechnology involves enhancing the ability of the plant or 
animal to create more product, the second application involves 
enhancing the producer's ability to create more plant or animal. 
In other words, by capitalizing upon the ability of products 
such as growth hormones to speed growth rates and enhance growth 
capacities, producers have sought to heighten their own capacity 
to create more product per animal or plant. A good example of 
this utilization of biotechnology is the development of the 
growth hormone porcine Somatotropin, or pST. The incorporation 
of pST into a hog-producing enterprise increases the rate and 
capacity of weight gain in treated animals, reduces feeding 
time, and increases the overall turn-around rate of pig 
production (Kliebenstein, 1989). 
A third manner by which biotechnology is proposed to hold 
considerable promise is in its potential to protect and improve 
plant and animal health. Biotechnological techniques have 
produced promising vaccines related to the control of 
pseudorabies, hoof and mouth disease. Rift Valley fever, 
trichinosis, mastitis, and a variety of other viruses and 
disease-producing organisms (CAST, 1986). With the help of 
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biotechnological advancements, the toll incurred by these 
diseases and many others may be dramatically reduced in the 
future. Medical applications of agricultural biotechnology may 
also contribute to increased animal production through the 
prevention of loss of life due to injury, still-birth, premature 
death, and others. 
Biotechnology may also serve to alter the reproductive 
capacities of plants and/or animals. Seidel (1989) states that; 
In the next several years we can expect to see animals with 
genes from other species, offspring from either two female 
or two male parents, and animal clones numbering in the 
thousands. These creatures will resist diseases better, 
reproduce more efficiently, grow faster, and yield higher 
quality products, (p. 42). 
A final means by which it is proposed that biotechnology 
may improve agricultural production is through its potential to 
decrease the cost of plant and/or animal production by obtaining 
higher rates of product output for lower levels of input (e.g., 
nitrogen fixing and improved feed conversion efficiency). For 
example, 80-85% of the nutrients consumed by cattle are from 
"forages" (crops harvested by grazing animals or harvested 
mechanically and fed or stored as hay or silage-- CAST, 1986). 
Since the systemic breakdown of forages is primarily caused by 
microorganisms in the animals' rumen, it could become possible 
to enhance the capabilities of such organisms so that they 
perform these functions more efficiently, resulting in more 
product for the same level of forage or feed (CAST, 1986) . 
Thus, it becomes possible to maintain--or even increase--current 
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production levels while simultaneously lowering the level of 
feed input for animals (Kliebenstein, 1989; CAST, 1986; Riepe, 
1989) . 
In light then, of this wide variety of potential impacts on 
agricultural production, some have proposed that biotechnology 
may play an important role in protecting the rural economy from 
events such as the widespread farm recession of the early-to-mid 
1980s--and restore health to those sectors that still suffer the 
aftereffects of that period. Indeed, some have come to feel 
that agricultural applications of biotechnology may well serve 
as a panacea by which the ails of the rural economy may be 
largely alleviated. Rule (1988) states that; 
Agricultural applications (of biotechnology) could well 
rival the medical in long-term economic and social impact. 
Genetic engineering offers the prospect of altering crops 
and livestock to fit human needs and environmental 
constraints. This can mean animals that grow faster or 
remain invulnerable to normally endemic diseases, of plants 
that thrive under normally inhospitable conditions. 
Success in even a small portion of the agricultural 
ventures now being attempted could have sweeping effects on 
food production--including significant benefits for farmers 
and consumers... (p. 431) 
In recent years, many farmers have also expressed 
considerable hopes regarding the possible affect that 
biotechnology may have on their operations. The 1987 Iowa Farm 
and Rural Life Poll revealed that approximately 60% of farmers 
polled believed it would be desirable if biotechnology brought 
an improved standard of living to most farm families, while only 
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5% of those polled responded negatively to the question (Lasley, 
1987) . 
As a result of this largely positive perception of 
biotechnology, considerable effort has been put into examining 
the role that biotechnology may play in spurring economic 
development and/or recovery in the nation's rural economy. 
Indeed, over the last decade many economic development projects 
around the country have sought to use technological research--
and biotechnological research in particular--as a means by which 
to promote economic development in rural as well as industrial 
economic sectors (Blumenstyk, 1992). Biotechnology has thus 
become a tool for a variety of economic development projects 
around the country. It is the intent of this paper to examine 
one such project in particular, and to gauge whether the initial 
optimism regarding its implementation has remained intact. 
The Role of Biotechnology in Economic Development 
Due to these promising preliminary efforts utilizing 
recombinant DNA technologies, as well as a desire to maintain 
the healthy operation of this nation's rural economy, federal 
and state governments, as well as a variety of private sector 
interests, have begun to invest heavily in research focussing 
upon genetic engineering and agricultural biotechnology. 
In 1988 for example, the federal government was spending 
approximately $2.7 billion dollars annually for basic research 
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in biotechnology (Lacy et al., 1988). While only $150 million 
of that money was earmarked specifically for the development of 
agricultural biotechnology, the National Research Council's 
Board on Agriculture recommended in 1988 that this level of 
funding be dramatically increased over a very short period of 
time, to approximately $500 million annually by 1990 (Moses et 
al., 1988). 
A good example of the involvement of state governments in 
agricultural biotechnology is that of the State of Iowa's 
funding of a comprehensive program of biotechnology research and 
development. In 1985, the Iowa Development Commission, at the 
behest of the Seventy-first Iowa General Assembly, allocated the 
sum of $10 million to the State's Board of Regents, public 
universities, and/or independent colleges to explore the 
potential for biotechnological industries, and their products, 
to assist in the recovery of Iowa's ailing rural economy (Laws 
of the Seventy-first General Assembly, 1986 session: 295-296). 
After initial investments began to show promise, additional 
biotechnology monies were appropriated to the State's 
universities to further develop their growing proficiency in the 
field. As a result, biotechnology has now become an area of 
research expertise in many academic departments at the State's 
universities. 
The cornerstone of this effort in Iowa has been Iowa State 
University, a land-grant institution with an enrollment of 
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approximately 25,000 students. In fiscal year 1985, the Iowa 
General Assembly allocated $500,000 to Iowa State University for 
the purpose of agricultural biotechnology research. Additional 
appropriations were to follow, with the allocation of $3.75 
million in 1986, and $4.25 million each for fiscal years 1987, 
1988, and 1989 (Laws of the Seventy-first General Assembly, 1986 
session). Projects resulting from these appropriations have 
included the development of new biodegradable plastics, 
technologies for using cholesterol reductase to produce animal 
products with lower cholesterol content, and molecular and 
genetic techniques for the isolation of maize genes to control 
crop yields (among many others- Worthy, 1989). 
With the explicitly-stated mission of the project being 
economic development, Walter Fehr, Chairman of the Oversight 
Committee of the Iowa State Biotechnology Council, describes the 
means by which this goal is to be achieved; 
With regard to the vision for biotechnology at Iowa State 
University, our ultimate goal is to use the new techniques 
of molecular biology to enhance the economic welfare of the 
state. We believe that this will occur through research in 
three primary areas; (1) the development of new products 
from our traditional commodities through bioprocessing; 
(2) improving the efficiency and profitability of crop and 
livestock production; and (3) development of new products 
and processes through the genetic modification of plants, 
animals, and microorganisms. The vision of Iowa State 
University's biotechnology program is strongly influenced 
by the desire to fully utilize the agricultural resources 
of the state for the welfare of its constituents. (Fehr, 
1987). 
In order to bolster the effectiveness of this 
research-centric approach to economic development, technology 
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transfer networks have also been put in place at I.S.U. These 
networks are designed to enhance the speed and accessibility 
with which innovations may be transferred from the lab to local 
industries desirous of the new biotechnological advancements 
(e.g., an Eastman Kodak fermentation plant in Cedar Rapids, a 
Cargill biotechnology facility in Eddyville, and a Ajinomoto 
Heartland Lysine feed-additive plant, also located in Eddyville, 
Iowa--Worthy, 1989). 
The transfer of biotechnological innovation from the 
laboratory to the marketplace has thus followed a clear and 
logical progression: technological breakthroughs have occurred 
as a result of basic research in universities; these 
technological innovations and breakthroughs spark business 
interest and investment; applied research and development occurs 
in order to create an investment payoff; products are created 
and marketed by business and industry, and put to use by farmers 
and other agricultural producers. 
State policy makers have appeared to be content with the 
results of the biotechnology-grounded economic development plan. 
Iowa's General Assembly has extended appropriations for the 
operation of the Biotechnology Council, and for the entire 
program of biotechnology research, beyond the initial three-year 
implementation period. In assessing the general effectiveness 
of the project, the state's governor, Terry E. Branstad, states. 
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Iowa is turning biotech breakthroughs into business success 
stories. Partnerships between private industry and Iowa's 
two world-class research universities are resulting in 
innovative products and economic progress. {Worthy, 1989). 
Governor Branstad has even proposed budget increases for 
economic development projects based on university research like 
that taking place at Iowa State (Blumenstyk, 1992). 
The effort to stimulate economic development through the 
creation of the biotechnology program at I.S.U. therefore 
appears to have met with a substantial degree of success. But 
it is important to note that this type of project may have very 
different results for those at different stages or levels of the 
economic development process. While local industries may be 
satisfied with increased levels of profit and/or production, and 
the state government may be pleased with the increased revenues 
resulting from these profits, questions have arisen as to 
whether the project has had, and will have, a beneficial result 
for those it was originally intended to help--the state's 
farmers. These questions have focussed on several key issues. 
The fundamental concern related to the development of 
biotechnology is the general increase in production that will 
result from its use. Whether such increases take the form of 
higher milk production, higher yields, faster growth rates, more 
growth capacity, etc., it is clear that the ability to produce 
more product per plant or animal through the utilization of 
biotechnology may drastically alter current methods and 
standards of production (Riepe and Martin, 1988; Fallert, 1987; 
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Mix, 1987; Hayenga, 1989; Hansel, 1986; and many others. • 
For example, with specific regard to the utilization of 
bST, Alper (1987) states; 
Bovine growth hormone, which is slated to come on the 
market in 1988, should increase milk production by about 
30%. Yet dairy farmers are already plagued with surplus 
milk. So most farmers see little need for a product that 
will result in further surpluses, (p. 60). 
Thus, to economic sectors in which supply is short and 
demand is strong, such production-enhancing technologies would 
be highly welcome and beneficial to producers as well as 
consumers. However, when supply is strong and demand is static, 
the productive enhancement may be of a detrimental nature. And 
this detriment may not be limited to the farmers. The initial 
lowering of costs due to overproduction may at first appear 
attractive to consumers. However, if prices drop too far, a 
system of government subsidization may be required, with funding 
for such subsidization obtained at the taxpayers' expense 
(Alper, 1987; Hayenga, 1988; Wohlgenant and Lemieux, 1988) . 
A second, more specific set of concerns has been raised 
with regard to the effect of biotechnological production 
practices on small farms and the rural way of life. Patrick 
Madden and Paul Thompson (1987) illustrate the manner by which 
farmers may be acting to their own economic detriment through 
the widespread adoption of biotechnological means of production 
enhancement ; 
.1.dislocation associated with new technology may be 
associated not with the scale or type of technology, but 
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with the rapidity with which a farmer is able to adopt it. 
Early adopters reap profits, but as many adopt and prices 
go down, adoption becomes a necessity in order to remain 
competitive, and many who cannot afford to adopt the 
technology are forced out of farming... If this picture is 
correct, farmers themselves may be the agents with greatest 
causal responsibility for changing farm structure, (p. 103-
104) . 
DuPuis and Geisler (1988) further summarize that; 
...large farms would adopt the technique first, reaping 
innovators' benefits. And smaller farms would be left to 
make ends meet in an environment of lower milk prices and 
more expensive dairy technologies. Some of the small farms 
would be expected to go out of business, (p. 408) . 
Kalter (1985) , similarly observes the potential for an 
eventual elimination of low-yield dairy farms from the 
productive environment, and discusses; 
...the necessity to design policy to encourage the orderly 
exodus of resources, including farmers, from dairying. 
Gary Comstock (1988) therefore concludes that. 
To the extent that potentially displaced dairy farmers have 
done nothing for which they ought to be punished; to the 
extent that the research establishment has clearly favored 
large producers in its development of techniques and 
technologies; to the extent that fiscal, monetary and 
economic policies have disadvantaged small dairy producers; 
and to the extent that bOH will only exacerbate the unjust 
consequences of the past; to that extent we ought to oppose 
this particular biotechnology, (p. 49). 
Considerable attention has also been devoted to this issue 
by Alper (1987); Pimentel et al. (1989); Fox (undated); Buttel 
(1988) and many others. 
A third, and closely related, set of concerns was raised by 
Kliebenstein (1989) , in an examination of the way in which 
various subgroup populations within the agricultural industry 
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would be affected by the widespread utilization of 
biotechnology. For example, through a combination of price 
reduction from increased production and product improvement 
through the lowering of fat and cholesterol content, pork 
producers may come to recapture the health-conscious and price-
wary consumers that currently purchase poultry or fish products. 
It is also pointed out that biotechnological products may result 
in uneven impacts upon feed producers, for example, through 
heightening the demand for high-protein feeds such as soybeans, 
and decreasing the demand for traditional feeds such as corn. 
Alper (1987) therefore states that: 
Although pig farmers will benefit, grain farmers will be 
hurt, as PGH-treated pigs will consume less grain. And if 
consumers eat more pork, they will buy less beef, chicken 
and other meats, thereby hurting producers of these 
commodities, (p. 60). 
How though, have these concerns been received among the 
farmers who stand to be affected by them? Earlier, it was 
stated that a 1987 poll of Iowa farmers indicated high 
expectations regarding the impact that biotechnology in general-
-and the economic development biotech project in Iowa in 
particular—would have on that state's farming operations. But 
clearly, the biotechnology industry is very new, and changing at 
a very rapid rate. It stands to reason that, just as this 
industry is developing and changing at a rapid rate, as farmers 
continue to gain experience with the pace, applications, and 
impacts of biotech research, their perceptions of biotechnology 
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may also change at a rapid rate. 
Reichel et al. (1988) describe the manner in which farmers' 
perceptions of the potential of biotechnology may be greatly 
affected by the kinds of concerns just described; 
...farmers appear to mediate their support for economic 
development initiatives and university biotechnology 
research through their perceptions of the actual 
consequences of biotechnology research. Hence, farmers are 
not quite so apt to recognize economic development 
initiatives and biotechnology research as solutions to . 
state and local concerns without first taking into account 
the effects of biotechnology on their productive 
capacity... farmers are only willing to support economic 
development strategies, especially biotechnology research,• 
to the extent they can be made to appear relevant to their 
particular situation. Farmers' support of economic 
development and biotechnology is dependent, to some degree 
on the extent to which it is rationalized as being an 
appropriate strategy, (p. ) 
When concern is raised that agricultural biotechnology may 
create the kinds of problems discussed above (overproduction, 
displacement, and the like), it essentially stands to reason 
that the popular perception of biotechnology will be filtered 
through the heightened awareness of these possible consequences. 
In light of the rapidly changing nature of the 
biotechnology industry, increased attention and research into 
the potential detriments of biotechnological development, and an 
increased awareness on the part of farmers regarding these 
matters, it is the hypothesis of this study that farmers' 
attitudes towards biotechnology will reflect a growing degree of 
skepticism and concern regarding the likely impacts of the 
economic development biotechnology project in Iowa. 
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An important aspect of this study is also that Iowa 
farmers' changing perceptions of agricultural biotechnology is 
not only of benefit or relevance to the state of Iowa. In light 
of the vast nature of biotechnology, and the incredible 
diversity of practical applications for which it may be used, it 
is evident that all states—and all nations--stand to be 
affected by its development. The situation in Iowa therefore 
serves as a case-study by which the general dynamic of this 
development process may become more fully understood. 
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METHOD OF STUDY 
The primary mechanism by which this issue shall be examined 
is the Iowa Farm and Rural Life Poll. The Iowa Farm and Rural 
Life Poll (IFRLP) is an annual survey of approximately 3,500 
randomly selected farm operators within the state of Iowa. The 
IFRLP if funded by the Iowa State University Agriculture and 
Home Economics Experiment Stations, and the Cooperative 
Extension Service. It provides a representative sample of Iowa 
farmers based upon a statistical comparison with the 1987 Census 
of Agriculture (Lasléy et al., 1990). 
As has been previously discussed, respondents to the Iowa 
Farm Poll were first questioned regarding their opinions on 
biotechnology, and the biotechnology research effort at Iowa 
State University, on a 1987 survey. At that time, respondents 
were asked to rank their opinions on a variety of possible 
impacts of biotechnology on a five-point scale, including: 'Very 
Desirable,' 'Desirable,' 'Uncertain, ' 'Undesirable,' and 'Very 
Undesirable.' The results appeared to indicate some hope that 
biotechnology would provide solutions to many problems currently 
facing agricultural producers. 
Many of the same questions regarding farmers' opinions of 
biotechnology asked on the 1987 survey were then repeated on the 
1991 Iowa Farm Poll. The 1991 Poll was sent to a random sample 
of 3,461 farmers in Iowa. Usable responses were numbered at 
2,095, resulting in a response rate of 61 percent. On the 1991 
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survey, respondents were asked to rank their opinions on the 
desirability of a given outcome on a five-point scale, with 
responses including: 'Strongly Agree,' 'Agree,' 'Uncertain,' 
'Disagree,' and 'Strongly Disagree.' Due to this alteration in 
question format (from measuring perceived desirability in 1987 
to personal agreement of desirability in 1991) response 
variations may reflect either a change in the response category, 
or a change in the assessment of biotechnology (Lasley, 1991). 
For this reason, caution should be used in drawing any direct 
comparisons between the two sets of responses. 
A second mechanism by which the agricultural impact of 
biotechnology is gauged is to measure the opinions not of those 
for whom the products of biotechnology are targeted, but those 
who play a large role in the creation of those products--
university researchers. As has been said, Iowa State University 
has been a cornerstone in the economic development biotechnology 
project in that state. Prior to the 1991/1992 academic year, 26 
biotechnology faculty had been hired at the university in 
conjunction with this effort. Of these 26 researchers, 23 were 
interviewed by the author regarding their opinions on some of 
the likely or eventual impacts their research may have on the 
Iowa farming community--and the rural sector in general 
(interviewees were questioned on a variety of other issues as 
well). Three faculty refused to be interviewed. 
The findings of this study thus represent a methodological 
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triangulation, in that the perceived or anticipated impacts of 
the biotech project in Iowa—and biotechnology in general--are 
being viewed from the perspectives of the creators, as well as 
the likely consumers, of these products. 
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FINDINGS 
A summary of the findings of both the 1991 and 1987 surveys 
is contained in Table 1. Regarding the 1991 results, less than 
half of the respondents (47%) held agreement with the statement 
that biotechnology would assist in finding new uses for crops 
and livestock--which would in turn assist in solving the problem 
of farm surpluses. An even smaller minority (31%) agreed with 
the statement that biotechnology would help to improve the 
standard of living for farm families. .A majority of respondents 
(53%) also agreed with statements that biotechnology would lead 
farmers to become more dependent upon large corporations, and 
benefit large producers more than persons on small and middle-
sized farms (61%). 
On the positive side, varying majorities held agreement 
with statements that biotechnology would eventually promote 
nitrogen fixation in corn (57%), increase the efficiency of feed 
conversion in livestock production (77%), allow farmers to 
become less dependent on agricultural chemicals (60%), and 
assist in promoting sustainable agriculture (54%). 
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Table 1. Questions and response rates from the 1987 and 1991 
Iowa Farm and Rural Life Polls 
strongly Strongly 
Agree Agree Uncertain Disagree Disagree 
Percent 
a. Biotechnology will help solve the problem of farm surpluses by finding new uses for crops 
and livestock 
1991 7 40 34 18 2 
1987* 32 29 29 5 4 
b. Through genetic changes, new varieties of corn will be able to fix their own nitrogen from 
the atmosphere, thus reducing the need for commercial fertilizer 
1991 11 46 37 6 1 
1987* 50 31 13 4*1
c. Research in biotechnology will increase the efficiency of feed conversion in livestock 
production 
1991 8 69 21 2 0 
1987* 26 46 20 6 2 
d. Biotechnology will bring improved levels of living for most farm families 
1991 4 27 50 16 3 
1987* 32 28 34 2 3 
e. Biotechnology will enable farmers to become less dependent upon agricultural chemicals 
1991 8 52 31 8 1 
1987* 52 29 15 2 1 
f. Biotechnological research will assist the movement towards sustainable agriculture 
1991** 5 49 36 9 1 
g. Biotechnology will lead farmers to become more** dependent upon large corporations for many 
of their inputs, such as seeds, growth hormones, and feed additives 
1991 7 46 33 12 1 
1987* 2 7 18 38 35 
h. Advances in biotechnology will probably benefit persons with large farm operations more than 
persons on middle-sized and small farms 
1991 16 45 22 15 2 
1987* 2 8 25 31 33 
i. Confinement livestock producers will benefit more from biotechnological research than non-
confinement livestock producers 
1991** 6 33 45 15 1 
j. Concern over the treatment of animals will be an increasingly important consideration in 
biotechnological applications 
1991** 13 49 30 7 1 
*— 1987 response categories were: l=very desirable; 2=somewhat desirable; 3=uncertain; 
4=somewhat undesirable; 5=very undesirable. 
**— Items were included only on the 1991 survey. 
***— 1987- this item was worded less dependent. 
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Beyond this descriptive analysis, the ten questions 
described in Table 1 were factor analyzed using a varimax 
rotation of the extracted factors (Harman, 1976). Two factors 
were generated; one dealing primarily with the specific 
potentials of biotechnology (containing questions a-f in Table 
1), and the other dealing primarily with the threat 
biotechnology may present to small and medium-sized agricultural 
producers (containing questions g-j in Table 1) . Reliability of 
the two scales was evaluated using Cronbach's Alpha (Cronbach, 
1951). 
The scale containing variables a-f (relating to the 
potentials of biotechnology) was determined to have a non-
standardized Alpha of .77, and was therefore retained for 
correlation and regression analyses (Yl). The scale containing 
variables g-j was determined to have a non-standardized Alpha of 
.53, and was therefore not retained for further statistical 
analysis. However, three of the individual items within this 
factor retain their theoretical importance in understanding the 
overall perception farmers hold towards the potential impact of 
biotechnology; g--dependence on corporations (XI); h--benefit to 
large farmers (X2), and; i--benefit to confinement operations 
(X3). Three basic demographic factors also hold importance for 
an overall analysis of farmers' perceptions of biotechnology: 
age of Farm Poll respondent (X4) ; educational level of the 
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respondent (X5); and farm size, in number of acres (X6). 
A correlation analysis of the relationships of these 
factors is contained in Table 2. 
Table 2. Correlation matrix for fairmers' perceptions of the 
potential outcomes of agricultural biotechnology 
Y1 XI X2 X3 X4 X5 X6 
yi 1.0 
XI -.1448** 1.0 
X2 -.2395** .4542** 1.0 
X3 .0324 .1524** .2637** 1.0 
X4 .0266 -.1134** -.1488** -.0969** 1.0 
X5 -.0664** -.0049 .0408 -.0109 -.3236** 1.0 
X6 -.0587** .0300 .1167** .0449* -.1750** .1692** 1.0 
*-- significant at the .05 level 
**— significant at the .01 level 
Yl=fanners' views on potential of biotechnology 
Xl=biotech will increase fanners' dependence on corporations 
X2=biotech will provide more benefits to large farms 
X3=biotech will provide more benefits to confinement producers 
X4=age 
X5=educational level 
X6=farm size (per number of acres) 
The two factors that have the greatest impact on farmers' 
perceptions of the potential of biotechnology (Yl) are their 
perceptions of whether biotechnology will make them more 
dependent upon large corporations (XI), and whether it will have 
a greater benefit for larger farms (X2). Both of these 
relationships are negative, statistically significant, and in 
the weak-to-moderate range. Fears over dependence on 
corporations are also moderately correlated with concerns over 
greater benefits for larger farms (.4542) and weakly correlated 
with the belief that biotechnology would result in greater 
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benefits for confinement producers (X3--.1524). Both of these 
relationships were positive, and statistically significant. The 
three demographic factors included in the analysis (age--X4; 
education level--X5; and size of farm by acres--X6) held some 
statistically-significant relationships with the other 
variables, but they were generally of a weak to very weak 
nature. 
A path-model regression utilizing these variables was also 
constructed, where independent variables included age (X4), 
educational level (X5) , and farm size by acres (X6) . 
Intervening variables included concern over dependence on large 
corporations (XI), fear that biotechnology would result in 
greater benefits for larger farms (X2), and the belief that 
biotechnology would favor confinement producers (X3). The 
dependent variable (Yl) consisted of the first factor described 
earlier, regarding general perceptions of the potential impacts 
of biotechnology. Overall, the path analysis failed to reveal 
impressive findings (Table 3). 
Generally speaking, while many of the regression 
calculations yielded statistically-significant findings, these 
findings were of a very weak nature. The notable exception 
arises when examining the relationship between farmers' 
perceptions of biotechnology and fears that it will result in 
greater benefits for larger farms. This relationship is 
statistically significant, of moderate strength, and negative. 
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Table 3. Regression analysis of factors related to farmers' 
perceptions of the potential outcome of biotechnolgy 
research (standardized Beta scores indicated) 
Dependent Variable 





X4 -.040 -.133** -.139** -.105** 
X5 -.062** -.049* -.021 -.049* 
X6 -.025 .015 .088** .039 
*-- significant at the .05 level 
**— significant at the .01 level 
Yl=farmers' views on potential of biotechnology 
Xl=biotech will increase farmers' dependence on corporations 
X2=biotech will provide more benefits to large farms 
X3=biotech will provide more benefits to confinement producers 
X4=age 
X5=educational level 
X6=farm size (per number of acres) 
On the whole then, these findings indicate that Iowa 
farmers have substantial concerns over the affect biotechnology 
may have upon their farming operations. In basic descriptive 
terms, the raw data clearly indicates that farmers are concerned 
that biotechnology may have a negative affect on their standard 
of living, threaten their independence from corporate influence 
or control, and result in an inequitable distribution of 
benefits from its use. More advanced statistical tests then 
reveal that overall opinions regarding the potential of 
biotechnology tend to be filtered through these concerns--with 
the result being a more negative opinion of biotechnology in 
general, and a more skeptical opinion of the affect it will have 
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on their lives. 
As was discussed earlier, a second mechanism by which this 
study seeks to examine the impact of biotechnology on the rural 
economy is to also gauge the opinions of those who are creating 
the products that will result in these impacts--the university 
researchers. Ironically, many of these researchers appear to 
share farmers' concerns regarding the uneven impact of 
biotechnological products. 
Researchers were asked, "Will advances in biotechnology 
benefit persons with large farm operations more than persons on 
middle-sized and small farms?" Somewhat surprisingly, almost 
half of the researchers responded positively to this question. 
The following are indicative of their responses; 
Some products have really been a disaster, because they've 
been so expensive. Yes, from what I've seen so far, people 
with more money are going to get more benefit from this. 
Yes, this is a concern. The best opportunity to take 
advantage of biotechnological innovations will be for large 
wealthy growers and agribusinesses. 
Some of the products coming out will be very 
expensive. Yes, if this is the case there may be some 
unequal benefits for the people with more money to buy the 
products. 
Biotechnology goes against those who can't afford it. 
You need access to the technology if you're going to use 
it. 
Yes, the initial expense on products will be high, but 
eventually these costs come down, and then the impact evens 
out some. 
Eleven out of the twenty-three biotechnology researchers 
interviewed felt that this unequal impact was a real concern for 
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the biotechnology industry and agricultural producers. 
Ten researchers responded that they simply didn't know if 
there would be a problem with uneven or unequal impacts: 
They (the biotechnology companies) will have to decide 
this. I don't know. It's up to them. 
This question doesn't arise at my level. It arises 
at the level of the companies selling seeds--the seed 
companies. Whether thev out-price individuals would have 
no connection with anything I do. 
I'm not well informed on it. The big companies are 
the ones who are into it... It's part of the current 
system and biotechnology won't really change it. 
Only two of the researchers responded that this issue has 
little merit. One of these researchers explains that: 
...there'll be no real difference in impact. For 
example, vaccines would be very cost effective, and provide 
access for all that need them--even in Third World 
countries. 
The biotechnology researchers were asked a second question 
of relevance to this study: 'Will biotechnology lead farmers to 
become more dependent upon large corporations for their 
production inputs, such as seeds, growth hormones, and feed 
additives?' Seven researchers responded affirmatively to the 
question: 
I think I'm a Philistine--! don't really think about these 
things. It depends on the demand--if it's small it leads 
to a bigger problem. And it can depend on the company. 
Some companies just have better ethics than others. I think 
it's quite possible. It sounds like another one of the 
seedier aspects of capitalism. 
Yes, I see a danger in this. Especially if there's 
a connection between the company that produces, for 
example, the corn strain and the herbicide, I'm not 
totally opposed to that system, but it has to be monitored. 
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Yes, this could be a problem, but it's not a problem 
limited to biotechnology. It's just the economic system as 
a whole, and it's a bigger question than biotech. 
In some cases, yes. In an area where you have very 
few producers—say two to three percent--controlling about 
90% of the industry, there could be a problem. But with a 
product like vaccines, it wouldn't be a problem. 
Nine of the biotechnology faculty felt that overdependence 
on companies or agribusinesses is not a real concern: 
No. There are too many different mechanisms to produce 
these things, and other companies would simply do it. So 
there wouldn't be a problem with overreliance on one 
company or business. 
There won't really be a significant impact. There are 
so many companies out there that farmers can jump around 
from one to the other. 
This won't be a problem in our work. Different 
companies have it (the means for biotechnological 
production) so others can reproduce products. 
Biotechnology is a basic science that can be applied in 
many ways. 
Seven of the researchers responded that they did not know 
if biotechnological products would increase the dependence of 
farmers on companies. 
The responses of the biotechnology researchers thus lend 
credence to some of those issues raised by farmers in the Iowa 
Farm Poll. The possibility of unequal benefits, as well as of 
an increased reliance/dependence on corporate entities in the 
rural economy, were both acknowledged by a substantial minority 
of the researchers to be valid concerns for the rural sector. 
Farmers and researchers alike are thus in an apparent state of 
agreement that the impact of biotechnology on the rural economy 
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of Iowa may not be of the wholly positive nature some have 
perceived or promoted it to be. It may therefore be wise for 
rural economies in states and countries around the world to make 
note of the situation currently developing in Iowa, and take 
some heed as to the affect biotechnology may eventually have on 
them. 
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DISCUSSION AND CONCLUSIONS 
A theoretical framework that holds considerable relevance 
in explaining the development and impacts of the economic 
development biotechnology project in Iowa is multiple-
constituent theory, or the 'constituency approach' (Connolly et 
al., 1980). The basic proposition of this approach is that an 
overall assessment of any venture (such as the biotechnology 
program in Iowa) is very difficult to achieve, in light of the 
fact that a wide variety of groups or constituents will 
experience vastly divergent benefits and drawbacks as the result 
of a given project. Each constituency essentially has a 
different criterion for assessing project effectiveness, since 
each constituent group will have a different set of interests, 
concerns, or expectations related to a project. With this in 
mind, it is clear that a variety of constituent groups are 
involved with the biotechnology project in Iowa: state 
government, local industries, universities, farmers, and 
possibly others. 
As has been previously stated, many officials of the state 
government in Iowa appear to be very pleased with the 
preliminary outcomes of the biotechnology project. In a state 
currently facing severe budgetary problems, the prospect of 
increasing revenues by lowering the rate of unemployment, 
increasing industrial profits, and improving farm production 
(all supposed outcomes of the economic development project) 
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holds much appeal. It also bears mentioning that a vested 
interest of many of those involved in state government is re­
election. Should the project proven to have been a waste a 
considerable amount of the taxpayers' money, this interest would 
have certainly suffered. 
With regard to local industries, there is some evidence to 
indicate that production has at least begun to benefit from the 
preliminary results of the research taking place at institutions 
such as Iowa State University. There also appears to be 
optimism that, as the program continues to develop, profit and 
production levels will either maintain or increase growth 
levels. Therefore, with increased profits being a clear 
expectation of this constituent group, some grounds exist for a 
positive--albeit tentative—assessment of the biotechnology 
project. 
The university system in Iowa has also benefitted to a 
substantial degree (at least, in financial terms) from the 
biotechnology effort. While the primary intent of the 
biotechnology appropriations was the stimulation of general 
economic development, the university system in Iowa served as 
the primary means by which this plan of economic development was 
to be carried out. Therefore, while the biotechnology 
appropriations were designed to assist the farming the 
industrial sectors of Iowa's economy, they also served to 
provide much-needed financial support to Iowa's public 
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universities in a time of severe financial difficulty. The 
glowing assessments of program officials such as Walter Fehr 
(described earlier) clearly demonstrate the positive view many 
university administrators hold towards the project. 
These constituents—the state government, industrial 
producers, and the university system--thus appear to have 
benefitted from the implementation of the economic development 
research program in Iowa, and appear to hold positive views 
regarding its continued operation and potential social and 
economic impacts as a result. 
However, it must be remembered that it was for the benefit 
of the farmers of the state of Iowa that the biotechnology 
project was supposedly established. Earlier, several majpr 
concerns related to the agricultural impacts of biotechnology 
were discussed (the potential for overproduction, displacement 
of small farms, disruption of the rural way of life, and 
negative secondary impacts on various subgroup populations in 
the agricultural industry). The fundamental concerns raised by 
farmers in this study—that biotechnology may have a negative 
affect on their standard of living, threaten their independence 
from corporate control, and provide large producers with 
disproportionate benefits--are closely related to these issues, 
and lend considerable credence to those who have raised them. 
These findings also lend credence to the claim that those 
for whom the biotechnology project was to have the most benefit 
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have in fact received little benefit from it, and may even 
suffer long-term detriments as a result of its development. 
Based upon the findings of this study, it therefore appears that 
the farmers of Iowa--as a constituent group--hold considerable 
skepticism regarding the alleged benefits of the biotechnology 
project, and are in fact fearful of the long-term implications 
it may hold for their way of life. 
The biotechnology project in Iowa has therefore created a 
considerable dilemma: several powerful constituent groups that 
were to have been secor^dary beneficiaries of the project appear 
to hold positive assessments of its impacts, while the primary 
constituent group for which the project was originally intended 
appears to have received little benefit from it, and may 
ultimately be harmed by it. It is evident that the assessments 
of the former constituents have taken priority over the 
assessment of the latter, in light of the continued growth and 
development of the project. 
Summary 
The relatively recent introduction of biotechnological 
products to the farming sector has to date rendered a full 
analysis of its possible social, economic, environmental, and 
other impacts difficult to ascertain. Many cursory 
investigations have taken place, touching on a wide variety of 
economic, social, environmental and ethical concerns. The 
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results of the cumulative body of these analyses remain somewhat 
unclear: some purport that biotechnological advancements in 
agricultural production will result in a nearly universal 
benefit to the overall society in which we live, while others 
see a tremendous potential for harm in the utilization of such 
technologies. 
We have, for the most part, already received the 
assessments of governments and businesses regarding the 
implications of the economic development biotechnology program. 
However, in measuring the concerns of farmers, a somewhat 
different--and more skeptical--assessment of this program 
appears to be evident. This assessment is lent some credence 
through its apparent corroboration by some of the researchers 
involved in the biotechnology project. It is thus clear that, 
while this biotechnologically-grounded program of economic 
development may be of benefit to some, it may not necessarily 
hold equal benefits for others. Proponents of, and participants 
in, such a program must therefore take this fact into account 
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The research contained in this dissertation demonstrates 
that any public program or policy may have a wide variety of 
impacts-- intended as well as unintended. 
With regard to the organizational impacts discussed in 
Papers 1-3, it is evident that universities around the nation 
have become increasingly desperate for alternative sources of 
funding as traditional sources of funds have decreased 
considerably. The need for funding is real, and the effort to 
attain it is valid. However, we as a society must acknowledge 
the transforming effect that alternative funding sources-- and 
the specialized or targeted research projects that accompany 
them-- may have upon the general structure of our 
universities. Against the historical backdrop of the 
traditional role and purpose of the university, we must 
examine whether this transformation may hinder universities 
and colleges from performing the social functions they were 
originally intended to perform. 
With regard to the social impacts discussed in Paper 4, 
it is clear that the rural economy-- as well as the economy in 
general-- is in need of technological and structural 
improvements if it is to retain its effectiveness in today's 
extremely competitive international environment. Efforts to 
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assist the rural economy such as that undertaken in the state 
of Iowa are indeed admirable in their intention to achieve 
this end. However, one must also focus careful scrutiny on 
such efforts, to insure that they are indeed bringing such an 
end about. Should the effort to assist the rural sector 
ultimately result in its long-term disruption, then the 
positive intentions behind such an effort are of little worth 
or consequence. 
However, as has been stated several times throughout this 
dissertation, it is not my intent to propose that the 
biotechnology project at Iowa State University, or other types 
of economic development projects around the country, are of no 
worth. Projects of this nature may provide many useful 
insights and breakthroughs that are of great importance to the 
long-term health of our economy and society. Hopefully, this 
will be the end result of the biotechnology project in Iowa. 
As Rule (1988) states; 
"The conclusion one must finally accept regarding 
biotechnology is scarcely that it should not be pursued, 
nor indeed that it should never be pursued within 
university settings. It is that its pursuit must not be 
allowed to erode those special qualities of openness to 
new ideas and primacy of intellectual values that make 
universities distinct." (p. 436). 
So, I would argue, should the application of 
biotechnology not be allowed to erode the traditional aspects 
of rural life and the rural economy that make them equally 
distinct. 
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While biotechnology therefore shows considerable promise 
to positively affect our society in a wide variety of ways, we 
must also be on guard for the possible detriments that may 
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